Expression of Toll-Like Receptor 3 in the Preterm Brain after White Matter Injury:A Post-Mortem Study Applying Immunohistochemistry and In Situ Hybridisation by Vontell, Regina Theresa
This electronic thesis or dissertation has been 











The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 
 
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT                                                                         
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 
International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to: 
 Share: to copy, distribute and transmit the work  
 
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any 
way that suggests that they endorse you or your use of the work).  
 Non Commercial: You may not use this work for commercial purposes. 
 No Derivative Works - You may not alter, transform, or build upon this work. 
 
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 








Expression of Toll-Like Receptor 3 in the Preterm Brain after White Matter Injury




Download date: 28. Dec. 2017
  
  
Expression of Toll-Like Receptor 3 in 
the Preterm Brain after White Matter 
Injury: A Post-Mortem Study 
Applying Immunohistochemistry and 





Regina Theresa Vontell/ 1260464/1 
 
A thesis submitted for the Degree of Doctor of Philosophy in the School of Imaging 




Centre for the Developing Brain, Perinatal Imaging & Health 





Toll-like receptor-3 (TLR3) has been identified in a variety of intracellular structures of 
cells and has been shown to detect viral molecular patterns and damage-associated 
molecular patterns (DAMPs). This study investigates the cellular and subcellular 
localization of TLR3 and its downstream signaling pathway in post-mortem brain 
sections from preterm infants (26-32 weeks; gestational age) with and without white 
matter injury (WMI) pathologies. These results were compared with a sheep model of 
fetal inflammation by the administration of intravenous bolus infusion of either 
Escherichia coli lipopolysaccharide (LPS) or saline at 102.5 +/- 0.5 days of gestation, 
analyzed 10 days post insult. 
In this study, we utilised double-labeling immunofluorescence techniques and in 
situ hybridization to identify the protein and messenger ribonucleic acid (mRNA) 
expression of TLR3. Furthermore, we assessed astroglia, microglia, oligodendroglia, 
neuronal populations and growth cone structures in the periventricular white matter, 
cortex, thalamus and in the posterior internal capsule. Additionally, we explored the 
TLR3 colocalisation with endosomal and phagosomal compartments. We hypothesise 
that after WMI or LPS exposure has occurred, the localization and activation of TLR3 
alters in grey matter structures. 
We observed an increase in TLR3 mRNA expression in the WMI cases and the LPS 
exposed sheep compared to the controls.  Moreover, mRNA translated into TLR3 protein 
expression that was more diffuse in WMI cases. We confirmed that in the WMI cases, 
there was an increase in TLR3 colocalisation with the endoplasmic reticulum and with 
the autophagosome suggesting that autophagy may be a response to stress associated with 
WMI. Furthermore, we show that growth cone structures and neuronal densities are 
altered in WMI cases.  
Identifying changes in TLR3 expression during fetal development may improve our 
understanding of disturbances seen in neuronal migration and reduced volumes of grey 
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 Preterm Birth 
Preterm birth is the number one cause of newborn death and in 2012, in England 
and Wales alone, 7.3% of live births were preterm (Statistics, 2014). Globally, 15 million 
babies are born preterm every year, equating to 1 in 10 births (WHO, 2014). The World 
Health Organisation classifies preterm birth according to the gestational week (GW) of 
development at the time of birth. The classification of preterm birth (< 38 GWs); includes 
extremely preterm (< 28 GWs), very preterm (28 to 32 GWs) and moderate to late preterm 
(32 to 37 GWs) (WHO, 2014). Preterm babies that survive are at increased risk of illness, 
cognition problems, such as reading, math disabilities (Johnson et al., 2009, Marlow et 
al., 2005), and movement disorders. The movement disorders are usually in the form of a 
cerebral palsy, (Bax et al., 2005) a disorder that affects muscle tone, movement, and motor 
skills (see Figure1.1). Aetiologies associated with the increase in preterm birth include; 
increased maternal age, a greater use of infertility treatments and an increase in the 
incidence of infection (WHO, 2014, Salmaso et al., 2014). Comorbid with these factors 
are maternal illnesses such as diabetes and high blood pressure (Statistics, 2014). The 
survival rate following preterm birth has increased since 1995, but the pattern of major 
neonatal morbidity and the proportion of survivors affected remains unchanged (Costeloe 
et al., 2012). Analysis of post-mortem immature or developing brains enables an in-depth 
investigation of the broad spectrum of injuries following preterm delivery and thereby an 





 Injury to the developing brain 
Following preterm delivery, the brain shows sebsequent alterations in normal patterns of 
corticogenesis (Lagercrantz, 2010). Axons formed prior to and during the timing of the 
preterm birth are vunerable due to an enhanced changing susceptibility of the immature 
oligodendrocytes (cells that make the myelin sheaths that wrap around the axons; see 
section 1.11) (Dean et al., 2011, Favrais et al., 2011). The compensatory mechanisms that 
the preterm brain demonstrates to promote regeneration and recovery of the neurons, 
axons and oligodendrocytes after an injury is under intense investigation (Vaccarino and 
Ment, 2004). The most common injuries to the preterm brain are germinal matrix 
haemorrhage-intraventricular haemorrhage (GMH-IVH; with and without parenchymal 
infarctions) and periventricular leukomalacia (PVL), now termed within the spectrum of 
white matter injury (WMI) or as encephalopathy of prematurity (Zubiaurre-Elorza et al., 
2011, Volpe, 2008). GMH-IVH involves bleeds within the prolific region, germinal 
matrix (GM) or the thick cellular layer of immature cells located under the ependymal 
lining of the ventricles (Volpe, 2008).  GMH-IVH is graded according to the extent of the 
haemorrhage (see Figure 1.1) as it can rupture into the ventricles, occupy the lateral, third, 
and fourth ventricles or result in periventricular venous infarcts and subsequent 
hemorrhage into the surrounding white matter (Volpe, 2008, Lagercrantz, 2010).  
Periventricular venous infarction occurs adjacent to the ventricle and is characteristically 
wedge-shaped on ultrasound (Ballabh, 2014). Non-cystic WMI’s include punctate lesions 
in the periventricular white matter (PVWM) that may be overtly haemorrhagic (Volpe, 
2009, Niwa et al., 2011) and are visible as high-signal intensity on T1 weighted magnetic 
resonance imaging (MRI) sequences (low S1 on T2). However, these lesions are not 
visible  routine cranial ultrasonography during the neonatal period (de Vries and Volpe, 
2013). The diffuse white matter abnormalities are thought to consists of astrocytosis and 
microgliosis, that lead to maturational deficits of the axons and white matter  (de Vries 
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and Volpe, 2013). It is imperative to understand the normal development of the human 
immature brain to appreciate the complexities of GMH-IVH and WMI as both injuries 





 Figure 1.1 Patterns of preterm brain injury 
 Drawing A represents the most frequent documented regions of injury in the preterm 
brain. In WMI the injury involves the periventricular white matter above the ventricles 
and below the subcortical regions. Whereas in germinal matrix haemorrhage (GMH), 
the injury is localised in the germinal matrix (grade 1) or in GM and intraventricular 
region (GMH-IVH; grades 2 or 3) or in the GM, intraventricular region and 
surrounding white matter (grade 4). Drawing B illustrates the usual symmetrical 
lesions seen in WMI that affects the motor pathways; mainly the lower limbs (blue 






 Neuronal migration  
Neurons migrate in a succession of waves but follow two basic migration paths, either 
radial or tangential (Volpe, 2008). Radial migration is used by projection neurons, which 
originate in the dorsal region of the subependymal germinative zone or the ventricular 
zone (Lagercrantz, 2010). In the early GW’s (7-10 weeks) the radial progenitor cells 
generate clonally related neurons before they migrate into the more superior regions of 
the subventricular zone, intermediate zone, subplate zone, cortical plate and marginal 
zone (Volpe, 2008) (see Figure 1.2). The glutamatergic neurons from the radial migration 
will mature into two main morphologies the pyramidal cells, and the spiny stellates 
(Sequerra et al., 2010, Volpe, 2008). In the mature cortex, pyramidal somata are situated 
in layers 2–6 and spiny stellates’ are mainly located within layer 4 of primary sensory 
areas (Harris and Shepherd, 2015). See Figure 1.4. 
 Radial migrating neurons use the radial glia as a guide for migration using an amoeboidal 
movement along the entire length of the radial extension from the ventricular zone to their 
ultimate position of the cortical plate (Volpe, 2008, Leviton and Gressens, 2007). Around 
13-25 GW’s radial neurons will have translocated through the intermediate zone (an area 
where afferent axons grow (Volpe, 2008)) and travel to the cortical plate (Wang et al., 
2010). Between 19-25 PCW, the immature cortex or the cortical plate, begins to show 
signs of lamination. The most superficial layer, which will develop into the marginal 
zone, contains bipolar neurons with apical dendrites that bifurcate or fork into branches, 
throughout the marginal zone and downwards into the cortical plate (Volpe, 2008). The 
thick, lower part of the cortical plate is an area containing immature pyramidal neurons 
that have two thick main dendrites with small side branches. The six-layer structure only 
becomes visible after 26 PCW (Vasung et al., 2010, Counsell et al., 2007). The granular 
layer IV, becomes more prominent around 26 PCW as the pyramidal neurons somata 
begin to enlarge with extensive arborizations (Erzurumlu et al., 2006, Molnar and 
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Blakemore, 1995) that project to the upper cortical layers. Layer III, contains 
glutamatergic cells arranged in columns with somata that have long apical dendrites that 
spread into the marginal zone (Marin and Muller, 2014). Layer I has Cajal Retzel cells 
that are important for the laminar patterning of the brain, which send linear projections 
downward into the cortex (Volpe, 2008). See Figure 1.2 and Figure 1.4. 
During the second trimester, neurons will also migrate to the subplate region (an area 
below the cortical plate and above the intermediate zone) and make contact with incoming 
axons, other subplate neurons and cells in the cortical plate (Erzurumlu et al., 2006). The 
subplate is visible using MRI on T2 sequences as an intense band at 23 GA weeks (Wang 
et al., 2010) and is abundant in hyaluronic acid complexes, glia and blood vessels 
components (Judas et al., 2005). The subplate will continue to develop into a subcortical 
white matter network and its growth is concurrent with the cortex until the third trimester 
when it gradually decreases in size and have more of a patchy appearance (Wang et al., 
2010).  See Figure 1.2. 
The tangentially migrating neurons also translocate in a succession of waves and are 
composed of mainly gamma-aminobutyric acid (GABA) interneurons (Erzurumlu et al., 
2006, Sultan et al., 2014). The GABAergic neurons originate from the ganglionic 
eminence and migrate tangentially across the radial glial fibers (Kolasinski et al., 2013, 
Marin and Rubenstein, 2001). Similar to the radial migratory neurons,  most GABAergic 
neurons will translocate through the subplate plate before reaching the cortical 
plate(Arshad et al., 2015). These GABAergic neurons have a variety of shapes and sizes 
and will form dendritic arborizations that innervate distinct portions of the glutamatergic's 
dendrites, somata or axonal segments (Somogyi and Klausberger, 2005, Clowry, 2014). 
GABAergic interneurons follow guidance cues from the extracellular matrix and express 
distinct proteins that are particular to the region of origin. For instance, medial ganglionic 
eminence neurons are positive for parvalbumin and somatostatin (Sultan et al., 2014, 
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Clowry, 2014); caudal ganglionic eminence neurons express calretinin and neuropeptide 
Y (Wonders and Anderson, 2006). The interneurons differ in shape (e.g., basket or 
bipolar) and have different points of contact on the glutamatergic neurons (direct somata 
contact or dendritic cuff targeting) and are produced well into the third trimester of 
gestation (Wonders and Anderson, 2006, Arshad et al., 2015). 
 GABAergic neurons use the enzyme glutamic acid decarboxylase (GAD) to 
decarboxylate glutamic acid to form GABA. The GAD gene exists in two forms GAD 65 
and GAD 67, which are localised in secretory synaptic vesicles or plasma membrane 
respectively (Siegel, 2006). GABA transmission is coupled to two distinct classes of 
receptors GABAA (ionotropic receptor) or GABAB (metabotropic receptors) (Siegel, 
2006, Sherman et al., 2006). Once the inhibitory GABAergic neurons make synaptic 
contact with the excitatory glutamatergic projection neurons, they modulate by reversing 
the membrane potential of the glutamatergic neuron. Modulation of the relay neurons 
works by silencing neighboring relay neurons to ensure a strong signal message (fast-
spiking relay) reaches the cortex (presynaptic inhibition) and by resetting the action 
potential of the relay neuron (postsynaptic inhibition) (Sherman and Guillery, 2013).  
Animal models of preterm birth and human post-mortem studies of brains with WMIs 
show a reduction of both migratory populations of cortical neurons (Dean et al., 2011, 
Vontell et al., 2013b) and specifically of inhibitory neurons in cortical layer VI and in the 
subplate (Robinson et al., 2006, Leviton and Gressens, 2007). Moreover, preterm infants 
with GMH-IVH show a reduction of proliferation proteins in the ganglionic eminence, 
which may explain why there is a decrease in cerebral volume and impaired brain 
development (Del Bigio, 2011, Ball et al., 2015). Comorbid with neuronal loss is a 
perturbation of the supporting oligodendrocytes and astroglia (Salmaso et al., 2014). 
Certain areas in the developing PVWM contain a complex grid referred to as crossroads, 
which is an area of projection (afferent and efferent), commissural (callosal), and 
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associative ipsilateral cortico-cortical fibers (Judas et al., 2005). Crossroads areas are 
vulnerable targets after WMI, which leads to a complex involvement of different motor, 
sensory, and associative systems (Judas et al., 2005). These studies highlight the need to 
test the hypothesis that GMH-IVH and WMI seen in preterm birth are associated with 
excessive death of migrating neurons and an increse in microglia (Leviton and Gressens, 
2007). However, further studies need to determine whether decreased cortical volumes 
result from neurons; having a lack of proliferation in the GM, expressing excessive 
apoptotic signals during migration, or being exposed to cytokines released from glia (i.e., 


























































































































































































































































































































 Growth cones 
During migration and formation of processes, neurons have an elongated structure 
referred to as a  growth cone that is expandable and motile. The growth cone is the tip of 
a leading branch of the neuron that surveys the extracellular environment and guides the 
neuron to its destination (Gordon-Weeks, 2000). Growth cone structures also assist in 
elongating axons and dendritic processes. Growth cones are primarily made up of α and 
β microtubules organised into parallel bundles by microtubule-associated proteins 
(MAPs) (Conde and Caceres, 2009). During neuronal development, a flexible 
cytoskeleton allows for neuronal plasticity should a leading end be severed.   
The growth cone is a wrist-like structure organised into two domains of polymerisation. 
The C-domain, the area where the microtubles fan out, is important to redirect the 
cytoskeleton and thereby aid the flexibility and mobility of the growth cone wrist. In the 
P-domain, the lamellipodia, the microtubules become de-fasciculated. The microtubules 
will eventually align alongside the F-actin bundle forming the tip or filopodia that will 
project past the flattened lamellipodia (Conde and Caceres, 2009, Gordon-Weeks, 2000). 
Synaptic connections in axons and dendrites form by capture of the microtubular proteins 
linked with endbinding proteins at the end point of the P domain. The microtubules work 
in combination with the protein and ligands to merge with the postsynaptic processes 
(Conde and Caceres, 2009, Geraldo and Gordon-Weeks, 2009).  See Figure 1.3. 
The P-domain of the growth cone contains proteins that allow it to sense components of 
the extracellular matrix for guidance and repulsive cues (Conde and Caceres, 2009). 
Collapsing response mediator protein 2 (CRMP2) and Semaphorin 3A are common 
growth cone proteins that function by forming complexes with molecular ligands 
(Gordon-Weeks, 2000).  Kinesin family members (KIF) are ligands that work in concert 
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with growth cone proteins to depolymerize or polymerize microtubules using the energy 
from ATP hydrolysis (Gordon-Weeks, 2000). One set of ligand cues that captures the 
filopodia and promotes protrusions are KIF5C and CRMP2. These ligands are involved 
in transporting and binding tubulin heterodimers and oligomers to the tip of the growing 
axon (Conde and Caceres, 2009, Marques et al., 2013, Brittain et al., 2009). CRMP2 
advancing capabilities work in opposition to Semaphorin 3A, found  in the lamellipodia, 
which causes the growth cones to retract and prevents the binding of the tubulin fibers 
(Gallo, 2008). Immediately after hypoxic insults (i.e. 0.5-4 hours) active CRMP2 is 
highly upregulated in the developing brain as axonal repair requires cellular cytoskeletal 
components to maintain the structural integrity of neurons directly after an insult (Xiong 
et al., 2012) .  
Once CRMP2 and KIF5C have formed the parallel microtubule bundles with MAP 
proteins (i.e., MAP1B or MAP2) then excessive collateral branching is prevented by tau 
proteins that stabilize the axonal cytoskeleton. Microtubule bundles and actin filaments 
(F-actin) interact with the growth cone tip to form the synaptic connection. This is 
accomplished via the recruitment of another set of ligands, end binding 3 (EB3) and 
drebrin proteins (Geraldo et al., 2008, Conde and Caceres, 2009).  Drebrin phosphorylates 
on Serine 142 by activated cyclin-dependent kinase 5 (Cdk5). Phosphorylated drebrin 
allows for a conformational (referred to as an open conformation) change of its structural 
domain. F-actin bundling and microtubule-binding protein EB3 can only occur in the 
open conformational state of phosphorylated drebrin (Sonego et al., 2015, Geraldo and 
Gordon-Weeks, 2009). In vitro studies that knock-down drebrin expression in cortical 
neurons demonstrate that the consequence of EB3 and drebrin disruption are shorter 
neurites with abnormally bundled microtubules in the growth cones and an inability to 




CRMP2 works in opposition with another depolymerisation protein, stathmin (SCG10), 
which sequesters tubulin dimers to reduce the concentration of tubulin available for 
assembly (Cassimeris, 2002). The complex of KIF2 and stathmin induces microtubule 
catastrophe (Conde and Caceres, 2009) by breaking down MAP1B complexes. This 
action keeps the cytoskeleton in a splay formation so that the growth cone can continue 
to extend the neuritic extensions and avoid tubulin capture. Recently it has been shown 
that growth cones are reduced in the hippocampus of midgestational human cannabis‐
exposed foetuses. Activated cannabinoid-1 receptors inactivate stathmin resulting in the 
premature capture of the filopodia. This may account for the cortical deficits seen in 
children exposed to maternal cannabis abuse in utero (Tortoriello et al., 2014). Stathmin 
knock-out mice have amygdala that differ from the wild type, which manifests as 
behavioral deﬁciencies in innate and learned fear, such as failure to retrieve pups (Martel 
et al., 2008). However, recently it has been shown that particular stathmin knockout mice 
lack detectable phenotyping, which demonstrates that the stathmin family may 
compensate for an inactive member (Chattopadhyay and Sen, 2014). See Figure 1.3 for 
growth cone anatomy. 
Studies show that disruption of functional stathmin via fetal exposure to delta 9-
tetrahydrocannabinol leads to miswiring in the brain and unusual cortical development 
(Tortoriello et al., 2014). Post mortem studies on the adult brain have shown a decrease 
in synaptophysin and drebrin in patients with known bipolar disorders. The decrease in 
drebrin in biopolar disorders is thought to be associated with mild cognitive impairments, 
as it normally allows for plasticity in the brain (Kim et al., 2010) and formation of new 
synaptic connections. Another post mortem study on patients with multiple sclerosis, 
showed that inflammatory mediators cause microtubular collapse  (Bsibsi et al., 2010). In 
the developing brain the collapse of a growth cone could have a devastating effect on 
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migrating neurons as it could either trigger apoptosis or induce permanent wiring errors 























































































































































































































































































































































































































































































































































































































































































































 Cortical Anatomy 
The areal organization of the cortex is based on sensory-specific, hierarchical and parallel 
functions. The divisions of the sensory-specific cortex are segregated by functional and  
hierarchical differences that stem from the findings of Brodmann’s (1909) study on 
cytoarchitectonics. Brodmann’s map identified differences in cell numbers and cellular 
densities throughout the cortical mantle (i.e., motor cortex is different from premotor). 
 The theory of canonical microcircuits 
 Parallel organisation is based on multiple overlapping or repeated sensory 
representations (e.g., retina, auditory, and tactile), identified in areal and laminar 
formations (Hubel et al., 1978). Laminar structures or cortical columns (a hypothesis that 
perpendicularly cortical areas have nearly identical receptive fields, which  modulated 
within a cortical region) were very popular views as they were easy to understand and 
explain for one module, such as ocular dominance. But they failed to explain the 
comparative differences between response times in cortical areas (Horton and Adam, 
2005). In other words, thalamocortical loops anticipate upcoming actions and prepare 
relay neurons before a stimulus is administered (Sherman and Guillery, 2013).  
Haber 2006, emphasizes that the frontal inputs to the striatum match thalamic input to the 
striatum, implying that cortex and thalamus work in concert with one another and are not 
separate processing centers. Murray and Sherman (2006) call this concept an alternative 
view to the cortical processing which includes drivers and modulators being present in 
both the cortex and thalamus (Sherman et al., 2006). Recently this concept has been 
upgraded to include subcortical networking, where efferent copies of information pass 
through lower cortical networks to thalamic nuclei (Sherman and Guillery, 2013). The 
communications between cortical and thalamic networks demonstrate the importance for 




 Laminar Organisation and connections to the thalamus 
Another laminar organization is seen in the layered morphology of the cortex. Excitatory 
cells (glutamatergic) account for approximately 70% of the neuronal population of the 
cortex, and these spiny neurons include pyramidal cells and stellate cells. The remaining 
30% of the neuronal population, non-spiny neurons, are inhibitory (GABAergic) 
interneurons, which are a heterogeneous group found in all layers of the cortex with varied 
morphologies and electrophysiological properties (Markram et al., 2004). These two 
populations of neurons maintain the balance between inhibition and excitation that is 
necessary to modulate the afferent, and efferent signals of the six-layered cortex. Layer I, 
the molecular layer, is considered pauci-cellular as it is composed of dendrites/axons or 
Cajal Retzel cells that send linear projections to all layers of the cortex and is therefore 
important for cortico-cortical connections. The molecular layer receives substantial 
afferents from the intralaminar core and matrix of the thalamus (i.e., non-specific thalamic 
nuclei) as does layer II (Smith et al., 2004). Small pyramidal axons ramify most 
extensively in layers II-III (the external granular layer and external pyramidal layer) to 
make cortico-cortical connections with other local pyramidal cells.  
Additionally, layer III pyramidal axons have been found to project into the white matter 
suggesting that this layer may also provide trans-callosal projections (Thomson and 
Morris, 2002, Hoffmann et al., 2015). Layer III, also contains cells arranged in columns 
with somata that have long apical dendrites that spread into the marginal zone or layer I 
(Bannister, 2005); suggesting that it may provide small canonical microcircuits within 
each columns (Hoffmann et al., 2015). Thalamic efferent signals mainly terminate in the 
spiny stellate cells of layer IV, the internal granular layer. Layer IV projects to layers II 
and III. Layer V, the internal pyramidal layer, sends collaterals to all cortical layers and 
projects axons to the forebrain, basal ganglia, transcallosally and the non-specific nuclei 
of the thalamus (Somogyi and Klausberger, 2005). Betz cells, found in layer V of the 
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motor cortex, are large pyramidal projection neurons that send corticospinal fibers that 
innervate the spinal tract (Decosta-Fortune et al., 2015, Clowry et al., 2014). Layer VI, 
the multiform layer, has spindle-like pyramidal cells with short and long processes that 
project to all cortical layers and provide corticothalamic outputs to specific thalamic 
nuclei (West DC et al., 2006, Sherman and Guillery, 2013) (see Figure 1.4-1.6).  The 
cortex and the thalamus require that very precise reciprocal interconnections are formed; 
consequences of neuronal malpositioning during development have been linked to several 














































































































































































































































































































































































































































 Thalamic Anatomy 
The thalamus acts as a central relay station to the cerebral cortex, but it is more complex 
than a simple gateway as it is also a source of modulation and executive function. The 
bulk of the thalamus is divided into three sections, medial lateral and anterior, by a thin 
sheet of curved myelinated fibres that make up the internal medullary lamina.  
The lateral group of nuclei consists of a dorsal tier and a ventral tier (Nolte and Sundsten, 
2002), which is further subdivided. The dorsal portion mainly the large pulvinar nucleus 
that interconnects with the ventral posterior (VP) nucleus; these structures receive and 
project to the parietal-occipital-temporal association cortex. The ventral tier contains the 
ventral anterior (VA) nucleus, the ventral lateral (VL) nucleus, and the ventral posterior 
(VP) nuclei. Ventral tier nuclei are highly complex as these receive and project specific 
relay nuclei for sensory (VP), motor (VL) and limbic systems (VA) (Sur and Rubenstein, 
2005). For instance, the basal ganglia projects to the VA nucleus, which then projects to 
the dorsal lateral prefrontal cortex, whereas the cerebellum relays to the VL nucleus, 
which then targets the premotor cortex and motor cortices (Jones, 2007, Nolte and 
Sundsten, 2002). The VP relays somatosensory input from the spinal tract, this in turn, 
projects to the somatosensory cortex (de Lafuente and Romo, 2006). 
In the lateral ventral regions specific thalamic relay neurons, are topographically arranged 
in organised clusters composed of round large (RL) neurons. RL neurons receive 
excitatory glutamatergic input from peripheral sensory pathways and cerebellar pathways 
(Jones, 2001, Sur and Rubenstein, 2005, Sherman and Guillery, 2013) and project long 
axonal extensions to the cortex. Specific neurons in the thalamus are internally modulated 
via GABAergic inputs from the reticular nucleus (Jones, 2001) which forms a sheath 
lying over the ventral aspect of the thalamus. The posterior internal capsule forms 
organized topographical fibres that extend from the cerebral hemisphere to the thalamus. 
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These continue medially to the globus pallidus and then send projections to specified 
regions of the thalamus (Nestler et al., 2001).   
The medial group or the medial dorsal (MD) nuclei are made up of round small (RS) 
association nuclei (i.e., non-specific relay). The MD region interconnects with the orbital 
medial prefrontal cortex and is involved with mood affect and foresight thought processes 
(Alelu-Paz and Gimenez-Amaya, 2008). MD neurons are not modulated via the reticular 
nucleus and can send collaterals not only to the cortex, but also to specific thalamic 
neurons (Sherman et al., 2006). Closely associated with the MD group is the anterior 
group of nuclei that receive specific input from the mammillothalamic tract (limbic 
system) and the hippocampus and this thalamic region is also made up of RS clustered 

























































































































































































































































































































































































































































Figure 1.6 A diagram of the specific and nonspecific thalamocortical connectivity.   
Shown are the layers of the cortex and the large pyramidal cells (black arrow heads) 
with the afferent projections to the thalamus (solid lines) and efferent connections from 
the thalamic nuclei (dotted lines). The cortical information enters mainly layer 4 (and 
layer 6) and then is sent to layers 3 and 2. The signal is modulated and sent to layers 5 
(signals destined for non-specific regions) and 6 (targeting specific nuclei) before 
exiting the cortex to activate subcortical and thalamic regions. The large black arrows 
in layer 2/3 and 5 represent the interconnection made between other cortical regions 





 Thalamo-cortical connections 
Vasung et al. (2010) used acetylcholinesterase (AchE) staining and Diffusion Tensor 
Imaging (DTI) to reconstruct and follow the growth patterns of thalamic cortical 
pathways. This survey on human fetal brains ranging from 8-34 postconceptual weeks 
(PCW), demonstrated that by 19 PCWs thalamocortical axonal growth cones reach the 
periventricular crossroads. Crossroads contain hydrophilic extracellular matrices (ECM)  
and radial glia that are rich in guidance molecules (Vasung et al., 2010, Judas et al., 2005). 
At 19-23 PCW, fibers from the different thalamic nuclei travel via guidence molecules 
towards neurons in the cortex and establish synaptic connections with their prospective 
cortical efferents (Volpe, 2008) in the ventral telencephalon, a region of the internal 
capsule (Judas et al., 2005). This concept that growing cortical efferents meet thalamic 
axons in the ventral telencephalon and intermingle  to form life-long synaptic connection 
is referred to as the ‘hand shake hypothesis’ (Molnar and Blakemore, 1995). This meet 
and greet time forms the scaffolding for the subsequent thalamic-cortical trafficking 
(Erzurumlu et al., 2006). See Figure 1.7. 
After the glutamatergic thalamic relay axons grow from the thalamus to the internal 
capsule the neuronal cytoplasm and the somata of the cells within the thalamus increase 
exponentially to support the axonal extension (Jones, 2007). Bipolar GABAergic neurons 
invade the thalamic structures from the ganglionic eminence or corpus 
gangliothalamicum (Kostovic and Judas, 2010). Growth cones that form the dendritic 
extensions on the thalamic neurons will form synaptic connections with the GABAergic 
axons from the reticular nucleus and other thalamic relay cells. As the relay neurons 
enlarge, the specific thalamic regions will continue to expand and are more discernible 
when the white matter tracts have myelinated postnatally (Jones, 2007). 
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Figure 1.7 The maturation of thalamocortical and callosal connections.
A summary of the maturation of thalamic and cortical maturation from mid (A and B) to 
third trimester (C - E) gestation. In image A and B, the ventricular zone and ganglionic 
eminence have a vast number of neurons that are migrating and will make life-long 
synaptic connections with the thalamic axons and callosal fibres. Crossroads, seen in C 
(black arrows) have a honeycomb appearance and are areas of associative and callosal 
neuronal traffic. In images B and D, the subplate or the subcortical network becomes 
less dense, the afferent fibres from the thalamus penetrate the cortical plate and the lami-
nation of the cortical layers becomes more definitive. By 31 postconceptual weeks 
(PCW), depicted in E, the thinning of the subplate continues as the cortical development 
advances and the thalamus region widens. The black stars identify the vulnerable 
periventricular white matter zone where WMI occur in the frontoparietal lobe. The light 
purple outlined seen in images A, B, D and E represent the marginal zone, an area with 
bipolar neurons with apical dendrites that will expand downward into the cortical plate. 









 Astroglia maturation 
In the subventricular zone, there are multifunctional neural stem cells or radial glia cells 
that not only give rise to the radial glia, but also neurons, astroglia and oligodendrocytes 
(Barry et al., 2014). In early embronic development, radial glia processes extend though 
the subventricular zone and the developing cortical plate to the pial surface above the 
cortex (Barry et al., 2014). The specialised radial glial system forms clusters of fibres, 
which have a distinctive trajectory to each specific cortical region (Volpe, 2008) and are 
positive for glial fibrillary acidic protein (GFAP; a protein that is specific for radial glia 
and mature astrocytes). The best characterised function of radial glia is to guide the new-
born neurons from the subventricular zone to the correct lamina of the cerebral cortex 
(Barry et al., 2014). Around 26 week's gestation, radial glial cells will give rise to 
astrocytes and oligodendrocytes in the GM (Stipursky et al., 2014). The newly born 
supporting astroglia will form the blood-brain barrier by migrating from all domains of 
the neuroepithelium (Jacobsen and Miller, 2003). Supporting astroglia have long 
filamentous processes that wrap around the blood vessels (that are now in the subcortical 
region) making pseudopodia (foot-like structures), which are GFAP positive. The 
astroglia pseudopodia support and protect the neuronal environment by forming a 
semipermeable barrier that separates the circulating blood from the fluid in the 
extracellular matrix of the brain. Around 32 weeks gestation, the existing radial glial will 
also differentiate into astrocytes later in development (Barry et al., 2014). The exact 
mechanism of how radial glia differentiate into protective astrocytes is unknown, recently 
it has been shown that transforming growth factor-β1 transforms into radial glia to 
astroglia by disrupting the polarity of the cell (Stipursky et al., 2014).  
 Blood vessel maturation 
Fetal neuronal and most glial development is highly active between 8 and 32 GWs, but 
astroglia proliferation and differentiation begins around 20 GWs (Kostovic et al., 2015). 
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During this time, there are distinct proliferative regions of the brain, such as the GM, a 
thick cellular layer of immature cells located under the ependymal lining of the ventricles. 
This region is vulnerable to injury during 20-32 postmenstrual age (PMA) as seen in 
GMH-IVH because it is a metabolically active area; supplied by an extensive capillary 
bed formed from the artery of Heubner (Pape and Wigglesworth, 1989). The fragile blood 
vessels in the developing regions lack elaborate glial sheets and supportive connective 
tissues (elastic, collagen and smooth muscle fibers) leaving the capillary beds vulnerable 
to breakage (Lagercrantz, 2010). The lack of supporting structures on the blood vessels 
predisposes the immature brain to haemorrhages as poorly supported structures are prone 
to rupture with changes in blood pressure. The artery of Heubner is an extension of the 
anterior cerebral artery. It is prominent during fetal life but will eventually only supply a 
small area at the head of the caudate nucleus in the mature brain (Lagercrantz, 2010, Pape 
and Wigglesworth, 1989). The GM supplies neurons that migrate and follow the radial 
glial which guide the neurons to the developing cortex. At 24 weeks gestation age (GA), 
the cortex has differentiated layers of migrating neurons making up the cortical layers and 
gyrification begins (see section 1.3).  
As the cerebral hemispheres enlarge, the blood supply shifts from the GM to the cortical 
and subcortical white matter regions, it leaves the area around the ventricles, the PVWM 
vulnerable to injury (Pape and Wigglesworth, 1989).  Blood vessels branch upwards to 
the cortex at right angles to the surface (Pape and Wigglesworth, 1989). In the preterm 
brain, (before 32 PMA) the PVWM and subcortical regions around the sulci of the cortex 
have watershed areas that form between the centripetal and centrifugal arteries (Pape and 
Wigglesworth, 1989). Watershed areas are found in the convex areas of the subcortical 
regions (under the sulci) that can be exposed to prolonged times of hypotension, making 
these areas susceptible to infarctions (Edmond and Foroozan, 2006, Clowry et al., 2014). 
Conventional pathology studies show that diffuse astrocytosis in the PVWM area are a 
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common occurrence in the preterm brain and have detrimental effects on the maturation 
and survival of mature oligodendrocytes that normally form the cerebral WM 
(Lagercrantz, 2010, Haynes et al., 2003). 
The fragility of the blood vessels within WM at this stage of development is debated. 
Other investigators claim that the blood vessels during this time have a mature 
morphology, demonstrating prominent tight junctions and uninterrupted basement 
membranes. In this opposing view, the blood vessels are in contact with immature 
astroglia endfeet that are positive for the protein Vimentin (Bass et al., 1992) a marker of 
immature astrocytes.  
 Formation of the blood-brain barrier 
Immunohistochemical investigations using GFAP antibody (see Figure 1.8) demonstrate 
the fragility of the blood vessels in the subplate at 24 PMA (Figure 1.8 B). The oblong 
blood vessels lie between the vertically lined radial glia, but at this age there are very few 
supporting astrocytes. Neurons are seen migrating proximal to the blood vessel (Figure 
1.8 C) and are, therefore, vulnerable if a blood vessel breaks and inflammatory mediators 
leak into their incomplete blood-brain barrier. At 26 GA, the radial glial develop into 
protective astrocytes that form a protective barrier around the blood vessel (Figure 1.8 D) 
(Kostovic et al., 2015). This barrier is formed, in part from the astrocytic processes (the 
pseudopodia; seen on histology using anti-GFAP),which will wrap around the blood 
vessel wall and from the vessel endothelium. WMIs that occur around 28 PMA have the 
pathological characteristic of broken vessels (Figure 1.8 E) that may have ruptured; 









































































































































































































































































































































































































































































































































































































 Activated microglia friend or foe 
Microglia cells are a heterogeneous cell type derived from primitive myeloid precursors 
cells (i.e., formed outside of the brain) which give rise to the monocyte-macrophage like 
lineage (Harry and Kraft, 2012, Goldsby et al., 2003, Baburamani et al., 2014, Ginhoux 
et al., 2010). Microglia, can also come from primitive macrophages that differentiate in 
the yolk sac early in development (Ginhoux et al., 2010) and defend against invading 
pathogens and changes in the neuronal environment by proliferation of local resident 
microglia (Smith et al., 2014). Historically microglia have been classified by the 
morphology of the cell; amoeboidal, ramified and intermediate (Verney et al., 2010). 
However, recently it has been suggested to classify microglia based on the functional 
nomenclature; quiescent/surveying, reactive/activated and phagocytic/ED-1(Lajtha and 
Reith, 2007).  
Cluster differentiator (CD)45, also called leukocyte common antigen, is expressed on 
nucleated haematopoietic cells and myeloid-derived leukocytes. Early proliferated 
microglia and monocytes express CD45 and ionized calcium binding adaptor molecule 1 
(Iba-1; a marker of all microglia morphologies) (Verney et al., 2010). In the 
quiescent/surveillance mode, the morphology consists of rod-shaped somata with subtle 
processes with low levels CD45 cell-surface antigen (Lajtha and Reith, 2007). These 
resident cells can rapidly respond to invading microbes or alterations in brain activity and 
provide the first line of defense.  
The loss of regulatory signals in the brain or neuronal injury shift microglia out of the 
quiescent state into a reactive/activated state, (i.e., the cells express CD68). The microglia 
internally switch their phenotype to change from a quiescent state to activated state, 
currently termed as M1 and M2 (Sierra et al., 2013, Colton, 2009) phenotypes. The 
microglia acquire diverse and complex phenotypes to participate in the cytotoxic 
response, immune regulation, and injury resolution.  
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In the M1 state, ramified activated microglia, the cells have an elongated cell body with 
long and thick processes (Lajtha and Reith, 2007). The microglia expressing a M1 
phenotype are considered to be in a classic activated state or killing phase, which is 
induced by pathogen-associated molecular patterns (PAMPs) or endogenous molecules 
(Damage-associated molecular patterns; DAMPs) and pro-inflammatory cytokines 
(Colton, 2009). M1 phenotype microglia will respond to injury by the release of cytotoxic 
agents and an increase expression of TLRs and proinflammatory cytokines to rid the 
region of a pathogen (Colton and Wilcock, 2010). 
In the third stage, the microglia express M2 phenotypes and have an alternate activation 
state to begin the process of repair and regeneration (Colton, 2009). The alternative active 
state inhibits proinflammatory cytokine production and increases in the scavenger 
receptors on the microglia. The M2 phenotypes are further subdivided to include M2a, 
M2b, M2c. M2a expressing microglia are denoted by the presence of a round-shape cell 
body with short stout processes. M2b, an immunoregulatory phenotype, has a higher 
expression of scavenger receptors. The fourth stage, or M2c phenotype, express acquired-
deactivating signals and are in the phagocytic phase. M2c microglia are round with large 
vacuolated cytoplasm and processes are absent (Lajtha and Reith, 2007, Colton and 
Wilcock, 2010). These fourth stage microglia have dense expression of ED-1, CD68 (as 
do, macrophages and perivascular macrophages) and Iba-1. Microglia M2 phenotype 
expression serves to activate certain cytokines in order to wall off the site of injury and 

































































































































































































































































































































































































































During neuronal development, waves of newly arrived microglia colonise the brain 
especially around 19–30 GWs where they accumulate at the axonal crossroads in the 
white matter (Verney et al., 2010). The wave of colonisation coincides with radial glia 
formation, neuronal migration and the beginning of myelination. During the critical time 
for blood vessel maturation (24-30 GWs) if an injury or insult occurs, inflammatory 
mediators circulating in the blood stream can easily leak into the brain through torn fragile 
blood vessels and affect neuronal migration via cytokine release or excitotoxicity 
(Leviton and Gressens, 2007). Inflammatory conditions can induce apoptotic signals in 
the migrating neurons that affect each successive wave of neurons via the activation of 
resting microglia which become positive for CD68 (Supramaniam et al., 2013). This is 
seen in studies that show that in hostile environments, migrating neurons will display an 
‘eat me’ signal even when they do not appear to be apoptotic (De Simone et al., 2004). It 
is not fully understood if inflammatory stimuli alter receptors in the migrating neurons 
via excitotoxicity or if neurons simply get stuck amongst the white matter damage and 
are targeted by the activated microglia. 
Another theory is that the consequences of over stimulated microglia from prolonged 
exposure to an inflamed or excitotoxic environment may cause microglia to function as 
neuronal killers (Leviton and Gressens, 2007) because they are predisposed to 
inflammatory mediators in the early resting stages. The role of CD68 + or activated 
microglia appears to be more than an immunological response to injury, as they may also 
have a developmental role  in axonal guidance (Verney et al., 2010). Activated microglia                
in a reparative role during injury or inflammation are recruited via signal released by 
cytokines and chemokines (Colton, 2009). The activated microglia might be detrimental 
to the migrating neurons during corticoneurogensis (Leviton and Gressens, 2007) because 
of the increase of inflammatory mediators, which could lead to risk of cerebral palsy  
(Hagberg et al., 2012). 
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 Verney et al (2010) found an accumulation of activated microglia in the junctions of the 
internal capsule in human preterm brains, but yet claimed that the posterior thalamus did 
not have any overt pathology (Verney et al., 2010). Activated microglia are important for 
normal sculpting of the post-migratory cells as they can ingest unwanted or redundant 
cells (Verney et al., 2010). We reported that the number of co-localized Iba-1/CD68 
positive cells significantly increased in cases of GMH-IVH when compared to non injured 
preterm brains. Furthermore, CD68 positive microglia in the periventricular white matter 
and germinal matrix, were significantly higher than the number of microglia that co-
localized with Iba-1 / CD45 in the normal preterm brains (Supramaniam et al., 2013). 
Meaning that the increase in CD68 positive microglia in the periventricular white matter 
is largely due to a quick change in phenotype or surface antigen. Another source of CD68 
postive cells  could be from a rise in perivascular macrophages (Supramaniam et al., 2013, 
Harry and Kraft, 2012) that leak in through broken blood vessels. Although these immune 
labels have provided a means to discuss microglial morphologies, conflicting 
interpretations demonstrate the need to study the causes of microglial activation and the 
roles of different phenotypes.  
 Oligodendrocytes 
Oligodendrocytes are the predominant cell type within the white matter that form the 
elaborate myelin membrane that wraps and insulates the axons. Myelination begins 
during the second trimester of pregnancy and will continue into adulthood. Myelination 
proceeds in two phases: proliferation/differentiation and myelin deposition (Volpe, 2008, 
Kinney and Back, 1997, Back and Volpe, 1997). The cell body is always positive for 
oligodendrocyte (OL) transcription factor 2 (Olig2) but the plasma membranes express 
different proteins on the cell surface as maturation occurs. Oligodendrocytes originate 
from the radial glia in the subventricular zone and are generated from midgestation to 
early postnatal life. After proliferation, the oligodendroglia migrates from the 
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subventricular zone into the cerebral white matter and align along the axons (Volpe, 2008) 
and express A2B5 and neuro glia (NG2) proteins (Back and Volpe, 1997). During the 
migration the oligodendrocytes transform from the progenitor cell to the 
preoligodendrocyte stage. Preoliodendrocytes or NG2 + cells retain a proliferative 
capacity (Higgins et al., 2014), but the cell surface expression in oligodendrocytes change 
to mainly sulfatide (O4). Around 28 GWs the preoligodendrocytes will differentiate into  
a postmitotic immature oligodendrocyte, with dense multipolar processes and although it 
can be detected with O4 antibodies, the cell surface is also positive for 2',3'-Cyclic-
nucleotide 3'-phosphodiesterase (CNPase) and galactosylceramidase (O1) (Volpe, 2008). 
The oligodendrocyte continues to develop linear processes  that extend and wrap around 
the axons and these can be seen by using antibodies made against myelin basic protein 
(MBP) (Back and Volpe, 1997) from 32 GW. See Figure 1.10. 
As the oligodendrocyte extensions mature, they will insulate the axons by creating a 
myelin sheath which will form the white matter tracts. One cluster of white matter tracts 
make up the internal capsule that forms a barrier between the lentiform nucleus and the 
lateral portion of the thalamus. The topographically organised white matter fibres in the 
internal capsule fan out forming the corona radiata or radial fibre bundles. The radial fibre 
bundles then blend in with the interconnecting cortical areas, which is referred to as 
asociative fibre bundles  (Judas et al., 2005). The formation of the internal capsule and 
other WM structures is important for insulating the thalamocortical and corticocortical 
pathways (Nolte and Sundsten, 2002). See Figure 1.10.  
In animal models of preterm inflammation-induced white matter injury (preterm mice 
pups treated with an inflammatory mediator, interleukin-1β) myelin deficits were linked 
to stunted oligodendrocyte differentiation (Favrais et al., 2011). In brain MRIs, WMI seen 
in human preterms are typically associated with with damage to the WM and a 
maturational blockade of oligodendrocytes has also been reported (Dammann et al., 2001, 
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Back and Volpe, 1997). Microscopically, focal lesions seen in WMI cases produce a 
loosening of the cerebral WM with gliosis (hypertrophic astrocytes) and lipid-laden 
macrophages (that also have CD68+ cell membrane). Preterm infants are known to be 
vulnerable to WMI as a result of inflammation and ischaemia (Buser et al., 2010, Vasung 
et al., 2010). The WM damage is associated with subsequent grey matter atrophy and 
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Figure 1.10 Progression of oligodendrocyte lineage and a midsagittal view of the 












In drawing A, the oligodendrocytes progression is outlined and shows the changes in 
the cell’s morphology and cell surface antigen expression from a migrating progenitor 
stage to mature oligodendrocyte. The premyleinating stage includes proliferation and 
migration which begins in the early weeks of GA and will continue until midgestation 
(i.e., around 28 GA weeks). After 28 GA weeks, myelination of the axons begins and 
the oligodendrocytes mature and insulate the axonal fibres. The timing of the 
myelination stage varies with brain region and will continue to progress after birth.   
Image B, the thalamus and lentiform nucleus have been removed to show the principal 
components of the mature white matter tracts including the internal capsule (thick 
dotted line) and the corona radiata (small dotted line) and the associative fibre bundles 
(above the small dotted lines or the gray/pale areas). The coloured lines represent the 
tracts of the different thalamocortical pathways. Adapted from (Volpe, 2008) and 




 Thalamic development following WMI in preterm infants 
Following WMI neurons can be directly injured whilst migrating which may decrease the 
numbers in the cortex and leave some neurons abnormally placed in the WM. Although 
the pathological mechanism involved in neuronal loss seen in the cortex is unknown, it 
has been speculated that this is due to a disruption of the late migrating neurons (Judas et 
al., 2005). The neuronal connections may also be lost within the cortex or there might be 
injury to axons going to or coming from the thalami. Both imaging and pathological 
studies have suggested that thalamic injury and subsequent atrophy are a consequence of 
WMI (Graham et al., 2004, Martinez-Biarge et al., 2010, Billiards et al., 2008, 
Alderliesten et al., 2011, Ball et al., 2012). Axonal injury of thalamic neurons may disrupt 
particular pathways (e.g. the motor tracts) and lead to atrophy of the thalamus (Leviton 
and Gressens, 2007).  
Periventricular infarction in the immature brain often involves the thalamocortical axons 
that project into the PVWM and disruption of these results in cerebral palsy in the 
majority of infants. Many of these infants with PVWM lesions will have additional 
cognitive impairments (Pape and Wigglesworth, 1989). The motor impairments usually 
take the form of bilateral spasticity, described as a diplegia as the legs are more affected 
than the arms, unless there are widespread, deep subcortical lesions where a spastic 
quadriplegia is likely (Pape and Wigglesworth, 1989, Volpe, 2008). Imaging studies on 
expreterm infants with milder WMI have identified reduced thalamic volumes in regions, 
such as, the medial dorsal and the pulvinar, which have been correlated with long-term 
cognitive function in working memory and a decline in verbal intelligence in the absence 
of cerebral palsy (Billiards et al., 2008). 
Ligam et al. (2009) assessed the thalami in neonates that died with a neuropathological 
diagnosis of WMI (GA 32.5 ± 4.8 weeks) and compared them to non-WMI controls. This 
autopsy study concluded that thalamic damage occurred in approximately 60% of infants 
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with WMI with distinct injurious patterns, which may have potential clinicopathologic 
correlations in surviving infants. Thalamic damage in WMI included diffuse gliosis 
patterns of micro-infarcts and macro-infarcts. Ligam and colleagues (2009) hypothesised 
that the thalamic injury and atrophy in the MD would be more prevalant in the WMI cases 
than to the control cases. The investigation lacked a full assessment of other thalamic 
regions besides the MD and was based on the gliosis patterns (Ligam et al., 2009). 
However, it would be important to consider reactive astrocytic populations in other 
thalamic regions, as these would have a host of inflammatory signals that can activate 
inflammatory mediators (Anderson et al., 2014). Inflammatory mediators, such as 
interleukins and cytokines, being released by neighboring astrocytes may have a potential 
to impact on neural functions and prolong injurious signals or induce excess apoptosis. 
Factors that determine the eventual pattern of injury and the site of injury include the 
nature of the insult, the frequency and the susceptibility of brain regions at different 
gestatonal ages and how the brain responds. For instance, the basal ganglia are vulnerable 
after an acute hypoxia-ischaemia (HI) injury in term infants and most commonly observed 
with Hypoxic Ischemic Encephalopathy (HIE) (Rutherford, 2002). From MRI studies we 
know that the posterior limb of the internal capsule ,which is actively forming myelin is 
ususally involved when there is damage in the basal ganglia and thalami. The thalami are 
considered vulnerable because of the high metabolic rate and the high number of 
glutamatergic cells. Of interest is that the basal ganglia and thalami will also show injury 
in a preterm infant if there is a severe acute HI insult (Logitharajah et al., 2009). 
Characteristically however, injury to the preterm brain is not usually a severe acute 
hypoxic insult and is most often observed in WM. The enhanced susceptibility of pre-
oligodendroglia to cell death from hypoxic injury, inflammation and oxidative stress is 
related to maturation-dependent differences in the expression of ionotropic and 
metabotropic glutamate receptors, cytotoxic cytokine receptors and the presence of free 
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radicals (Blomgren and Hagberg, 2006, Back et al., 2007, Back and Volpe, 1997). For 
instance, fetal exposure to lipopolysaccharides (LPS) prior to myelination has been shown 
to impair WM and cortical development in large animal models of maternal/fetal infection 
(Dean et al., 2011). Characterization of the mechanisms involved in WMI and careful 
study of the thalamic changes that accompany WMI is essential for developing treatment 
strategies (Clowry et al., 2014, Hagberg et al., 2015) and to prevent life-long disabilities 
in infants who have suffered hypoxic-ischaemic or infectious insults. 
 Toll-Like Receptors 
 Brief History of Toll-like receptor 
Toll-like receptors (TLRs) are members of the pattern recognition receptor family that 
detect components of foreign pathogens (i.e., PAMPs) or endogenous molecules DAMPs 
released in response to injury.  After an infectious injury, endotoxins, such as LPS, are 
released from Gram-negative bacteria and bind to the serum LPS–binding protein and 
glycosylphosphatidylinositol-anchored CD14 (Lehnardt et al., 2003). Pathogen-serum 
complexes activate macrophages and microglia that respond to the injury (Hagberg et al., 
2012) via different pattern recognition receptors, such as TLR’s (Colton, 2009).  Thus in 
the innate immune system, TLRs recognize pathogen-derived compounds or endogenous 
molecules released by the host in response to an infection or inflammatory injury (Wang 
et al., 2011).  
TLRs are a transmembrane receptor consisting of an extracellular domain, a 
transmembrane domain and a cytoplasmic domain. The TLRs have a single block of 
leucine-rich repeats (LRR) units that fold into a curved, solenoidal structure with a c-
terminal capping structure.  The LRR units are connected to a single transmembrane α-
helix on the convex surfaces (Abbas et al., 2012, Gay et al., 2006). This α-helix structure 
connects to the cytoplasmic domain, known as the Toll/interleukin-1 receptor (TIR) 
domain, which has β loops (BB loops) or turns (Abbas et al., 2012) that allows for the 
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TLR flexibility (Akira and Takeda, 2004). Upon stimulation TLRs from hetero or 
homodimers within the TIR domain and the BB loop link the recognition of microbes to 
the cellular immune response and/or allow for TIR/TIR interaction with another TLR 
(Gay et al., 2006, Davis et al., 2006).  
There are nine TLRs recognised in humans and thirteen in mice. TLRs 1,2,4,5 and 6 are 
located on the cell surface, while TLR 3,7,8 and 9 are found in intracellular compartments 
(Gay et al., 2006, Mallard, 2012, Abbas et al., 2012, Goldsby et al., 2003). The TLRs 
found on the cell surface recognise various PAMPs that are released into the extracellular 
environment from bacterial products (Abbas et al., 2012). For instance, TLR2 recognises 
bacterial lipopeptides released from gram-positive cocci such as those found in 
staphylococcus and streptococcus infections. TLR4 detects LPS in gram-negative 
bacteria released during such infections as E.coli. Intracellular TLRs are mainly 
expressed on the endoplasmic reticulum (ER) and endosomal membrane, where they 
detect abundantly expressed microbial nucleic acids (Gay et al., 2006). For example, 
double-stranded ribonucleic acid (RNA) binds to TLR3 as seen in Rotaviral infection a 
common cause of acute gastroenteritis. Unmethylated CpG motifs are common in the 
prokaryotic deoxyribonucleic acid (DNA), such as in E.coli bacteria, and bind to TLR9. 
Microbial RNA and DNA seen in the endosomes also include host DNA from cells that 
have died as a result of the infection. Intracellular TLRs can distinguish healthy self from 
damaged self and foreign invaders via a protein called uncoordinated 93 homolog B1 
(UNC93B1) on the ER, which allows for the migration of the TLRs to the endosomes 
(Abbas et al., 2012, Kim et al., 2008, Lee and Barton, 2014, Brinkmann et al., 2007).  
TLR activation via ligand recognition results in a cascade of inflammatory pathways and 
transcription factors that are essential to induce an inflammatory response. Once the TLR 
is presented with a ligand, dimerization of the TLR proteins occurs. This change in 
conformation allows for the TIR domains to be close to one another (Botos et al., 2011) 
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and to activate a cascade of events. One pathway is mediated by the adaptor protein TIR 
domain containing adaptor inducing interferon-β nuclear (TRIF), (Johnsen et al., 2006). 
Another pathway is via myeloid differentiation primary response gene 88 (MyD88) which 
is a downstream effector of TRIF-related adaptor molecule (TRAM) interactions (Ohnishi 
et al., 2012). TRIF and TRAM interactions will ultimately results in the activation of 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-mediated 
transcription (Abbas et al., 2012). Stimulation of NF-κB expression encodes the genes 
required for inflammatory responses, such as cytokine (Tumor necrosis factors (TNF) and 
interleukin-1) and chemokine release (CCL2 and CXCL8) (Botos et al., 2011). The 
pathways that are activated by TLRs vary in the literature, but this may be due to the 
flexibility of the TIR domain to form heterodimers with different TLRs. For instance, 
dimers of TLR2 and TLR6 form in response to peptidoglycans released in eubacterium 
(Abbas et al., 2012) infections. 
 
 TLR3 role in detecting viral patterns 
TLR3 (CD283) has a large horse-shoe like configuration that allows it to form dimers 
with neighboring TLRs. TLR3 contains glycoprotein on the outer side of the structure, 
but the inner part of the molecule contains amino acids. The amino acids are highly 
positive charged making the TLR3 highly attractive for negatively charged dsRNA (Choe 
et al., 2005). TLR3 can be activated via a synthetic ligand polyinosinic: polycytidylic 
acid (Poly I:C) which is structually simular to a double-stranded RNA. TLR3 also 
responds to fragments of dsRNA released from DAMPs (Alexopoulou et al., 2001). TLR3 
has been identified intracellularly in the endosomal membrane, via the action of 
UNC93B1 in the ER, after detecting viral dsRNA molecular patterns in a variety of cells  
(Lee and Barton, 2014, Kim et al., 2008, Brinkmann et al., 2007, Alexopoulou et al., 
2001). Once there, TLR3 recognizes its dsRNA ligand from viruses and activates a 
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cascade of events mediated by the adaptor protein TRIF (Johnsen et al., 2006), such as in 
the TRIF/TRAM activation of NF-κB. The TIR domain in TLR3, can mediate another 
non-canonical TRIF interaction with tumor necrosis factor receptor-associated factor 
(TRAF). The TRIF/TRAM interaction results in Tank binding kinase (TBK)1 
phosphorylating nuclear translocation of interferon regulatory factor 3 (IRF-3) and the 
subsequent production of type I interferons (IFN; α/β). Type I IFNs mediate antiviral 
activities through the induction of cellular proteins that in turn participate in RNA 
degradation and inhibition of translation (Alexopoulou et al., 2001). Recent studies 
suggest that RNA released from either damaged tissue or dying cells also serve as ligands 
for TLR3 (Watanabe et al., 2011, Matsumoto et al., 2014, Kariko et al., 2004, Sun et al., 
2011) which make this TLR an interesting target in prolonged injured states. See Figure 









A drawing depicting toll-like receptors (TLRs) and their specific ligands. TLR 1,2, 
4,5 and 6 are found on the cell membrane and respond to bacterial fragments. 
Whereas, TLR 3,7,8 and 9 are found intracelluarly and migrate to the endosomes 
when activated by nucleic acid stimuli. The inset describes the anatomy of a TLR. 





































































































































































































































































































































































































































































































































































 TLRs regulatory role in development and repair 
1.13.3.1 Development 
In recent years, TLRs have been identified in the developing mammalian nervous system 
and in placental tissue (Zhang and Yang, 2012, Cameron et al., 2007, Mallard, 2012). 
Members of the TLR family were originally thought to be limited to the glial cells, 
however, recent studies using mice and human tissue sections suggest that neurons and 
neural progenitor cells express TLRs and regulate cell-fate decision (Rolls et al., 2007, 
Cameron et al., 2007, Lathia et al., 2008, Bsibsi et al., 2010, Sun et al., 2011). Several 
TLRs have been reported to be expressed in developing neurons and influence both 
proliferation and differentiation (Cameron et al., 2007, Lathia et al., 2008). For instance, 
TLR8 has been shown to regulate neuritic outgrowth and apoptosis during development 
in mice (Ma et al., 2006). Other studies show that TLR2 deficient adult mice have 
impaired hippocampal neurogenesis, whereas the absence of TLR4 resulted in enhanced 
proliferation of the hippocampal neurons (Rolls et al., 2007). Furthermore, the systemic 
stimulation of TLR2 via agonist administration reduced neonatal grey and white matter 
volume and increased the number of cerebral microglia in mice (Du et al., 2011).   
1.13.3.2 Repair 
TLR4 activation in microglia has been shown to induce a cascade of cytokine and 
chemokine responses that initiate a killing phase to get rid of the pathogen, which is 
considered to be a classical activation state (Colton, 2009). After the initial infection, an 
alternative activation state occurs for tissue support, repair and to engulf the debris as the 
gene profile of microglia changes from a pro-inflammatory to an anti-inflammatory. This 
is accomplished by cytokine release that suppresses the TLR4 receptors (Elward and 
Gasque, 2003, Colton, 2009). In the acquired deactivation state, different cytokines and 
chemokines are released that serve to repair the extracellular matrix to enable neuronal 
63 
  
maturation to continue (Dean et al., 2011). Thus defining the constituents of TLR 
pathways may also lead to a greater understanding of the process that occurs and the 
consequences to the developing CNS after an inflammatory exposure. 
1.13.3.3 Prolongation of injury by “repair” mechanisms 
These activation states may seem straightforward, however in the immature brain 
molecular and cellular studies show that white matter injury progresses after the initial 
inflammatory injury (Hagberg and Mallard, 2005). For instance, animal studies in mice 
that lacked functional TLR4 demonstrate less cortical neuronal damage after an LPS 
exposure and hypoxic-ischaemic insult than their wild-type controls (Lehnardt et al., 
2003) Lehnardt and colleagues (2003) suggested that there might be prolonged activation 
in TLR4 that is detrimental to neuronal development. Further studies on the consequences 
of prolonged TLRs activation are necessary to understand developmental and 
degenerative pathologies seen in the CNS after infection and/or damage. 
 Developmental role and irregular function of TLR3 
More recent studies demonstrate that TLR3 has a functional role in regulating neuronal 
proliferation in the developing brain (Cameron et al., 2007, Lathia et al., 2008, Bsibsi et 
al., 2010, Mallard, 2012). Cell proliferation and growth cone (see review of growth cones 
1.3.1) mobility requires vigorous cytoskeletal changes and TLR3 activation could 
function as an inhibitory process (Lathia et al., 2008). Moreover, Bsibsi et al. (2010) 
found that the microtubule regulator, stathmin, acted as an agonist for TLR3. During the 
inflammatory process of multiple sclerosis, TLR3 and stathmin were colocalized on the 
surface of astrocytes, neurons and microglia in postmortem human brain samples. In vitro 
studies show TLR3 activation via synthetic poly I:C or mRNA has been shown to reduce 
the numbers of neurospheres. TLR3 was found to be concentrated in the growth cone and 
its activation caused growth cone collapse or inhibited neurite extension (Lathia et al., 
2008). Thus TLR3 activation in other cells, such as neighbouring neurons and glia cells 
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may be associated with premature collapse of the growth cone and neuron during fetal 
development (Ma et al., 2006, Bsibsi et al., 2010). The multiple roles that TLRs have in 
both inflammatory responses and in developmental processes can ultimately lead to the 
induction or suppression of genes that orchestrate normal brain development. 
 
 Autophagy 
Autophagy is a cellular process used by cells for degradation of recyclable protein 
components and cellular organelles and is regulated by autophagy-related genes (ATG’s). 
Autophagy refers to the packaging and facilitation of recycling cellular proteins for 
digestion that occurs inside lysosomes in mammals (Boya et al., 2013, Mizushima et al., 
2011). Various types of autophagy are described in the literature, in one type, chaperone 
mediated autophagy, the folding protein is tagged by a chaperone molecule heat shock 
cognate of the Hsp 70 family. The tagged complex is recognised by lysosomal membrane 
proteins (LAMP) 2a  and allowed to pass into the lysosomal membrane where degradation 
and recycling occurs (Alvarez-Erviti et al., 2010). In another form of autophagy, 
macroautophagy, macromolecular complexes are formed and various ATG’s regulate 
induction (e.g. ATG1 and Beclin1), autophagosome formation (the processing of 
encoding microtubule-associated protein light chain 3 (LC3) to three different forms 
(LC3, LC3-I and LC3-II) by various ATG’s (ATG8, ATG4 and ATG7) fusion and 
recycling processes (e.g ATG22) (Mizushima et al., 2011). Both chaperone mediated 
autophagy and macroautophagy play an important role in the turnover of misfolded or 
aggregated proteins (Ma et al., 2013). 
Autophagy can be either non-selective or selective in the removal of specific organelles, 
ribosomes and protein aggregates. For instance, in mitophagy the autophagosome engulf 
dysfunctional mitochondria and the components are recycled (Green et al., 2011). In 
addition to the elimination of intracellular aggregates and damaged organelles, 
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autophagy, protects against genome instability and prevents necrosis. Recycling of 
mitochondria is particularly important in the CNS as damaged mitochondria produce 
excessive amounts of reactive oxygen species, promote inflammation and have a lower 
threshold of permeabilization leading to cell death (Hagberg et al., 2014). Furthermore 
under metabolic stresses, including energy deficiency, nutrient starvation, and 
pathological situations autophagy acts as a pro-survival mechanism for coping with stress 
and cells undergo a substantial amount of recycling of damaged material.  
Dysregulation of autophagy has been shown to have profound implications and has been 
associated with numerous diseases in the adult brain (Alvarez-Erviti et al., 2010). In our 
preliminary studies, in the human preterm brain, we have shown that in cases of WMI 
LC3-II is upregulated and is colocalised with the mitochondria, which suggests that 
another method of cellular adaptation to WMI may include mitophagy (Vontell et al., 
2013a, Vontell et al., 2015). The implications of continuous mitophagy in the developing 
brain are not well understood, however it is important to investigate how cells of the 
developing brain recycle mitochondria and the consequences of these processes of having 
a stressful event such as WMI or HI (Thornton et al., 2012). 
 TLR3 role in autophagy 
Similar to the other endosomal linked TLRs (i.e., TLR7 and TLR9), TLR3 has recently 
been identified in a variety of intracellular structures (e.g. endosomes, endoplasmic 
reticulum and mitochondria) in human monocyte-derived dendritic cells. The exact 
subcellular compartments that can provide a platform for TLR3 and dsRNA interaction 
and associated dsRNA-TLR3-mediated signalling are largely unknown (Sun et al., 2011, 
Johnsen et al., 2006). In dendritic cells, it has been shown that TLR3 remains in the ER 
until challenged with dsRNA viral stimuli and then translocates to endosomes and 
promotes endosomal maturation seen by the expression of lysosomal-associated 
membrane protein 1 (LAMP-1) (Johnsen et al., 2006). The ER contains resident proteins 
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such as calnexin and calreticulin (Desjardins, 2003) that serve as chaperones. As the ER 
components break away and form the phagosomes, they still contain calnexin and 
calreticulin, meaning that the ER is important to phagophore nucleation. Phagophore 
conjugation with LC3-II forms the autophagosome; an important mediator to autophagy 
and mitophagy or the degradation of damaged proteins and dysfunctional mitochondria 
(Sun et al., 2011, Hagberg et al., 2014, Zhu et al., 2005). Identification of TLR3 in neurons 
and glial intracellular structures is important to fully comprehend neuronal dysfunction 
after WMI has occurred as TLR3 could respond to endogenous damage signals and may 
influence premature collapse of the neuron with resultant atrophy of grey matter 
structures. Recently, it has been shown that TLR3 sensitizes the brain to HI injury (Stridh 
et al., 2013b) and TLR3 activation with Poly I:C during early fetal life produces 
behavioural problems resembling autism and schizophrenia in animal models (Meyer, 





 Reasoning, hypothesis and aims of the studies 
 Reasoning 
Preterm infants have reduced volumes of grey matter and impaired cortical development. 
Identifying changes in TLR expression may be key to understanding the disabilities in 
some children that were born preterm with WMI. TLR3 recognizes dsRNA, a form of 
genetic information carried by some viruses and DAMPs. The activation TLR3 induces 
the translocation of NF-κB and IRF-3 from the cytoplasm to the nucleus that will, in turn, 
stimulate the production of type I interferons. Recently TLR3 has also been shown to 
direct cell proliferation and growth cone fate although the mechanism of action is not 
entirely clear. In human derived cell culture experiments, TLR3 is robustly expressed on 
astrocytes, microglia and in neurons after activation of innate immune responses (Jack et 
al., 2005, Bsibsi et al., 2006). In human pathology studies of multiple sclerosis, TLR3 is 
predominately expressed on neurons and astrocytes (Bsibsi et al., 2010). In cases of WMI, 
altered TLR3 expression might influence normal developmental processes within the 
immature human brain especially in the PVWM regions. Furthermore, TLR3 activation 
might be a key factor in the decrease of thalamic volume seen in imaging studies of WMI 
as it may indicate that the cells are responding to extracellular DAMPs and are using 
inflammatory mechanisms to cope with an injurious environment. TLR3 activation has 
been shown to disrupt grown cones (Bsibsi et al., 2012), which would disrupt the 
migrating neurons that adhere to the radial glia or those that travel from the ganglionic 
eminence. Furthermore, growth cones are necessary for dendritic extensions that form 
after the neuron has reached its target. The role of TLR3 and the cellular populations 





Our hypothesis is that in the immature brain TLR3 expression can be identified on 
neuronal processes, functioning as a guidance signal. Secondly, we hypothesize that when 
the brain is challenged with LPS or WMI there is an increase in intracellular and 
extracellular DAMPs and alterations of TLR3 mRNA and TLR3 protein expression can 
be seen in both PVWM and in cortical structures. Moreover, we hypothesize that there is 
a redistribution of TLR3 receptors in thalamic neurons after WMI insult and that 
enhanced TLR3 expression in certain neuronal populations hinders thalamocortical 
connectivity. Finally, we hypothesise that an abundance of TLR3 activation on glia in the 
PVWM may also cause premature growth cone collapse, by either the breakdown of the 
radial glia structure or emission of inhibitory cues. The advancement in our understanding 
of how TLR3 behaves will continue to provide important insights into the function of 












TLR3 mRNA will be compared in LPS treated fetal sheep to sham sheep and in preterm 
human brain sections with and without WM pathology. Secondly, we will investigate if 
TLR3 mRNA translates into protein expression by the use of immunohistochemistry. 
Finally dual immunofluorescence-labeling techniques will be completed to visualise the 
TLR3 protein and define which cell populations express this protein in the PVWM and 
cortical regions of the frontal and parietal lobes.  
The second study investigates the subcellular localization and activation of TLR3, and its 
downstream signalling pathway in the thalamus and the posterior limb of the internal 
capsule.  
The last study investigates TLR3 expression on the growth cone seen in post-mortem 




 Materials and Methods 
 Tissue Samples 
 Human Cases 
Informed parental consent was acquired for post-mortem examination to include research 
according to National Health Service UK and Human Tissue Authority guidelines. Study 
ethics was obtained from the National Research Ethics Service (West London), UK 
(ethics number, 07/H0707/139; Post-mortem Magnetic Imaging (MRI) Study of the 
Developing Brain). Fourteen very preterm post-mortem brains (< 32 weeks gestational 
age (GA)) from neonates were used in this study. The primary cause of death in each case 
was given by the clinician and confirmed by the pathologist (Josephine Wyatt-Ashmead 
(JWA)). Evidence of chorioamnionitis was confirmed in the cases where the placenta was 
retained for examination. However, none of the cases had leptomeningitis or vascular 
thrombosis. Seven of the brains, that showed no significant brain pathology on gross and 
microscopic examination from post mortem examination were used as non-
neuropathological controls (control cases). The remaining seven brains showed cerebral 
white matter gliosis, lipid-laden macrophages and focal lesions with evidence of WMI 
upon pathological examination (WMI cases) using hematoxylin and eosin histochemical 
staining and immunohistochemical staining (i.e., GFAP and Iba-1). Cases with known 
cortical maldevelopment and germinal matrix haemorrhages were excluded from this 
study. Table 2.1 consists of a list of all of the cases, gestational age at delivery, the post 
menstrual age at death and the primary cause of death (see Table 2.1 Case data and 
comorbid factors). Additionally, human brain tissue from a case that was 35 GA weeks 
with disseminated Cytomegalovirus (CMV; a member of the viral family, Herpesviridae: 
CMV control) was used as a positive control. CMV infections in human peripheral blood 
mononuclear cells demonstrate an increased in TLR3 expression (Nahum et al., 2012).  
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 Tissue preparation  
The bodies were refrigerated (4 °C) prior to post-mortem examination that was performed 
within 2.5 days of death. Towards the end of the fixation period (5-10 days), the brains 
were sliced by a pathologist (JWA), and the tissue blocks were paraffin infiltrated using 
a  Bright Tissue Processor (Bright Instrument Co Ltd, Cambridgeshire, UK; see section 
2.3). Then the paraffin-embedded tissue blocks were sectioned at 6μm using a Leica 
RM2245 microtome (Leica Microsystems (UK) Ltd, Bucks, UK). Paraffin-embedded 
tissue sections from the frontal and parietal lobes (i.e, anterior and posterior level of 
Ammon’s horn) were used for immunohistochemistry. The location of the anatomical 
position were identified by JWA and confirmed by using a human adult atlas and a human 
preterm brain atlas (Mai and Paxinos, 2012, Bayer and Altman, 2002). See Appendix I 





















































































































































































































































































 Anatomical Location 
In order to correctly and confidently identify the regions of interest (ROI), I marked out 
different adjacent anatomical landmarks in the coronal plane. The position of caudate, 
lentiform nucleus, amygdala and the Ammon’s Horn were defined during the gross 
assessment of the brain. During microscope examination, I confirmed the position of the 
landmarks and the ROIs in the tissue sections using an adult and a preterm human brain 
atlas (Nolte and Sundsten, 2002, Bayer and Altman, 2002, Mai and Paxinos, 2012, Jones, 
2007, Sherman and Guillery, 2013).  
In Chapter 3, the cellular density and the TLR3 immunopositive cell counts were 
measured in ROIs from the anterior (F1, P1) and lateral (F2, P2) PVWM (primary region 
after WMI has occurred) from the frontal (F) and parietal (P) lobes. F3 defined a ROI in 
the premotor cerebral cortex from the frontal lobe sections. The regions were outlined 
using a standard hematoxylin eosin stain (Figures 3.1 and 3.2). Inferior anatomical 
landmarks associated with the frontal lobe (F3) and the PVWM region (F1 and F2) 
contained regions of the caudate head/body, the lentiform nucleus, amygdala and anterior 
Ammon’s Horn. A semi-quantitative analysis through the centre of the contour of region 
F1 was used to assess the density of TLR3 positive neurons (NeuN) and glia (astroglia, 
microglia and oligodendroglia). The F1 ROI was in the PVWM superior to the head of 
the caudate and the lateral ventricle; directly above the GM. F2 PVWM was lateral to the 
ventricle and directly above the top portion of the anterior internal capsule. The 
anatomical landmarks used to define the parietal lobe were the posterior caudate body/tail, 
the putamen island and mid-Ammon’s Horn (i.e., the dentate gyrus was visible). The 
parietal regions (P1 and P2) were designated as begin superior to the tip of the ventricle, 
whereas, P2 was lateral to the ventricle and above the tip of posterior internal capsule.  
In Chapter 4, the cellular populations explored were from the ventral lateral posterior 
(VLp), ventral posterior lateral nuclei (VPL) and the medial dorsal (MD) thalamic 
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regions. Additionally, two regions from the posterior internal capsule (PLIC) adjacent to 
the VLp (PLIC-VLp) and the VPL (PLIC-VPL) were investigated. These regions were of 
interest as secondary atrophy of the thalamus and the internal capsule have been found in 
imaging studies of WMI (Counsell et al., 2007). Sampling areas and the strategy for how 
the regions of interest were identified are shown using a standard haematoxylin and eosin 
stain (Figure 4.4). 
Three thalamic regions were determined by the anatomical landmarks (including the 
position of the globus pallidus in the lentiform nucleus), and the cellular architecture 
described in Sherman (2013), Jones (2007) and Bayer and Altman (2002). The ventral 
lateral posterior nuclei (VLp) and the ventral posterior lateral nuclei (VPL) were 
demonstrated as being medial to the external and internal globus pallidus respectively. In 
the thalamus, the VLp borders the ventral anterior (VA) and distinction is mainly 
determined by the change in cellular morphology. In the VA, the cells are composed of 
tightly packed cells, whereas, in the VLp the cells are larger, loosely arranged and are 
aligned along the finger-like projections from the internal capsule.  
The VPL and the ventral posterior medial are demarcated by the arcuate lamella, a slim 
white matter track. The medial dorsal (MD) nuclei was defined as lateral to the internal 
medullary lamina.  
Chapter 5 investigates the processes and the dendritic connectivity from the frontal lobe 
region and the thalamic regions explored in chapters 3 and 4. 
 Tissue Processing 
The preparation of tissue sections used in human neuropathology is generally performed 
in paraffin-embedded tissue as this method is optimal for investigations that require cell 
counts or the application of multiple antibodies (Dapson et al., 2005). Tissue embedded 
in a wax base can be sectioned with the use of a microtome, at 5-10 μm in thickness, and 
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then immediately mounted on a slide. The slides can be stored for months without 
compromising the protein stability (Key, 2006).  
The first requirement for preservation of morphological detail involves formalin fixation 
of the tissue that functions by crosslinking aldehyde groups in the fixative to the amino 
groups of proteins in the tissue (Carson, 1997). Fixation has an additional advantage in 
that it provides stability to the soft brain tissue, allowing the pathologist to slice the whole 
brains into tissue blocks. Once the tissue slices are properly fixed, they are processed by 
dehydration in a series of degrading ethanol solutions that removes, the free, non-
molecularly bond water in the tissue. The period in ethanol solutions must be kept 
consistent as excessive dehydration will remove the molecularly bound water making the 
tissue hard and brittle (Dawson et al., 2003), but if the dehydration is incomplete the tissue 
will be too soft and difficult to section (Carson, 1997). Normally heat and vacuum 
features are enabled during the tissue processing protocol, but the brain is composed 
mainly of molecularly bound water within the fatty matrix, thus heat and vacuum will 
only shrink the tissue. In order to compensate for the lack of heat and vacuum, prolonged 
times in ethanol are required for brain tissue (Vontell et al., 2010, Dawson et al., 2003). 
 Next the tissue is infiltrated with a clearing solvent, usually an aromatic hydrocarbon, 
such as butanol or xylene, that is miscible with both the dehydration agent and infiltration 
medium (Dawson et al., 2003, Carson, 1997). The reagents for this step have a high 
refraction index and render the tissue clear or transparent (Carson, 1997, Sheehan and 
Hrapchak, 1980). Finally, the tissue blocks are infiltrated and embedded in a mould using 
a supporting medium, paraffin, which holds the cells and cellular structures in place. 
Paraffin is an inert mixture of hydrocarbons and includes additives such as beeswax, 
rubber and plastics (Carson, 1997) that hardens at room temperature. The paraffin tissue 
blocks are sectioned using a microtome, an instrument that facilitates cutting tissue into 
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thin sections to enhance the ability of investigators to view nuclear detail and count cells 
in one slice of brain tissue (Vontell et al., 2010).  
 Sheep Brains 
Generation of the animal model and provision of tissue samples was carried out by Carina 
Mallard (Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of 
Gothenburg, Gothenburg, Sweden) as detailed below. Fetal sheep were randomly 
assigned to receive intravenous (i.v.) bolus infusion of either saline vehicle (control 
group; n=6) or 200 ng Escherichia coli LPS (055:B4; Sigma-Aldrich, St Louis, MO; LPS 
group; n=6) at 102.5 days of gestation (term 147 days). All experimentation was approved 
by the Animal Ethical Committee of Gothenburg, Sweden (#307-2006) and conformed 
to international guidelines on the ethical use of animals. All efforts were made to 
minimize the number of animals used and their suffering. At 10 days after LPS, ewes and 
fetuses were killed by i.v. overdose of sodium pentobarbitone. Fetal brains were perfusion 
fixed in situ with 0.9% NaCl solution then 4% paraformaldehyde in 0.1 M phosphate 
buffer (Histofix; Histolab, Gothenburg, Sweden). Brains were postfixed in 4% 
paraformaldehyde and paraffin processed. The paraffin-embedded tissue blocks were 
then sectioned at 10 μm using a Leica RM2245 microtome (Leica Microsystems) six to 
eight sections from the frontal region per brain where sent to King’s College London. 
Subsequent immunohistochemistry and in situ hybridisation was carried out by myself. 
 Immunohistochemistry (IHC) 
 Antibody-antigen interaction 
The antibody–antigen reaction in immunohistochemistry takes place between two protein 
macromolecules. The antibody, a glycoprotein, and the antigen (protein, glycoprotein or 
a  lipoprotein) have electrovalent attractions towards one another and form hydrogen 
bonds or hydrophobic adhesions on the fragment antigen binding (Fab) site (Goldsby et 
77 
  
al., 2003) also referred to as paratope. Antibodies consists of two pairs of chains, chains 
heavy (CH) and chains light (CL), are molecules that can be broken down into four proteins 
but together make a shape like a capital letter “Y” as they are linked by disulphide bonds. 
The tip of the “Y” has a constant and variable domain within the light and heavy chains. 
The variable domains or fragment variable (FV) contain numerous sequences that 
determine the complements or the composition of the glycoprotein. This region is 
designated as variable light (VL) and variable heavy (VH) to differentiate it from the 
constant chains. The structure of the “Y” consists of a fragment crystallizable receptor 
(FcR) and the heavy chain determines the isotype (i.e. IgA, IgD, IgE, IgG, IgM and IgY 
antibodies) referred to as the immunoglobulin. Certain enzymes (e.g., pepsin) act to 
cleave the base of the Y structure (CH2 and CH3) to expose the Fab fragment. The 
cleaved region is referred to as the fragment crystallised (Fc). See Figure 2.1.  
Antibodies are produced by plasma cells and used by the immune system to identify and 
neutralise invading or foreign proteins. Commercially antibodies are raised in host 
organisms, such as mice, rabbits, goats and guinea pigs. A foreign protein is injected into 
the animal (host) and the host will produce specific antibodies against the foreign invader. 
Most species (with the exception of mice and birds) will produce antibodies that are 
polyclonal IgG immunoglobulins, meaning that there are multiple antibodies to target the 
antigen (slight differences in the FV regions). Polyclonal antibodies target different sites 
of the antigen and have different rates of interaction. Temperature of incubation impacts 
the rate of interactions of polyclonal antibodies. In order to slow down the faster binding 
antibodies, it is recommended that incubation commences at 4 °C.  
 Antigen Retrieval 
The paraffin processing method can be problematic for application of some antibodies as 
the proteins tend to coil in shape making it difficult for the antibody to detect the antigen 
site (Tacha and Teixeira, 2002, Ino, 2003). The established immunohistochemical 
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technique used for antigen detection is more effective if additional steps are taken to 
amplify antigen sensitivity and decrease endogenous staining. The use of antigen retrieval 
(AR) methods have been reported to enhance antibody linkage to the antigen in several 
studies in pathology (Cartun et al., 2002, Key, 2006, Vontell et al., 2010, Lloyd, 2001). 
The mechanism of action of AR is not fully understood, but the most accepted theory is 
that it breaks the protein-formaldehyde crosslink formed during fixation and further 
enhances the antigen detection (Ino, 2003, Key, 2006).  
Several methods of AR are used in IHC, such as enzyme digestion (Pepsin, Trypsin and 
Ficin), heating with either a citrate buffer (pH. 6.0) or a detergent type buffer (pH. 8.0) 
(Sundquist and Nisenbaum, 2005). There are also various methods for heating the AR 
solution such as the use of a microwave oven, autoclave, water bath or steamer. In general 
studies that have investigated various AR techniques report that the stain was more robust 
with the use of AR, compared to the conventional methods (Ino, 2003, Cartun et al., 
2002). Studies performed on rat brain demonstrated that the use of citrate buffer (pH 6.0; 
heated in a steamer or microwave oven at 90-100 °C) intensifies the antigen detection 
(Vontell et al., 2010, Ino, 2003, Lloyd, 2001) of the antibody to the antigen site. Some of 
the problems encountered by this technique were tissue destruction and uneven staining 
due to partial dehydration and temperature fluctuations (Ino, 2003). The use of steam has 
been reported to maintain the optimal temperature of 90 °C, decrease the amount of tissue 
damage, and provide even staining (Tacha and Teixeira, 2002). Most manufacturers of 
antibodies recommend AR. However, this is considered to be best for paraffin-embedded 
tissue sections cut at 5.0-8.0 µm and fixed in formaldehyde. The development of a 
paraffin processing protocol makes AR possible without experiencing tissue loss. 
Methods that decrease endogenous staining and increase sensitivity can easily be applied 
in studies using both human and animal tissue sections (Vontell et al., 2010). 
79 
  
 Routine IHC 
I adapted the routine IHC described in pathology and neuropathology investigations 
(Vontell et al., 2010, Cartun et al., 2002). Paraffin removal was completed by heating the 
slides at 60 °C for 30 minutes which loosens and melts the wax. Next, the wax is fully 
removed by using three changes of xylene and rehydration by sending the slides through 
a series of containers with descending concentrations of ethanol (i.e., the opposite 
sequence described in tissue processing). 
Endogenous peroxidase activity was blocked by placing the slides into 3% hydrogen 
peroxide (H2O2) for ten minutes. This blocking step is routinely done as some cells 
contain endogenous peroxidase that will react with the substrate or the chromogenic 
solution, leading to false positive results (Sheehan and Hrapchak, 1980). Sections were 
immersed in preheated AR consisting of 10 mM citric acid (VWR International Ltd., 
Leicestershire, England) that has been pH to 6.0 with 5 ml of Tween 20 (VWR) for 30 
minutes and cooled in cold water. The key to AR is to allow the pH shift to occur prior to 
adding the tissue sections by heating the solution to a temperature above 90 °C for 20 
minutes (Key, 2006). The addition of Tween 20 to the AR solution allows for cell 
permeabilization, which creates pores large enough for antibody penetration without 
dissolving the plasma membrane. It is required for the detection of transmembrane 
proteins especially if the epitope is located in the cytoplasmic region (Key, 2006).  
Non-specific immunoperoxidase reactions of the antibody can bind to the highly charged 
collagen and connective components on the tissue sections unless these are blocked using 
an normal serum solution prior to adding the antibody (Sheehan and Hrapchak, 1980). 
The protein will bind to the charged sites and eliminate non-specific binding of the 
primary antibody (Carson, 1997).  Normal serum from the same host species from which 
the secondary antibody is made is the most common. The blocking solution that I applied 
was either a 5% horse serum or 5% goat serum (Vector Laboratories, Burlingame, CA) 
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depending if the secondary antibodies were horse anti (α)- mouse or goat α rabbit. As the 
project progressed in second and third investigations double and triple labelling were 
employed, and a universal blocking solution of 5% foetal bovine serum (FBS; Sigma-
Aldrich) was applied instead. Each blocking reaction was for 20 minutes before the 
primary antibody was applied.  
Problems with IHC can occur with inconsistencies in fixation or processing that can affect 
the antigen binding site making it unrecognisable to the epitope of the antibody. 
Inadequate AR times or AR solution that has not been properly pH fails to release the 
protein-formaldehyde crosslinks on the tissue section and the antigen site will be 
undetectable to the antibody (Key, 2006). The amount of antibody dilution should enable 
the macromolecules to move freely to avoid bombardment or the antibody proteins 
knocking each other off the antigen Fab site (Boenisch et al., 2001). The antibody solution 
should form a dome over the section to allow for proper movement and sufficient 
detection (Lloyd, 2001). Another problem can occur if there is too much serum or if 
protein additives are added to the antibody dilution buffer as this affects not only the pH, 
but also prevents the antibody from finding the antigen site (Montero, 2003). For the latter 
considerations, I chose to dilute the primary antibody in phosphate buffer saline (PBS) 
and incubate overnight at 4 ºC without adding preservatives to the buffer. The primary 
dilution was determined by running a series of primary antibody titration series on tissue 
sections that were outside the region of interest (ROI) to obtain the optimal dilution and 
to check for consistency between cases. Nonspecific chromogenic reactions were tested 
by using control sections that were run without the primary antibody as suggested 
(Boenisch et al., 2001).  Specificity of the TLR3 antibody was determined by using 
synthesized antigenic peptides from the protein of interest in a 10-fold excess with respect 
to the TLR3 antibody, which was mixed 24 hours before being added to the tissue section. 
In this type of preadsorption test, the antibody adheres to the peptide, which is specific to 
81 
  
the TLR3 protein. If there is immunoreactivity on the tissue section, then one can assume 
that non-specific proteins are in the antibody. However, the reliability of the 
preadsorption test is controversial as some studies show it fails to distinguish between 
labelling of the epitope of interest from splice variants (Holmseth et al., 2012). In animal 
studies, knock-out mice tissue samples are used to determine if an antibody cross-reacts 
with different epitopes (Baek et al., 2013, Holmseth et al., 2012). In human studies, 
antibody validation websites are recommended to check if an antibody has been 
previously used for the specific combination of application and species. Validation 
profiles of antibodies are included in databases such as Antibodypedia, CiteAb or Pivotal 
Scientific (Helsby et al., 2013).   
The following morning the slides were allowed to reach room temperature (1hr) and then 
rinsed in PBS to wash off excess antibody that had not adhered to the antigen in the tissue 
section. As the protocol was an indirect immunoreaction, I next added the biotinylated 
secondary antibody (1:100, Vector Laboratories) for 1 hour. The secondary IgG antibody 
is designed to detect both heavy and light chains on the primary antibody. The secondary 
antibody has been biotinylated meaning that it has a biotin molecule covalently attached 
to the protein. The biotin on the secondary antibody has a high affinity for the enzyme 
complex and will bind at a very fast rate, making it important to rinse the slides in plenty 
of PBS rinses to get rid of free roaming secondary molecules.  
The avidin biotinylated enzyme complex (ABC) is made up of avidin that has a high 
affinity for biotin molecules with four binding sites and the biotinylated peroxidase 
enzyme complex. The ABC must be made at least 20 minutes prior to linking the 
macromolecules to the biotin on the secondary antibody. For this reason, I consistently 
made the avidin-biotin complex 1 hour before incubating the slides for an additional 1 
hour in the ABC solution (1:200, ABC; Vector Laboratories). The primary, secondary 
and ABC complex produces a large molecule and is easily detected using a peroxidase 
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substrate. I visualised the reaction with a peroxidase substrate solution of 3, 3’-
diaminobenzidine (12 µg/ml; DAB) horse-radish peroxidase kit (Sigma-Aldrich 
Company Ltd.) made in PBS for 10 minutes. See Figure 2.1. 
The sections were then counter-stained with a solution of Gill’s haematoxylin (Thermo-
Fisher Scientific) which stains the nucleic acids in the nuclei (Sheehan and Hrapchak, 
1980). Finally, I dehydrated the slides through a series of ascending ethanol 
concentrations followed by a series of xylene rinses then coverslipped using a xylene 
compatible mounting medium. 
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Figure 2.1 Diagram of an immunoglobulin and the schematic diagram of the 
routine immunohistochemistry using the avidin-biotin complex reaction.
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The anatomy of the immunoglublin IgG is seen in image A that shows the within 
the fragment antigen binding site (Fab) there are variable regions (Fragment vari-
able (Fv) domains that allow for the specific interaction between antibody and 
antigen. Image B is a detailed drawing of indirect staining method used for routine 
IHC. 
  
 Double-label Immunofluorescence (IF) 
2.5.4.1 The purpose of IF 
Another indirect or direct way to identify proteins in tissue sections is via IF. The antibody 
and antigen interaction works much like IHC explained in 2.5.3.  However, in indirect IF 
techniques, the secondary antibody is conjugated to a fluorophore that can be detected via 
a fluorescent microscope (see Microscopy 2.6). The secondary antibody has a large 
number of fluorophore molecules per antigen to amplify the signal. In direct IF 
techniques, the primary antibody is chemically linked to the antibody. Although this 
method is less sensitive as the number of molecules linked to the primary antibody is 
limited, it has the benefit of being less time-consuming and showing limited cross-
reactivity. Fluorophore tagged primary antibodies are commercially available or can be 
made with fluorophore linking kits, such as Zenon. 
Double or triple labelling IF was used to identify the cellular location of the TLR3 protein 
within the WMI and the control brains. Each antigen, which was investigated was first 
tested on a single labelled specimen before co-labelling was attempted. This test was to 
assure that the antibody was optimised for IF and checked for non-specific 
immunoreactivity. The results from the individual immunoreactions were then compared 
to the dual reactivity to ensure that secondary antibodies did not bleed into other channels 
in order to control for false co-localisation. 
2.5.4.2 Compatible Reactions-antibodies made in different species 
The primary antibodies (e.g., mouse monoclonal and guinea pig polycolonal antibodies) 
that were compatible with the rabbit anti-TLR3 (0.1 μg/ml) were mixed in a cocktail 
solution in combination with the anti-TLR3. Sections were deparaffinised, blocked for 
endogenous peroxidase and pretreated with AR as described in 2.5.3 above, then sections 
were blocked in 5% FBS for 20 minutes before the primary antibodies were applied and 
incubated overnight at 4°C. Following primary antibody incubation as described in 2.5.3, 
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sections were rinsed three times with PBS, for three minutes each time before the 
secondary antibody were added. The samples were incubated for 1.5 hours in PBS 
containing the appropriate secondary antibody cocktails e.g. goat anti-mouse IgG 
conjugated to Alexa Fluor 488 (4 μg/ml; Invitrogen, Eugene, OR.) and goat anti-rabbit 
IgG conjugated to Alexa Fluor 546 (4 μg/ml; Invitrogen). Finally, the sections were rinsed 
three times with PBS, for five minutes each time. The sections were then coverslipped 
using ProLong Gold Antifade Reagent (Invitrogen) with 4', 6-diamidino-2.phenylindole 
(DAPI). DAPI stains all nuclei and is compatible with the reagents that prevent fading of 
the IF reaction. The slides are kept in the dark at 4 °C until analysis. (See Figure 2.2.) 
In order to co-label with incompatible markers or markers made in the same species, such 
as a specific marker of microglia (rabbit anti-ionized calcium binding adaptor molecule 
1 (Iba-1) Wako Chemicals GmbH, Neuss, Germany) and rabbit anti-TLR3, the antibodies 
were applied separately. In brief, one antigen-antibody interaction was labelled with the 
indirect IF technique, followed by direct antigen-antibody detection.   
The protocol involved using the same deparaffisation, endogenous blocking and AR steps 
as described in 2.5.3. and blocked as described in 2.5.4.2. except only one antibody (e.g., 
the anti-TLR3 (0.1 μg/ml; Abcam) was applied and incubated as described in 2.5.3. The 
following morning sections were rinsed three times with PBS, for three minutes each time 
and then were soaked for 1.5 hours in PBS containing Goat anti-Rabbit IgG conjugated 
to Alexa Fluor 488 (4 μg/ml; Invitrogen) followed by three rinses in PBS. The tissue 
sections were post-fixed in 4% paraformaldehyde (PFA) made in PBS for ten minutes 
and rinsed three times in PBS for 3 minutes each time. The aldehyde groups in the PFA 
would attract the amino groups on any unbound primary or secondary antibodies to 
prevent unwanted cross reactivity. An additional block in 5% FBS for 20 minutes was 
applied to the sections. During the blocking step the Fab-antibody complex was made, 
0.5 µg/ml of rabbit-anti-Iba-1 was conjugated to 2.0 µg/ml of Zenon Rabbit IgG 488 
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(Invitrogen) for five minutes followed by 2.0 ug/ml of Zenon blocking reagent for an 
additional five minutes (note: the Zenon conjugate to antibody mixture must be 4:1). The 
sections were then incubated with the Fab-antibody complex for 1.5 hours, which was 
followed by PBS rinses and postfixation in 4% PFA for twenty minutes and coverslipped 
as described in 2.5.4.2.  
Another incompatible marker combination was a rabbit anti-Neuronal Nuclear antigen 
(NeuN, Cy3 conjugate: Millipore) which stains the cytoplasm and nucleus of neurons, 
and rabbit anti-TLR3. Identification for the anti-TLR3 was the same as previously 
described above, except the secondary antibody to detect the TLR3 consisted of Donkey 
anti-Rabbit IgG conjugated to Alexa Fluor 488 (4 μg/ml; Invitrogen). Following the 
identification of the TLR3, the sections were rinsed in PBS and post-fixed in 4% PFA for 
ten mintues followed by incubation with NeuN, Cy3 conjugate (1:500) for 1 hour. Finally, 
the sections were placed under a coverslip as described in 2.5.4.2 
See Table 2.2 Primary and Peptides used for Immunolabeling and Table 2.3 Secondary 









647 546 488 DAPI 
The design for detecting three antigens on one tissue section and the fluorescence 
excitation and emission wavelengths. In image A, there are three antigens being 
targeted that linked with primary antibodies made in different species. The reaction 
will be linked to secondary antibodies conjugated with a specific fluorophore that is 
compatible with the primary antibody and will not cross react with the other 
secondaries. The excitation (dotted curves) and emission wavelengths (solid curves) 





























































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   






































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
































































































































































































































































































































































































   











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Brightfield microscopy (DM6000 Leica Microscope) 
In brightfield microscopy the dark sample is illuminated on a bright background via a 
light path. In the DM6000 Leica Microscope, the light source, a halogen bulb, sends a 
path of light through a condenser that modulates how much light is sent to the specimen. 
The sample contrast comes from absorption of light in the denser areas of the sample. The 
illumination sample contrast is magnified using different objectives, and the magnified 
image is viewed using the oculars or camera. Brightfield is used to see histochemical 
stains and routine immunohistochemical stains as described in 2.5.3. It was important to 
standardise the light intensity and the condenser to quantify the bright-field images. 
 Epifluorescence 
An epifluorescence capability is attached to the DM6000 Leica Microscope and uses a 
different light source (mercury-vapour lamp). The other components include an excitation 
pinhole, dichromatic mirror, objective, emission filter ocular and detector. The mercury-
vapour lamp has a glass tube with a small amount of mercury, which will emit high-
energy light when there is an electrical discharge. The light path runs from the source to 
the dichromatic mirror. The mirror reflects light shorter than a particular wavelength and 
transmits light longer than that wavelength; meaning that the shorter wavelengths from 
the lamp will be reflected towards the specimen and longer wavelengths are magnified in 
the objective. When a fluorophore reaction is added to the specimen, molecules absorb 
high-energy light (e.g., ultraviolet light). This reaction increases the energy of the 
molecules (excitation); some of the energy is lost internally but most will emit photons 
with less energy (e.g., green) or longer wavelengths. The longer wavelength will be 
transmitted through the dichromatic mirror to the emission filter which limits the 
returning light to one region of the spectrum that correlates to the range of emission 
spectra from the fluorophores. The fluorescence microscope has multiple channels with 
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different emission filters which allow for sequential imaging of different fluorophores 
before the light goes to the ocular lens. A conventional system will allow for the 
visualisation of fluorophores that have an emission spectra of approximately 405nm, 
488nm and 546nm. The light from outside of the focal plane cannot be filtered which is 
a limitation of an epifluorescence system as it limits the resolution of cellular structures. 
The optical resolution of an epifluorescence system is 200 nm, this is ideal for checking 
if the fluorescent reaction is visible but not for protein colocalisation. 
 Confocal laser scanning microscopy 
The confocal laser scanning microscope facilitates the acquisition of cellular and 
intracellular structures to reveal intricate resolution of 0.1-10 nm (Diaspor et al., 2008). 
The Leica SP5 spectral confocal microscope has the ability to sample in the axial or Z-
plane known as optical sectioning. The scanning is a combination of spot illumination 
and spot detection samples on the x, y-plane.  
The confocal system has four-point source gas lasers (diode laser 405nm, Argon 488nm, 
Helium Neon (HeNe) 543nm and 633 nm) to provide the excitation light. The laser hits 
two dichromatic mirrors which are mounted on motors; these mirrors scan the laser across 
the sample. The high intense emitted light passes through the dichromatic mirrors and is 
focused onto a pinhole to a detector or photomultiplier tube (PMT) to produce three-
dimensional difraction patterns called airy disks. The airy disks are seen on the screen as 
airy patterns or a disc surrounded by concentric rings (Diaspor et al., 2008). The PMT is 
a more advanced emission filter, with the ability to limit the light energy emitted by a 
fluorophore. Using one PMT at a time and limiting the light path permits the use of 
multiple fluorophores.  
Resolution or the ability to visualise two points as separate depends on the numerical 
aperture (NA) of the objective and the excitation wavelength. The resolution determines 
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the diameter of the pinhole or airy units (AU). The diameter of the pinhole defines the 
area of the airy disk that can be seen. Using Rayleigh criteria one can then determine an 
objects lateral and axial resolution in nm.  
NA=n *sinα 
Where n equals the refractive index of the immersion medium and sin α is the angular 
aperture of the objective (the fixed angle of the objective lens where photons are 
collected).   
Lateral resolution = 0.61 ƛ/ NA 
Axial resolution = 2ƛƞ/ (NA) 2 
This equation ƛ equals the excitation wavelength of a fluorophore (e.g., 488, 546 or 647).  
Using this Rayleigh criteria I could theoretically resolve structures with fluorophore 488 
or 546 using the 63x objective as small as 212 nm and 238 nm respectively using 1 AU 
pinhole. Lowering the pinhole diameter increases the resolution but then signal intensity 
is lost. Hence, keeping the pinhole at 1 AU maintains the signal intensity, and I further 
compensate for the resolution by scanning the same Z-plane multiple times a process 
termed binning. Binning allows optimal resolution and can be mathematically expressed 
as: 
Lateral resolution = 0.61 ƛ/ NA/sampling frequency 
Axial resolution = 2ƛƞ/ (NA) 2/sampling frequency.  
Using the example above and scanning an area 3 times would provide a resolution of 70 
nm and 79 nm respectively.  
These formulas help determine what the resolution could theoretically be and are useful 
as a guide to determine what cellular components can be investigated using the confocal 
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microscope. Another consideration, to obtain optimal resolution, is the projected pixel 
size of the sample, which is determined by objective power and expressed by the formula: 
Projected pixel size = 0.61*ƛ/NA*objective power 
For instance, using a 488 fluorophore and a 63x objective with an NA of 1.4, the projected 
size of the pixel is 13.34 per µm. Binning is factored in by dividing the projected size by 
the number of times the area is sampled.  
projected size after binning = 0.61*ƛ/NA*objective power/sampling frequency 
In the example above the projected pixel size, was calculated to be 13.34 per µm, 
factoring in a sampling frequency of 3, means that the optimal pixel size will be 4.44 per 
µm. The projected size is important to consider as it indicates what the pixel size of the 
detector or the charged coupled device (CCD) will be, i.e., the optimal resolution. In a 
confocal image, the smallest resolved structure should be represented by at least two to 
three pixels. Increasing the number of pixels in an image or increasing the zoom factor 
(decreased the area of imaging) can increase the optimal resolution of the CCD camera 
but it may overexpose the sample and cause photo-bleaching. Calculating how the pixel 
dimension and zoom option affects the pixel size can be done using the following formula. 
Pixels/µm = 𝟏/√(𝒂𝒓𝒆𝒂 (µ𝒎𝟐))/ (𝒑𝒊𝒙𝒆𝒍 ∗ 𝒑𝒊𝒙𝒆𝒍)) 
For example, a confocal image with the 63x objective will provide an area of 77.5*77.5 
(6006 µm2) and the camera set to image at 1024*1024 pixels (1048576 pixel2) will 
contain 13.21 pixels per µm. This resolution factor is important as the TLR3 (i.e., the 
smallest object on the image) seen in the ER convoluted surface measured about 0.5-2 
µm. Sampling at these dimensions equates to six pixels per object of interest, if the sample 
frequency is set to 3 then this is reduced to 2 pixels per µm. This setting is adequate as it 
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oversamples the objects, a factor that is important for colocalisation quantification 
discussed in the next section. 
  Colocalisation duals  
The cellular location of TLR3 was performed with a semi-quantitative analysis through 
the centre of the contour of region VLp, (see Chapter 4) as this thalamic region has 
neurons with the largest cell body and thick axons. An average of eight confocal double-
labelled and triple-labelled microphotographs per case were captured for each analysis 
using a Leica SP5 spectral confocal microscope. The microscope settings were 
appropriate to the fluorophores present using a 63x objective (0.006 mm2) to provide an 
average resolution of 75 nm, which allowed for optimal oversampling for the structures 
of interest. Colocalisation was tested in Image J (version 1.42; National Institute of 
Health, Bethesda, MD., USA) in three points in the z-stack of each image by the student 
volunteer (C.S.A.) who was blinded to the case data. All colocalisation duals that were 
performed were first evaluated using Costes approximation test, which determines if all 
the randomised images had worse correlation than the real images to assure that the 
similarity of shapes between two images was not due to chance. If  > 95% of the randomly 
generated pixel arrangements correlate worse than the real image, then the correlation 
coefficient can be trusted. The colocalisation coefficient is based on Mander’s correlation 
analysis (r) and formula: 
r= ∑  𝑺𝟏 ∗ 𝑺𝟐/ √∑(𝑺𝟏)𝟐 ∗ ∑(𝑺𝟐)𝟐 
S1: intensity in pixel in channel 1 
S2: intensity in pixel channel 2 
 
This formula describes the correlation of the intensity distribution from the bit images 
given by two channels and r will range between 0 (no colocalisation exists) and 1 
(complete colocalisation). The colocalisation analysis were first tested on IF where the 
antigens detected that did not contain overlapping pixels (e.g., astrocytes and microglia 
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staining; r = 0-0.2) and then antigens with complete overlapping pixels (e.g., mouse-anti-
olig2 and rabbit anti-olig2; r= 0.8-1.0).  
Data from the colocalisation duals in chapter 4 were analysed with a Student t test using 
a Mann-Whitney post-hoc test between groups (WMI and control) in the VLp thalamus. 
Data were presented as mean ± SD and significance was set at p < 0.05. All statistical 
analyses were performed using GraphPad Prism 6.0.  
 Qualitative methods 
Descriptive measures used in Chapters 3-5 complemented the cell counting methods 
(section 2.8). Qualitative analyses are descriptive interpretations of the staining results 
used to compare the control from the disease group. These analyses provide large amount 
of information. It is used to evaluate the precise location of the target protein and 
identifies what cell types are positive or negative. The morphology of the IHC, IF and 
ISH results were mainly qualified based on the distribution of staining results (i.e., focal 
to the nucleus or diffusely spread into the cytoplasm).  
 Cortical assement  
As described in section 1.4 the cortex is made up of six layers and each layer has a distinct 
cellular pattern. In the preterm brain these layers are not yet well defined (see section 1.3), 
however, there are certain aspects of the cortical layers that can be identified. The cortical 
region of the superior frontal gyrus was used in Chapter 3 to analyse the sheep and human 
brains. The cortical regions were imaged using 10 high power field  (hpf) images captured 
using a 40x objective (0.0426 mm2) with a bright-field microscope (DM6000 B; Leica 
Microsystems (UK) Ltd, Bucks, UK) equipped with a motorized specimen stage for 
automated sampling (MicroBrightfield, Inc.), a CCD colour video camera 
(MicroBrightfield, Inc.) and captured using Picture Frame software (MicroBrightfield, 
Inc). The images were stitched together using Photoshop Software (CS3; San Jose, 
California, USA). In the sheep sections, the IHC and ISH results were qualitatively 
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analysed by the morphology of the staining. In the human sections, the cortical images 
were divided into three regions. The first cortical region included layers 1-3 and was 
determined by the presence of the marginal layer and the small pyramidal neurons found 
extensively in layers 2-3 (i.e., the external granular layer and external pyramidal layer). 
Layer 4, has pyramidal cells and spiny stellates’, this layer is very thick in the frontal 
lobe. Thus, the second region analysed was mainly from the lower parts of layer 3 that 
were not included in the first region and layer 4. Layer 5 has distinct large pyramidal 
neurons (Betz cells) making this layer distinguishable from layer 4. The third region, 
included layer 5 and 6 which were marked by the presence of the large nuclei in layer 5.  
 Quantification methods 
 Cell counting methods in studies using human preterm brain tissue 
Histological based studies have historically been qualitative descriptions that lacked 
unbiased objective quantification (West, 2012). Stereology provides a way to randomise 
large sections of the brain and derive unbiased, stereological quantitative data.  In cases 
of WMI, the white matter is soft, and edema is found in the water shed areas which distorts 
the shape of these structures. Skill and patience are needed to section the brain material 
as these sections can easily tear or fragment. Methods using the stereology microscope 
are employed to ensure population estimates are unbiased and representative of an area 
of interest. An important aspect of stereology is that in the selected area all cells have an 
equal chance of being counted and each cell is counted only once (West, 2012). Moreover, 
the protocol or standard operating procedure used to acquire the data must be descriptive 
so that the test can be repeated.  
The methods applied in sampling human brain tissue vary. For instance, in Ligam et al 
(2009), the neuronal counts were assessed per mean using four hpf images taken at 40x 
(Ligam et al., 2009). This method is not very accurate as the investigators have to ensure 
that they are sampling with unbiased images and that the cells in one field of view are not 
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re-counted in the next image. Billards et al (2008) quantified cells using a stereology 
microscope and placing 1 mm2 grid outline on the tissue section and then assessed glia 
pathology based on the highest number of immunopositive cells pre hpf within the boxed 
region (Billiards et al., 2008). Although Billard’s method was more systematic, the 
authors did not reveal how many fields per view were assessed. Kinney et al (2012) 
employed a 2 mm2 grid outline using a stereology microscope and expressed the neuronal 
density as neurons/mm2 (Kinney et al., 2012) using Neurolucida to randomise the 
counting frame.  
I adapted Kinney’s method for Chapter 3 and discussed the parameters in more detail, 
such as how many hpf were assessed and specifics of the stereology. The Optical 
Fractionator Program for randomising cell counting was employed as it is more 
appropriate for a monolayer of cells (West, 2012). This stereological program is ideal for 
thin sections (less than 10 µm thickness) and for obtaining a population estimate when 
the protein of interest is not uniformly distributed throughout a wide area. Exhaustive 
counting eliminates sampling bias as several sites in a specific field are examined.   
As this study advanced into multiple brain regions in limited areas, it was decided to 
maximise the cell counting in several ROIs. In chapters 4 and 5, I utilised a slightly 
different method of counting cells using a large scan of the ROI (average 2.1 mm2). This 
method was achievable after the stereology was upgraded, and modules were added that 
allowed for mosaics to be made. Subsequently, we purchased a cell counter/analyser 
program, Image-Pro Premier (Media Cybernetics) which enabled us to write scripts for 
systematic counting and to quantify the immunoreactivity.  
2.8.1.1 Randomised Counting used in Chapter 3 
An unbiased count of the number of TLR3 immunopositive cells and the total number of 
cells were screened by two individuals (RV and CT; blind to the case data) using the 
Optical Fractionator Program (MicroBrightfield, Inc., Colchester, VT). The sections were 
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examined under bright-field microscopy using a light microscope (DM6000 B; Leica 
Microsystems (UK) Ltd, Bucks, UK) equipped with a motorized specimen stage for 
automated sampling (MicroBrightfield, Inc.) CCD colour video camera 
(MicroBrightfield, Inc.) and stereology software (Stereo Investigator, v8.27; 
MicroBrightfield, Inc). The average area of each contour of the PVWM regions (F1, F2, 
F3 and F4) was 14 mm2 made using a 1.25x objective. The area associated with the 
movement of the microscope stage to the sample location (a step) was 2.5 x 10
4 µm2. The 
dissector profile, or the sampled area frame (a frame) was 900 µm
2 for an average of 54 
counting sites which was conducted using a 40x objective (0.0426 mm2). The cortical 
area in the frontal lobe (F3) had an average contour of 1.5 mm2 made using a 1.25x 
objective. In F3 area of the a step 3.0 x 10
4 µm2 with a sample area or aframe of  3.6 x 10
3 
µm2 was used as cellular morphology required a larger sampling dissector. (See figure 3.1 
and 3.2 for anatomical locations). 
The total number of cells and the TLR3 positive cells counted was calculated as (N): 
N=∑ 𝒐𝒃𝒋𝒔 
The estimated number of total cells and TLR3 positive cells were made using the Optical 
Fractionator methodology (Ne): 







The sum of objects counted are multiplied by the reciprocal of the quotient from aframe/astep 
(asf) and the reciprocal of thickness sampling fraction (tsf). All analyses were normalised 
to mm2 by dividing the cells numbers by the area (mm2) of the contour. The data was then 
analysed as ratios; the TLR3+ cells were divided by the total number of cells.  In the pilot 
studies and in the analyses the counting frame and dissector profile described was deemed 
appropriate as the estimated coefficient of error (Gundersen m=1 and Scheaffer) was 
within an acceptable range (i.e., below 0.5) (Gundersen et al., 1999).  See Figure 2.3. 
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A semiquantitative analysis through the centre of contour of region F1 was used to assess 
the density of TLR3 positive, neurons (NeuN) and astrocytes (GFAP). The average 
number of TLR3 immunopositive cells were calculated from 20 images taken with a 40x 
objective (0.0426 mm2). The multichannel images were captured with a Leica microscope 
DM 6000 B (Leica Microsystems (UK) Ltd) equipped with a motorized specimen stage, 
which prevented redundant sampling. The images were processed in Image J (version 
1.42; National Institute of Health, Bethesda, MD) before final processing in Adobe 
Photoshop (version 11.0.2; Adobe Systems Inc., San Jose, CA). Finally, the images were 
counted using Image J (version 1.42) by two student volunteers (M.H.A. and C.S.A.) who 
were blind to the case data. Examples of the multichannel images were taken using a 
Leica SP5 spectral confocal microscope with settings appropriate to the fluorophore 
present using a 63x objective (0.006 mm2). 
Data from the PVWM investigations were analysed with a one-way ANOVA followed 
by Tukey’s multiple comparison tests to compare the ratio of TLR3 positive cells between 
groups (WMI and control) in the PVWM region of the frontal lobe and frontal-parietal 
lobe. The cortical assessment (F3) and semi-quantitative analysis through the region of 
F1 was analysed with a student T-test followed by a Mann-Whitney U test to analyse the 
data. Data were presented as mean ± SD and significance was set at p < 0.05. All statistical 






Figure 2.3 Systematic and randomised counting
A section counting grid is seen in A, 16 fields of view at 40x are represented by the 
white dotted lines that measure 2.5 x 104µm2. The dissector (900 µm2) region 
(green and red box) where the cells are counted and is seen in image A and B. In 
B one field of view, all nuclei are marked with the blue crosses in the dissector 
whereas the pink stamps mark the TLR3 positive cells. Note: the dissector will be 
randomly placed within the grid in each field of view.
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 Large mosaic counting used in Chapter 4 and 5 
2.8.2.1 Calibrating the cell counting program 
An unbiased count of the number of cells positive for each antigen of interest (i.e., TLR3, 
GFAP, Iba-1, HuC/HuD and Drebin) and the total number of cells (i.e., hematoxylin 
positive nuclei) were counted using the CM1 and CM2 modules for virtual tissue scan 
(MicroBrightfield, Inc., Colchester, Vt., USA). The sections were examined under bright-
field microscopy using a light microscope (DM6000 B; Leica Microsystems Ltd., Bucks, 
UK) equipped with a motorized specimen stage for automated sampling 
(MicroBrightfield, Inc.), CCD colour video camera (MicroBrightfield, Inc.) and 
stereology software (Stereo Investigator, v8.27; MicroBrightfield, Inc.). The microscope 
settings illumination, the aperture diaphragm and exposure time were calibrated 
according to manufacturer’s recommendation. The average area of each contour was 
encompassed by a region of 2.1 mm2, which was made using a 5x objective to provide an 
average of 40 high power field images per scan collected using a 40x objective (0.0426 
mm2) and then counts were automated using Image-Pro Premier Program (Media 
Cybernetics, Warrendale, PA). For each of the counting profiles described, I conducted a 
pilot study usings two students who were blind to the case data. First the students counted 
both the haematoxylin positive nuclei and the cells with immunostaining using Image J 
manual cell counter then counts were acquired from the scripts written with Image-Pro 
Premier Program. The pilot study showed that there was a minimal difference between 
the two methods of counting.   
2.8.2.2 GFAP and Iba-1 Scripts 
All cells (i.e., haematoxylin positive nuclei) were counted in MD, VLp, VPL thalamic 
nuclei and in both the PLIC regions with each glia and neuronal assessment performed. 
After the nuclei had been counted, the cellular density of GFAP and Iba-1 
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immunopositive cells were quantified by RV and a student volunteer who were both blind 
to the case data. The tissue scans were reviewed by RV to ensure that the glia had met the 
criteria of a haematoxylin positive nucleus (cells > 10 µm2) with an immunopositive 
cytoplasm to avoid counting non-specific staining, background or fragmented 
components. Using the Image-Pro Premier script writing program, we identified the 
nuclei based on color threshold intensity set at a range of greater than 0 bytes but less 
than 110 bytes in a 250 bytes scale this allowed for the identification of immunopositive 
cells and immunonegative (i.e., nuclei that were hematoxylin positive). The background 
correction channels was adjusted so that the script found objects defined in the color 
threshold parameters, but ignored the background (yellow circles; Figure 2.4). The 
morphology channels were set to define edges and find objects that fit the desired 
parameter. The immunopositive scripts for GFAP and Iba-1 used the above methodology 
to define background and morphology. However, the colour intensity was limited to being 
less than 60 bytes. Additionally a criteria for immunopositive GFAP or Iba-1 cells was 
defined, as begin attached to a haematoxylin positive nucleus and having a 
immunoreactive cytoplasm. The criteria helped exclude fragments from being counted as 
an immunopositive cell.  See Figure 2.4 
Data were analysed using a one-way ANOVA followed by Tukey’s Multiple Comparison 
tests to compare the ratio between groups (WMI and control) in the different thalamic 
nuclei and in the different regions of the PLIC. Data were presented as mean ± SEM and 
significance was set at p < 0.05. All statistical analyses were performed using GraphPad 







































































































































































































































































































2.8.2.3 HuC/HuD Script 
HuC/HuD is a neuronal marker that identifies the entire lineage of neurons from newly 
differentiated neurons to established (non-migrating) neurons. HuC/HuD has been 
historically used for mesenteric and cerebellar neurons (Phillips et al., 2004), we found 
that this marker was more consistent than the traditional NeuN marker. Although NeuN 
is routinely used to mark neurons, the protein expression has been shown to be 
compromised when neurons are challenged with a cerebral ischemic event (Unal-Cevik 
et al., 2004). The disadvantage of using the HuC/HuD antibody is that it is only available 
as a mouse monoclonal antibody, which meant that it was more challenging for some of 
the triple labelling techniques. However, the robust staining obtained from using the 
HuC/HuD antibody made this marker ideal for defining and calculating neuronal 
populations. 
HuC/HuD immunostaining results in dense staining of the nucleus and a granular 
cytoplasm. To calculate the HuC/HuD immunopositive neurons and not the HuC/HuD 
negative haematoxylin positive cells (i.e., the glia cells), I employed the use of the track 
and trace data analysis Image-Pro Premier Program (Media Cybernetics). The tracking 
data analysis uses the same program platform as the child-parent applications described 
in section 2.8.2.5. First all the counted cells were tracked using the same script as that  
described in section 2.8.2.2. Next the trace morphometry data analysis was applied to find 
those cells that were HuC/HuD positive cells (i.e., neurons). This quantification option 
enabled me to trace the neurons by setting the intensity level to count all cells less than 
60 bytes.  See Figure 2.5 Counting neuronal cells. 
Data were analysed using a one-way ANOVA followed by Tukey’s Multiple Comparison 
tests to compare the ratio between groups (WMI and control) in the different thalamic 
nuclei and in the regions of the PLIC. Data were presented as mean ± SEM and 
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significance was set at p < 0.05. All statistical analyses were performed using GraphPad 
















































































































































2.8.2.5 Parent Child Application 
The area of TLR3 immunoreactivity was determined by dividing each TLR3 scan into 
four equal quadrants (500µm2) and using the Image-Pro Premier, parent-child application 
(Image-Pro Premier, Media Cybernetics). I defined the nucleus and the cytoplasm with 
the TLR3 positive regions as the “parent.” Next, I defined the TLR3 immunoreactivity in 
the cytoplasm, each aggregate of TLR3 immunostaining was detected per cell and these 
were considered the “children” (Misselwitz et al., 2010). TLR3 immunoreactivity area 
(µm2) detected per cell (sum of the area in the children per cell) was averaged for each of 
the thalamic and PLIC regions (Misselwitz et al., 2010). See Figure 2.6. 
Data were analysed using a one-way ANOVA followed by Tukey’s Multiple Comparison 
tests to compare the ratio between groups (WMI and control) in the different thalamic 
nuclei and in the different regions of the PLIC. Data were presented as mean ± SEM and 
significance was set at p < 0.05. All statistical analyses were performed using GraphPad 













































































































































































































2.8.2.6 Analysis of IRF-3 signal  
Translocation of IRF-3 signal from the cytoplasm to the nucleus was determined using 
the parent-child application (Image-Pro Premier, Media Cybernetics) in a different 
manner. In each case, I tested an average of 50 nuclei obtained using a 63x objective on 
the confocal microscope in the VLp region of the thalamus (see Fig. 4-1). DAPI staining 
determined the nuclear boundary and the threshold were maximized to achieve a solid 
object (“parent”). Next the IRF-3 intensity was averaged using the confocal report 
generated for each image stack for all the cases (i.e., WMI and control). The IRF-3 signal 
intensity average was used to set the threshold minimum and maximum to register how 
much signal (“child”) was in each nucleus  (Misselwitz et al., 2010). The percent of the 
parent that contained children was measured for each nucleus. The averaged percent was 
then calculated for each case and entered as a data point for either WMI or control. 
Data were analysed using a one-way ANOVA followed by Tukey’s Multiple Comparison 
tests to compare the ratio between groups (WMI and control) in the different thalamic 
nuclei and then in the different regions of the PLIC. Data were presented as mean ± SEM 
and significance was set at p < 0.05. All statistical analyses were performed using 






Figure 2.7 Analysis of IRF-3 signal  
The script written to measure translocation into the nucleus. The nuclei stained with 
DAPI are seen in image A, these are converted into solid objects by maximising 
colour threshold (B). The intensity of the IRF-3 signal was averaged for all nuclei, 
this threshold was used to tag and measure the IRF-3 (C). The nuclei and the IRF-





2.8.2.7 Dendritic Spine Evaluation  
Chapter 5 involved identifying potential dendritic spines stained with mouse-anti-drebrin. The 
immunoreaction revealed fibrous extensions that projected from the cells of the thalamus and 
the cortex. The average area of each contour was encompassed by a region of 2.0 mm2, which 
was made using a 5x objective to provide an average of 40 high power field images per scan 
collected using a 40x objective (0.0426 mm2). Then the scans were divided into four equal 
quadrants (500µm2). Measuring the drebrin signal required the application of filters that 
thinned the immunopositive processes and segments of the branches (Image-Pro Premier, 
Media Cybernetics). The dendrites were segmented by applying a thinning filter to make them 
1-pixel thick. Then a branch end filter was used, which assigned different values to end-points, 
skeleton and branch points. In other words, pixels with pixels on each side made up lines, a 
one-sided pixel was considered an endpoint and three sided pixels were branching points 
(elements). After the pixels were vectorised the image made a skeleton of the dendritic 
extensions, which were measured in microns (length). Pilot studies were conducted using a 25 
µm calibration grid. In brief, images of the grid were taken, and different sections were 
eliminated in the picture, which provided a series of measurable objects. The images were 
calibrated; the lines were segmented, filters were applied, and the lines were measured. The 
measures of the lines were compared to manual measures that revealed that the program 
appropriately measured the solid lines of the alignment grid. See Figure 2.8 
Data were analysed using a one-way ANOVA followed by Tukey’s Multiple Comparison tests 
to compare the ratio between groups (WMI and control) in the different thalamic nuclei and in 
the different regions of the PLIC. Data were presented as mean ± SEM and significance was 
set at p < 0.05. All statistical analyses were performed using GraphPad Prism 6.0 (Graph Pad 









Figure 2.8 Measures of potential dendritic connections 
  In image A, the program was tested using an image from the 25 µm alignment 
grid for the microscope camera. Anti-Drebrin immunoreactivity is seen in 
image B. In C, the threshold was set to exclude the hematoxylin positive nuclei 
so that the thinning and vector filters could be applied so that the processed 





2.8.2.8 Cortical Dendritic Spine Evaluation  
The cortical regions evaluated in Chapter 5, were obtained as described in section 2.8.2 
using large mosaic scans to capture the entire cortical length. Then cortical regions were 
divided into regions as described in section 2.7.1, but with the addition of a grid overlay 
with 250µm2 spacing using the Image-Pro Premier processing application (Image-Pro 
Premier, Media Cybernetics). This enabled me to systematically measure the drebrin (as 
described in section 2.8.2.7) in each cortical region by maintaining the same calibration 
of the original scan, in order to normalise the data.  
 In situ hybridization (ISH) 
In-situ Hybridization (ISH) is the process of establishing a non-covalent, sequence-
specific interaction between two or more complementary strands of nucleic acids using a 
labeled deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) strand (i.e., probe) to 
localize a specific DNA or RNA target in a section of tissue (in situ). ISH represents a 
merger between molecular biology and histochemical techniques to study genetic 
expression. This is distinctly different from immunohistochemistry, which localizes 
proteins in tissue sections based on the affinity an antibody has to a particular antigen. 
ISH is used to determine the structure of chromosomes, measure and localize mRNAs 
within tissue sections (Lloyd, 2001) offering the ability to visualize very low levels of 
transcripts while preserving the cell’s integrity.  
In brief, polymerase chain reaction (PCR) amplifies a genetic sequence of interest which 
is then ligated and propagatated in bacterial culture. The bacteria cell that contains the 
desired genetic inset is allow to replicate. The plasmid deoxyribonucleic acid (DNA) from 
the bacterial culture is sequenced and compared to the orginal reference code. The DNA 
is then linearised using specific restriction sites. The transcription reaction produces a 
digoxigenin-dUTP labeled mRNA probe that can be applied to a tissue section.  
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  Probe Production for ISH 
2.9.1.1  PCR  
PCR is a method for amplifying a genetic sequence, used for both the production of 
complementary deoxyribonucleic acid (cDNA) templates and target DNA synthesis. A 
small fresh frozen sample of human or sheep brain tissue (100 mg) was required for RNA 
preparation. The tissue sample was homogenized using a Dounce type tissue grinder (10 
strokes) in 1ml of Trizol (Invitrogen). Chloroform (0.2 ml) was added to the homogenate, 
mixed thoroughly and centrifuged for separation into organic and aqueous phases. The 
aqueous phase was carefully removed into a fresh tube, ethanol added (0.53 v/v) and the 
solution applied to an RNAeasy mini column (Qiagen) where the total RNA bound to the 
matrix and contaminants were efficiently washed away. Purified RNA was then eluted in 
30 µl of sterile distilled water and analysed by a spectrophotometer to measure the RNA 
concentration and to ensure that there were no contamination from protein and 
polysaccharides. Once the RNA was isolated, it was combined with the following 
reagents: 0.8 µl Deoxynucleotide Triphosphate mix (dGTP, dCTP, dATP and dTTP), 2.0 
µl random primers, and 1.0 µl reverse transcriptase (a DNA polymerase) to create a 
single-stranded DNA (cDNA) using the PCR machine. The program comprised of initial 
heat cycle 25 minutes at 25 ºC followed by the enzyme activation at 37 ºC for 2 hours, 
then a deactivation of the enzyme at 85 ºC for 5 minutes and finally cooled at 4 ºC for 5 
minutes to stop the reaction.  
The cDNA template (1400 ng), was added to the gene-specific primers (0.5 µM forward 
and 0.5 µM reverse oligonucleotides; Sigma; Table 2.4) and 25 µl of thermostable DNA 
polymerase (myTaq; Sigma). In the PCR machine, the reactions went through 25 cycles 
that begin with denaturing the DNA at 95 °C and annealing the forward and reverse 
primers to the strands at 65 °C. The new DNA synthesis elongated and continued to 
extend as long as the temperature remained at 72 °C. Production of the synthesized DNA 
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is exponential, therefore having the PCR continue for 25 cycles, also allowed for enough 
DNA synthesis (PCR product) for insertion into the plasmid for bacterial amplification. 
A negative control, where the cDNA template was omitted, was run in parallel with the 
reaction to ensure that the DNA synthesis did not contain contamination from any other 
DNA present in the lab environment. See Figure 2.9.  
PCR products diluted in loading buffer (Orange G) were analysed by electrophoresis on 
a 1.5% agarose gel. PCR products were visualized under UV and the size (kb) of the 
product compared with the molecular markers to determine if the PCR product 
corresponded with its predicted size derived from the reference sequence (Table 2. 4). If 
the band was of the correct size, it was dissected from the gel and purified by binding to 
and eluting from a silica membrane column (Qiagen; in accordance with manufacturer’s 
instructions). This purification ensured that incomplete products or non-specific products 

















Beta Actin - NM_001009784.1 
 Forward 
GGTTGACAACGGCTCCGGC 
Beta Actin- NP_001092 
Forward 
TATGTGGGCGACGAGGCCCA 
Beta Actin – NM_001009784.1 
Reverse 
GACCCCGTCACCGGAGTCC 
Beta Actin- NP_001092 
Reverse 
TGGTGAAGCTGTAGCCGCGC 
TLR3 – NM_001135928.1 
Forward 
CAACCCTGGCGGCCCTGTTC 
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2.9.1.2  Cloning PCR product into plasmid that contains RNA polymerase 
promoters (SP6 or T7) 
Purified PCR product was ligated into the plasmid PCR II TOPO using the topoisomerase.  
This plasmid had both SP6 and T7 promoter sites, which generated the sense probe or the 
same genetic sequence that was the target in the tissue section (can be used as a negative 
control) and the anti-sense probe or the complementary sequence to our target (positive 
probe).  The ligated plasmid prep, was transformed into chemically competent E.coli by 
heat shock (30 seconds at 42 ºC) followed by a rapid repairing of the cell wall by 
incubation in 250 µl of  Super Optimal Broth with magnesium chloride (SOC media) for 
1h. 100 µl of the bacterial mixture was then plated onto broth containing 100 µg/ml 
Ampicillin and 40 mg/ml of 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-
gal) dissolved in dimethyl sulfoxide to aid selection of bacteria containing plasmids with 
the inserted PCR product. The presence of an active β-galactosidase in the bacteria can 
be detected by X-gal, a colourless analog of lactose that is cleaved by β-galactosidase to 
form 5-bromo-4-chloro-indoxyl, which then spontaneously oxidized to form a bright blue 
insoluble pigment. In cells containing the plasmid with an insert, no functional β-
galactosidase forms because insertion of the PCR product into the plasmid disrupts the 
reporter gene. Hence, the colony stays white in colour (Figure 2.10 and Figure 2.11). The 
colonies were allowed to grow overnight at 37 ºC; candidate colonies were  picked and 












DNA insert to be cloned 
 
Mix and ligate 
PCR 
Transform and screen colonies 
Figure 2.10 A cartoon showing the DNA (PCR product) annealing and joining the 


















Figure 2.11 An example of bacterial colonies in an agar plate with (white) and 
without the PCR insert (blue). 
During this process, the bacteria antibiotic-sensitive cells are transformed and only 




2.9.1.3 Purification of plasmid DNA   
At first, small-scale plasmid DNA purification (Qiagen) was carried out on 1ml of the 
bacterial mixture and recovered plasmids were tested by diagnostic digest and sequencing 
to ensure that the inserted DNA was free of mutation. Once we determined that the colony 
had the correct insert, a 0.5ml sample of liquid bacterial culture was frozen in 50% 
glycerol (1:1 v/v) for long term storage. Thus, we avoid variability, which can arise from 
repeated PCR and steps 2.9.1.1 and 2.9.1.2, will not have to be redone. Another sample 
of 200µl of the liquid bacteria culture was added to 200 ml of broth that contained 
100mg/ml of Ampicillin and allowed to grow overnight at 37 ºC. Once the bacteria were 
harvested by centrifugation (3000 rpm for 15 minutes at 4 ºC), large scale plasmid 
purification was performed by anion exchange column (Qiagen) which generated an 
average yield of 200 ng/µl. 
2.9.1.4 Products of digestion for Comparison of PCR product to the vector construct 
Here we took advantage of the restriction sites in the plasmid by using enzymes that 
cleave different portions of the eluted DNA (Figure 2.12). Cleaving at the EcoR 1 
restriction site will provide us with assurance that the PCR product still exists within the 
plasmid (Figure 2.12). This test was accomplished by incubating 1 µg of purified plasma 
DNA, 2 µl buffer H (Invitrogen) and 2 µl of EcoR 1 (Invitrogen) enzyme for 2 hours at 
37 ºC. The products of digestion were analysed by agarose gel electrophoresis as 
described before. The diagnostic digest were run on all samples of eluted DNA to assure 













Figure 2.12 The map of PCR II TOPO  
PCR II TOPO and the sequence that surrounds the TOPO cloning site. The large 
black arrows indicate the restriction site for EcoR I. Topo map taken from 




Figure 2.13 An example of agarose gel electrophoresis after EcoRI digestion.   
  
Human β-actin (448 bp, yellow arrows) and Sheep TLR3 (399 bp; green arrows) 
are of the correct length and these samples will be used. However, the red arrow 
is pointing to the results from a sample of what should be an eluded DNA sample 
of human Oligo-2, which should have a band of 365 bp. Absence of this band 
means that the PCR product has probably not inserted into the plasmid and that 
this is a plasmid colony only.  
  
2.9.1.5  DNA sequencing analysis 
Sequencing of plasmid DNA (500 ng) was achieved using 3.2 pmole of M13 forward 
primer or 3.2 pmole of M13 reverse primer by the Genomics Core Laboratory 
(Commonwealth Building, Imperial College London or Beckman Laboratories). The 
results were aligned with the reference DNA code, and the orientation of the PCR product 
with respect to the T7 or SP6 promotors determined for sense / antisense probe 
production. Finally, the sequencing results were used to locate the restriction sites that 
were embedded within the plasmid and confirmed if the same restriction sites happen to 
fall into the PCR product. If a restriction site did reside in the target sequence, we would 
choose a more appropriate site for subsequent linearization to avoid cleaving the PCR 
insert. See Figure 2.14.  
2.9.1.6 Linearisation the vector  
Linearisation of the plasmid vector was achieved using the same method as described for 
the products of digestion but with different enzymes. Based on the M13 reverse primer 
sequencing results, plasmids were either linearised with Xho I or Xba I restriction 
enzymes for sequences transcribed from the SP6 promoter (red arrows; Figure 2.15) or 
Hind  III or BamH I restriction sites (green arrows; Figure 2.15) for sequences from the 
T7 promoter. After digestion was complete, 10 µl of the sample linearisation of the 
plasmid vector was achieved using the same method as described for diagnostic digests 
but with different enzymes. Based on the M13 reverse primer sequencing results, 
plasmids were either linearised with Xho I or Xba I restriction enzymes for sequences 
transcribed from the SP6 promoter 1µl was kept aside, while the remaining template was 
purified from the digest reaction with 190 µl chloroform/phenol/isoamyl alcohol (VWR) 
and then rinsed with 190 µl of chloroform (Sigma) alone. The linearized template was 
then precipitated at -20 ºC overnight within a solution of 30 µl of 5 mM ammonium 
acetate and 500 µl of 100% ethanol. The solution was centrifuged at 4 °C, and a small 
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Figure 2.14 TLR3 T7 aligned with the reference DNA code 
  
The results from the M13 Forward Primer (Seq_2) with the TLR3 reference code 
(Seq_1). Highlighted in yellow is the restriction site for Xba I, using this restriction 
enzyme would cleave the PCR product. 
Seq_1  1516  GAAGAGGCTGGAATGGTGAAGGAGAGCTATCCACATTTTTAAGGGCCACCCTTCGGAGCA  1457 
                                                       |||||||||||||||||| 
Seq_2  43    ------------------------------------------GGGCCACCCTTCGGAGCA  60 
 
 
Seq_1  1456  TCAGTCGTTGAAGGCTTGGGACCAAGGCAAAGGAGTTCCTAGTCAGCTGCAGGTACTTGT  1397 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  61    TCAGTCGTTGAAGGCTTGGGACCAAGGCAAAGGAGTTCCTAGTCAGCTGCAGGTACTTGT  120 
 
 
Seq_1  1396  TGTAGGAAAGATAGATTTCGAAAATATTTTCTAGACCTCTCCATTCCTGGCCTGTGAGTT  1337 
             |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Seq_2  121   TGTAGGAAAGATAGATTTCGAAAATATTTTCTAGACCTCTCCATTCCTGGCCTGTGAGTT  180 
 
 
Seq_1  1336  CTTGCCCAATTTCATTAAGGCCCAGGTCAAGTACTTCTAGGTGGCCCAACCAAGAGAAAG  1277 
             |||||                                                        


























The map of PCR II TOPO and the sequence that surrounds the TOPO cloning 
site. The SP6 promoter is in red and the red arrows indicate the possible 
restriction sites (e.g., Xho I or Xba I) that might be used to cleave the vector. 
Whereas, the T7 promoter is in green and the restriction sites (e.g., Hind III 
or BamH I) are labeled with green arrows. The black arrows are pointing to 
EcoR I, the restriction site which will provides the assurance that the PCR 




2.9.1.7 Probe labeling using the Ambion Megascript Kit and digoxigenin – dUTP 
The linearized precipitated template that was made from cleaving the eluted DNA at 
specific restriction sites was assembled with a transcription reaction to produce yield 
digoxigenin-dUTP labeled RNA. Linearized precipitated template (1 ug) was added to 2 
µl of transcription buffer, 2 µl of each nucleotides (ATP/CTP/GTP/UTP) and 2 µl of 
enzyme mix, then 5 µl Digoxigenin-UTP was incorporated to this mixture, which 
provided a means of labeling the probe. After, incubation at 37 °C overnight, 1 µl of this 
mixture was set aside and to the remaining solution 1 µl of DNase treatment was applied 
to remove the template DNA.  
A degree of purification was required after transcription to fully recover the RNA. 
Initially, a solution of 7.5 M lithium chloride with 50 mM EDTA was used to stop the 
reaction and precipitate the RNA, which was chilled for 8 hours and centrifuged until the 
RNA formed a pellet. This pellet was rinsed in ethanol and recentrifuged to maximize the 
removal of unincorporated nucleotides. The RNA was then resuspended in buffer. 
However, this process resulted in the loss of RNA. Subsequently, the Ambion Mega Clear 
kit was used, which successfully recovered the RNA product. This was done by adding 
80 µl of elution solution, 350 µl of binding solution and 250 µl of ethanol to transcribed 
RNA. This was then filtered through a collection filter and the impurities were washed 
away while the RNA is trapped in the filtration disk. The RNA was recovered by the 
application of 20µl of elution solution to the collection filter, which was then incubated 
at 65ºC for 10 minutes. The last step of re-suspending the purified transcript was repeated 
using 80 µl of the elution solution (see Figure 2.20). The RNA concentration was then 
measured by the utilisation of a spectrophotometer.  
The sample of unpurified transcript that was set aside was diluted in 9 µl of sterile distilled 
water with 5 µl of Orange G. Then 1 µl of the purified RNA diluted in 9 µl of sterile 
distilled water with 5 µl of Orange G. All the samples were loaded on an agarose gel to 
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assure that the RNA product was the same size as the original PCR product and to see if 
some impurities still existed in the RNA. 
2.9.1.8 Estimate probe yield 
The agarose gel from the reaction described above indicates the length of RNA, but to 
estimate the probe yield, and if the digoxigenin can be detected, I performed a dot blot on 
each probe. This was important to ensure that the sense and antisense were used at the 
same concentration by conducting an immunohistochemical reaction on a charged 
membrane, where I blotted a serial dilution for each probe.  The dot blot can also be used 
as a guide for testing different digoxigenin antibodies and different chromogens as these 
can be run simultaneously with the anti-digoxigenin that is conjugated with alkaline 
phosphate. Although dot blots were not equivalent to detecting RNA on a paraffin slide, 
it did minimise the number of slides that are needed to titrate each probe and it can be 
completed in a few hours. Each probe was spotted in a serial dilutions ranging from 100 
µg to 1 pg on a positively charged membrane. Using the cross-linker (Thermo Scientific) 
for 24 seconds, the RNA was adhered to the membrane. The membrane was then washed 
in 0.1 M Maleic acid, 0.15 M NaCl; pH 7.5 (VWR) and blocked using 0.1 M Maleic acid, 
0.15 M NaCl; pH 7.5 with 0.3% tween and 1% blocking reagent (w/v; Roche Applied 
Science; blocking solution) for 30 minutes. After the membrane was incubated for 1 hour 
in a solution of anti-digoxigenin–AP (2 µg/ml; conjugated with alkaline phosphatase) and 
blocking solution. After a few rinses in 0.1 M Tris-HCl pH 9.2; 0.1 M NaCl  0.5 mM 
MgCl2  (AP1), the pH of the buffer was increased to 9.2 using 0.1M Tris-HCl pH 9.2; 0.1 
M NaCl  0.5 mM MgCl2 (AP2). 10 ml of AP-2 1 mM levamisole (Sigma) was appropriate 
for developing adding a solution of 3.5 mg/ml nitro blue tetrazolium and 1.75 mg/ml of 
5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP; Roche Diagnostics). 
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2.9.1.9 ISH detection method for the digoxigenin-labelled cRNA probe 
All pre-hybridisation solutions (including PBS) were made using RNase-free 
(autoclaved) water; containers used in this procedure were RNase-free kept separate and 
re-used after spraying with RNase zap (Ambion). Paraffin-embedded brain tissue blocks 
were sectioned at 6 µm and mounted on slides. The slides were baked at 60 °C and 
immersed in xylene to remove the paraffin before rehydration in a series of solutions that 
contained decreasing alcohol concentration. As described in, Darby and Hewitson, 2006, 
I noticed that cleaner results were obtained if the slides were pretreated with heated 10 
mM citric acid for 20 minutes and cooled for 10 minutes before the probes were applied 
(Darby and Hewitson, 2006).  
Thereafter the slides, were treated with Proteinase K (10µg/ml; Sigma) for 5 minutes at 
37°C, which digested and inactivated any nucleases that might otherwise degrade the 
DNA or RNA.  This enzyme was arrested by immersion in 0.2% glycine in PBS for five 
mins at room temperature, and the tissue was post-fixed in cold 4% paraformaldehyde in 
PBS for 5 minutes. One slide from each new specimen was sacrificed for an RNase-A 
treated negative controls. This negative control was necessary for checking specificity of 
probes. 
2.9.1.10  Hybridisation procedure  
During the pre-hybridisation procedure, the probe was diluted (dilutions range from100 
ng to 1 pg) in buffer and preheated to 50-55 °C before it was applied to the sections. Each 
section only required 100 µl of probe diluted in 50% formamide, 10% dextran sulphate, 
1x Denhardt’s solution, 5 x SSC, 0.1 mg/ml herring sperm DNA (hybridisation buffer) 
and was covered with clean parafilm, which spread the probe and protected the section 
from drying out. The slides were incubated in an oven with sterile distilled water poured 
around the base of the staining tray for increased humidity. Temperature of hybridization 
was kept constant at 55 °C with slight agitation applied 25 rpmi, which  
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seemed appropriate for probes that are between 100-500 bps. At this stage, we test for 
false positive results by the addition of another slide per specimen that was incubated 
with only the hybridisation buffer to ensure that results are not due to non-specific 
staining of the chromogen. 
2.9.1.11 Post-hybridisation washes and detection of bound probe 
After 24 hours, the parafilm was removed by immersing slides placed in slide racks into 
0.3 M NaCl, 0.03 M sodium citrate, pH 7.0 (2x SSC) buffer at room temperature. After 
many rinses in  2x SSC in varying  temperatures the slides were digested with RNase-A 
(Sigma) at 100 µg/ml in 2x SSC at 37 °C for 30 minutes to remove unhybridised single-
stranded digoxygenin-labelled RNA probes and this was the end stage of the hybridisation 
procedure. 
The rest of the process used immunodetection of the digoxigenin that conjugated to 
alkaline phosphatase. Therefore, non-specific binding was blocked by incubating in a 
solution of AP1 buffer that contains 3% bovine serum albumin (AP1/BSA), 30 minutes 
at room temperature. Next, anti-digoxigenin-AP conjugate (Roche), diluted to 2 µg/ml in 
AP1/BSA is applied and incubated for 1 hour. After, the pH of the buffer was increased 
to 9.2, by using AP2 buffer which was appropriate for developing in a solution of 100 
mg/ml nitro blue tetrazolium (NBT) and 50 mg/ml 5-bromo-4-chloro-3-indolyl phosphate 









































































































































































































































































































































































































































































































































 Methodological Optimisation 
 Troubleshooting the in situ hybridisation protocol 
 
Although all of the steps had challenges, the most challenging step was the linearisation 
of the vector, as the ideal results would be if the digested linearised template sample were 
the same size (4.0 kb + the DNA) as the extracted linearised sample ( Figure 2.17; lanes 
3 and 4). In some cases, the pellet did not form after the extraction of chloroform or the 
DNA degraded, which would appear as a faint or absent band after agarose gel 
electrophoresis (Figure 2.17; lane 6).  However, this was rectified by repeating the 
digestion and quickly placing the vial in the 37 °C incubator. Another indication, that the 
vector did not completely cleave, was when there were two bands that formed after 
electrophoresis; to avoid this problem, timing of the digestion was increased from 2 hours 






Lane   1           2             3               4                   5               6 
  
Figure 2.17 Linearised vectors from Human TLR3 probe after digestion with 
restriction enzymes 
Linearised vectors from Human TLR3 probe, digested with Bam H1 (lanes 1 and 
2), Hindi III (lanes 3 and 4) and Xba I (lanes 5 and 6). Lanes 1,3,5 are before the 
template was extracted, whereas, lanes 2,4, and 6 are samples of the extracted 
linearized template. 
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Each vector was linearised by at least two restriction sites from each promoter end, which 
should result in bands of equal size and intensities; these are then compared to eluded DNA. 
Figure 2.18 shows two bands from agarose gel electrophoresis of human beta-actin, the Not I 
restriction site is much higher than the BamH I. This is due to incomplete digestion at the Not 
I site or an overload of DNA. Eluted DNA has a relaxed band (top weak band; Figure 2.18.; 
lane 1) and a coiled band (very dark lower band; Figure 2.18 lane 1) which could be an 
indication that the plasmid is degraded, however repeating the digestion and quickly placing 








Figure 2.18 Linearised vectors from Human TLR3 probe 
Lane 1 has two bands, which may indicate that the DNA has degraded and in lane 3 
the Not I restriction site there was incomplete cleavage. Even though, lane 2 (BamH I) 




Figure 2.19 Linearised vectors corrected 
Proper linearised vectors with the eluded DNA before (lanes 1,3,5) and after (lanes 
2,4,6) the DNA was extracted at restriction sites BamH 1 (lanes 1 and 2), Not 1 (lanes 
3 and 4) and Xba 1 (lanes 5 and 6). Note that all bands are of equivalent size however, 
lane 2 and lane 6 are of equal intensities and therefore will be used for labeling with 
digoxigenin. 
  
Lane 1           2            3 
Lane    




After successfully linearising each vector at both sites, reclaiming the RNA labeled  
Digoxygenin usually took a few attempts. The most difficult hurdle was timing DNase 
treatment to completely remove the DNA template. Figure 2.20 demonstrates that lithium 
chloride and EDTA solution, which stops the reaction and precipitates the RNA was not 
an ideal protocol to make the single-stranded RNA probes (Figure 2.20; lane 1). The 
megaclear kit resulted in much better recovery of the RNA riboprobes, which do not 
degrade, and the unincorporated nucleotides were successfully washed away (Figure 













Figure 2.20 Agarose gel electrophoresis of the transcription reaction for rat beta- 
actin digoxigenin-dUTP labeled RNA (264 bp) 
The absence of the band in lane 1 shows that the RNA was not reclaimed after using 
lithium chloride and EDTA solution. However, by switching to the Megaclear kit the 
yield was higher and cleaner (lane 3 and 4). The undigested DNA product is seen in 
lane 2 
Lane    
         1         2            3           4          
  
  
Figure 2-202-19  Agarose 
gel electrophoresis of the 
transcription reaction for 
rat beta actin 
digoxigenin-dUTP 
labeled RNA (264 
bp).Lane    
         1         2            3           4          
  
  
Figure 2-212-19  Agarose 
gel electrophoresis of the 
transcription reaction for 
rat beta actin 
digoxigenin-dUTP 
labeled RNA (264 bp). 
  
Figure 2-222-19  Agarose 
gel electrophoresis of the 
transcription reaction for 
rat beta actin 
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 Toll-like receptor 3 expression in glia and neurons 
alters in response to white matter injury in preterm infants 
 
 Introduction 
 As discussed in Chapter 1, preterm infants are particularly susceptible to WMIs between 
22 and 32 weeks gestation (Volpe, 2009, Back et al., 2007, Judas et al., 2005). Preterm 
WMI is thought to be the result of inflammation/infection and ischaemia with immature 
oligodendrocytes showing increased susceptibility. WMI effects both local cell survival 
and maturation (Billiards et al., 2008) and may inhibit axonal growth, cortical 
development and subsequent thalamic cortical connectivity occurring during this time 
period (Counsell et al., 2007, Vasung et al., 2010). 
In human preterm infants, WMI is identified by grey sunken soft tissue patches seen 
macroscopically. Microscopically the histopathology of WMI shows dissolution of the 
white matter, axonal injury and foamy appearing histiocytes (Rodts-Palenik et al., 2004, 
Haynes et al., 2011). WMI is associated with a disturbance to differentiating 
premyelinating-oligodendrocytes (pre-OLs), impaired myelination, astrogliosis and 
microglial activation (Kinney and Back, 1997, Volpe, 2001, Volpe, 2008). The injury to 
white matter structures subsequently leads to reduced volume of grey matter structures 
(Ligam et al., 2009, Ajayi-Obe et al., 2000, Inder et al., 2005).  
TLR3 has been identified intracellularly in the endosomal membrane in a variety of cells 
and detects dsRNA from viral molecular patterns (Botos et al., 2011) and endogenous 
DAMP’s (Bsibsi et al., 2006). Recent studies demonstrate that TLR3 has a functional role 
in the innate immune system and in regulating neuronal proliferation in the developing 
brain (Cameron et al., 2007, Lathia et al., 2008, Bsibsi et al., 2010, Sun et al., 2011). 
TLR3 activation via synthetic poly I:C or mRNA has been shown to reduce the numbers 
of neurospheres (i.e., immature axonal extension) and can cause growth cone collapse, 
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inhibiting neurite extension (Bsibsi et al., 2010).  Thus, studies on the consequences of 
TLR3 activation are important for understanding developmental and degenerative 
pathologies seen in the developing CNS after infection and/or damage.  
This chapter describes the cellular populations, which express the TLR3 protein in the 
cortex and the PVWM of the developing human brain. Our hypothesis is that in cases of 
WMI, there is a redistribution of TLR3 in neurons and enhanced TLR3 expression in 
certain microglial and astroglia populations. An improved understanding of the 
expression of TLR3 will provide insights into its role in the normal and abnormal 
















These experiments were designed to determine the distribution of TLR3 in the immature 
brain human (24-32 weeks GA) and fetal sheep brain (equivalent to 28 wk human GA) 
in the  cortex and PVWM regions (refer to section 2.1 for details of the human brain 
preparation). We also sought to determine whether the presence of WMI in the human 
brain (in the frontal and parietal lobes; see Figures 3.1 and 3.2) or a model of WMI 
induced by LPS in the sheep brain (refer to section 2.4 for details on the sheep brain 
preparation) would alter the expression of TLR3 in the frontal lobe (in the sheep and 
humans; see Figure 3.1).  
A further aim of these experiments was to investigate if TLR3 mRNA expression differed 
from the protein expression with the use of in situ hybridization and 
immunohistochemistry. Due to the fact that human paraffin sections were being used, it 
was necessary to develop an in situ hybridization probe to ascertain the overall expression 
of mRNA in the tissue sections, thus beta-actin was chosen as a marker of overall cellular 









































































































































































































































































































































































































































































































































































































































































































































































































 In Situ Hybridisation Results 
3.2.1.1 mRNA expression of beta-actin and TLR3 is detected in a widespread 
population of cortical cells in fetal sheep exposed to LPS. 
The use of strong cross-linking fixatives (i.e., formalin) and paraffin embedding produces 
excellent morphology, but mRNA may be degraded because of the high temperatures 
used in paraffin processing (Darby and Hewitson, 2006). The first series of experiments, 
tested if the use of paraffin processing alters the overall mRNA integrity using a “house-
keeping” probe of the beta-actin gene in the frontal cortex (refer to section 2.9). Intense 
staining was seen with the sheep antisense probe for beta-actin mRNA (Figure 3.3 A and 
B) indicating that there was abundant sheep mRNA in the paraffin samples. The absence 
of staining with the sense probes for sheep beta-actin (Figure 3.3 C and D) confirmed that 
the probes produced was clear of non-specific detection.  A band of high intense staining, 
in layer 2/3 of the frontal cortex was seen in the sham sheep using the antisense probe for 
beta-actin (Figure 3.3 A).  The beta-actin mRNA band was detected in the LPS treated 
sheep, but the staining was not as intense (Figure 3.3 B). In the LPS treated sheep, there 
were slight gaps in beta-actin mRNA expression in cortical layer 3 and 4 whereas in layers 
5 and 6 the signal was more prominent (Figure 3.3 B). The cellular organization of the 
frontal cortex was less organized in layers 5 and 6 of the LPS treated sheep, compared to 
that seen in the shams.  
The mRNA expression of the antisense TLR3 probe in the sham sheep revealed a dense 
band of the signal in layer 2/3 with a less intense signal in other layers (Figure 3.4 A). 
The LPS sheep (Figure 3.4 B) had a similar high expression of TLR3 mRNA in layers 
2/3, but these layers did appear as dense as what was seen in the sham sheep. There was 
a high signal with the TLR3 probe in the subsequent cortical layers in the LPS sheep, but 
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it was not as intense as in the sham cortex. The LPS treated sheep had a reduction in 
cortical volume as shown in previous studies (Dean et al., 2011) which may have 
contributed to the differences seen in the beta-actin and TLR3 mRNA expression between 
the two groups. 
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Detection of in situ mRNA expression using beta-actin anti-sense probe (A and B) 
and the sense probe (C and D) in the frontal cortex of sham (A and C) and LPS 
exposed (B and D) fetal sheep. Note that in the sham cortical layers 2/3 are highly 
positive (red arrows) whereas, in the LPS exposed sheep the expression is not as 
dense (yellow arrows) in layers 2/3. In the LPS exposed sheep, the lower layers have 
denser patches of beta actin (blue arrows) than seen in the sham. The lack of staining 
using the sense probe confirms that non-specific hybridisation did not occur. Scale 
bar = 100 µm







Figure 3.4 The expression of TLR3 mRNA in Sheep
In situ hybridisation shows that the expression of TLR3 mRNA was denser in the 
layer 2/3 in the sham sheep (red arrows; A) than in the LPS exposed sheep (yellow 
arrows; B) using the antisense probe (A and B). The lack of staining seen with the 










3.2.1.2 mRNA expression of beta -actin and TLR3 in human sections (ISH control) 
Using the beta-actin probe, demonstrated that global “house-keeping” gene could be 
detected in sheep fetal brain tissue that was processed in paraffin. For the next set of 
experiments, a human beta–actin probe was created to check if the mRNA did not degrade 
in the human tissue processing protocol. Secondly, a TLR3 probe was generated to 
compare the mRNA signal in the human control group to the WMI group.  
The cytoplasm of the cortical neurons were densely positive with the beta-actin specific 
anti-sense probe (Figure 3.5, A and D) in the frontal cortical lobe in both the control and 
WMI cases. The antisense probe for TLR3 showed the mRNA expression within the 
cytoplasmic domain in frontal cortical cells in both groups (Figure 3.5, B and E) but in 
the WMI group the cells had denser staining. In the controls, pyramidal cells with 
cytoplasmic TLR3 mRNA expression were seen in layers 5/6 (Figure 3.5 B) however the 
overall stain was weaker than that seen using the beta-actin probe (Figure 3.5 A). WMI 
cases had considerable oedema throughout layers 5/6 of the cortex with abundant TLR3 
mRNA expression (Figure 3.5 E). The oedema seen within the extracellular matrix of the 
WMI cases may have contributed to the lack of the laminar uniformity of the cortical 
neurons. The specificity of the TLR3 probe wa confirmed by the absence of staining using 
the TLR3 sense probe (Figure 3.5 C and F) in the controls (Figure 3.5 C) and WMI group 












































































































































































































































































































































































































 Immunohistochemical results 
3.2.2.1 Specificity of anti-TLR3 antibody assayed using a positive case of 
Cytomegalovirus   
Due to the newness of the TLR3 antibody, the titration and preabsorption test were 
confirmed using a positive control, a case of 35 GA weeks with disseminated 
Cytomegalovirus in different brain regions. The sensitivity of the immunoreactivity of 
the TLR3 antibody proteins showed a consistent pattern of cytoplasmic labeling in the 
thalamus, posterior limb of the internal capsule (PLIC) and the frontal cortex (TLR3 IHC; 
Figure 3.6 A, D and G). These slides were run in parallel with another set of slides per 
brain region for the preabsorption studies, incubating with a cocktail containing the 
peptide and the TLR3 antibody (TLR3/Peptide; Figure 3.6 B, E and H). A third slide per 
brain region was used to test that the IHC results were not due to non-specific reaction of 
the chromogen (Negative Control; Figure 3.6 C, F and I). Since the preadsorption test and 
the negative control did not show any immunoreactivity, it was demonstrated that TLR3 































TLR3 IHC TLR3/Peptide Negative Control 
Rabbit anti-TLR3 reactivity with hematoxylin counterstain in the thalamus (A), 
posterior limb of the internal capsule (D) and frontal cortex (G). In images B, E and 
H, the TLR3 antibody adhered to the peptide, which is specific to the TLR3 protein the 
lack of staining demonstrated that the antibody does not contain non-specific proteins. 
Non-specific staining of the chromogen was tested using just the secondary antibodies 
and the chromogenic reaction (C,F and I). Scale bar in A represents 20 µm, all images 




The cortical TLR3 mRNA expression was similar in the sham and the LPS treated sheep 
in the frontal lobe sections. The intensity of the cortical TLR3 mRNA signal appreared 
greater in human WMI cases than in the controls. To ascertain if TLR3 mRNA signalling 
translated to TLR3 protein expression, experiments were conducted using TLR3 
immunohistochemistry. Experiments were designed to determine the distribution of 
TLR3 protein in the frontal cortex of the sham and LPS treated sheep. Additionally, the 
TLR3 immunoreactivity was visualised in the cortex and in the PVWM from the anterior 
frontal, lateral frontal, anterior parietal and lateral parietal regions (see Figures 3.1 and 
3.2) of preterm human brains (23-32 weeks PMA). We also sought to determine whether 
the presence of LPS in the sheep brain or WMI in the human brain altered the expression 
of TLR3. Furthermore, we investigated whether glial TLR3 expression differed between 
control cases and those with WMI, with the use of IHC and IF techniques described in 
sections 2.5 and 2.6.  
3.2.2.2 Cortical TLR3 protein expression is seen in the apical dendrites in sham and 
LPS treated sheep 
In the frontal cortical regions of the fetal sheep, the TLR3 expression was concentrated 
in the cytoplasmic domain extending into the apical dendrites of the neurons on both the 
sham (Figure 3.7 A and C) and the LPS (Figure 3.7 B and E) exposed sheep group. The 
apical dendrites seen on the neurons, in the sham group extended towards the superior 
cortical layers with TLR3 positivity seen within the processes (Figure 3.7 C insert).  In 
the LPS group, the dendrites of the neurons in the cortex were a mix of superiorly, 
laterally and inferiorly oriented apical dendrites with perinuclear TLR3 expression 
(Figure 3.7 E insert).  A further finding seen with using the TLR3 antibody, in the cortex 
of the LPS exposed group, were neurons grouped in clusters and adjacent to the clusters 
were glial-like cells  (Figure 3.7 E). Using the same preabsorption test  
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as discussed in the previous section, the lack of staining seen in both fetal sheep groups 









































































































































































































































































































































































3.2.2.3 TLR3 expression is seen in frontal and parietal regions of the immature 
human brain 
In the following experiments, the cellular populations analysis and TLR3 protein 
expression was investigated in the PVWM regions of the frontal (F1, F2) and the parietal 
(P1, P2) lobes anteriorly (F1, P1) and laterally (F2, P2) to the germinal matrix. A further 
semiquantitative study of cortical cell population was investigated in the anterior frontal 
lobe (F3). (See Figures 3.1 and 3.2). 
3.2.2.4 Cortical TLR3 expression differed between WMI and controls  
In the in situ hybridisation experiments, the TLR3 mRNA expression in the cytoplasm of 
the cortical neurons in the WMI cases was denser than what was detected using the beta-
actin mRNA probe. Additionally in the WMI cases, the cortical TLR3 mRNA was more 
prevalent than the control TLR3 mRNA. Therefore, the next series of experiments were 
designed to see if the increase in TLR3 mRNA observed in the cortex of the WMI cases 
translated into differences in TLR3 protein expression (refer to section 2.5 and 2.7 for a 
review of IHC and qualitative methods).  
In the WMI cases (Figure 3.9 B) dendrites/axons in the Cajal Retzel cells in layer I of the 
cortex had punctate anti-TLR3 staining that was absent in the control cases (Figure 3.9 
A). However, TLR3 expression was seen in both the control and WMI, in the apical 
dendrites in layers 2-4 (Figure 3.9 C and D). Similar to what was seen in the fetal sheep, 
the TLR3 staining appeared as fine linear extensions projecting upwards towards the 
superior cortical layers. The TLR3 upward pointing protein morphology was seen in the 
proceeding layers (5-6) in the neurons of the control cases (Figure 3.9 E), but in the WMI 
cases the upward orientation of the protein was not as consistently located (Figure 3.9 F). 
The larger pyramidal neurons, in layers 5 and 6 of the cortex in both the WMI and control 
group had a more perinuclear TLR3 expression. In the WMI cases, the TLR3 expression 
in the apical dendrite was more robust (Figure 3.9 F).  The data gathered from these 
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experiments suggests that the increase in the TLR3 mRNA observed in cortical region of 
































Immunoreactivity of anti-TLR3 in a control (A, C and E) and in a case with WMI 
(B, D and F) in a section from the frontal cortex. Layer 1, 2, 3 and 4 are seen in 
images A-D, whereas, layer 5/6 are visible in E and F. Note, that in layer 1, in the 
WMI case there is linear staining (yellow arrows; B) and in the control it is not 
present. In layers 2/3 in both groups there is punctate staining seen in the apical 
dendrites (blue arrows; A-D). The TLR3 protein expression differs between the 
groups in layers 5-6, appearing more diffuse in the pyramidal neurons in the WMI 
cases (green arrows; F). In addition the WMI cases, (black arrows; F) cells have 





3.2.2.5  The cortical density was lower in the WMI group compared to the control 
group 
The WMI cases had more areas of edema in the cortical layers and TLR3 mRNA and 
protein expression was denser in layer 5/6 in the WMI cortex than in controls. In order to 
ascertain if WMI was comorbid with a decrease in cortical density, we counted the 
hematoxylin positive cells in an average of 52 sites in a region of the superior frontal 
cortex (F3; see Figure 3.1). Additionally, TLR3 expression was quantified as a ratio of 
TLR3 positive cells to total cell was computed to compare differences between the control 
and WMI groups. (Refer to section 2.8).  
In the control group, the estimated density of the cortex was significantly higher in the 
sample of frontal cortex compared to the WMI group (p < 0.01; control 12356 ± 1479 
n=6; WMI 7032 ± 1518 n=6; Figure 3.9 A). The estimated number of cells with TLR3 
expression was significantly higher in the WMI group compared to the control group (p 
< 0.01; WMI 3335 ± 886 n=6; control 1679 ± 347 n=6; Figure 3.9 A). Finally, the ratio 
of TLR3 positive cells to the averaged hematoxylin positive cells revealed that in the 
WMI cases the TLR3 was more  prevalent in the cortical cells than what was identified 
in the controls (p<0.01; WMI 0.5 ± 0.09 n=6; control 0.14  ± 0.02 n=6; Figure 3.9 B) . 
The data gathered in the cortical region demonstrates that after WMI cortical volume is 





Figure 3.9 Frontal lobe (F3) averaged cell count and TLR3 immunopositive counts 
  
A graph of the averaged estimated hematoxylin positive nuclei and the TLR3 
positive cells in the F3 region of the frontal lobe (A) normalised to mm2. The data 
in B demonstrates the ratio of TLR3 positive cells to hematoxylin cells, after WMI 





3.2.2.6 The ratio of TLR3 positive cells increased in the PVWM in WMI cases.   
 
There were significant differences between the control and WMI groups in the cortical 
densities and the ratio of cells that expressed TLR3. It seemed logical to study the PVWM, 
the region most affected by the WMI. Therefore, in the next series of experiments the 
distribution of TLR3 protein in the neuronal and glia cellular populations was investigated 
in frontal and parietal WM regions (see Figure 3.1 and 3.2). 
 In the PVWM of the cases without overt brain pathology, the TLR3 immunoreactivity 
was globular and restricted to the perinuclear region of cells, which is consistent with the 
endosomal domain (Figure 3.10 A). The WMI cases also showed TLR3 expression in the 
PVWM, but there was more diffuse staining outside of the nucleus of cells and within the 
processes in contrast to the more focal nuclear localization seen in non-injured brains 
(Figure 3.10 B). One-way ANOVA showed a significant increase of cells with TLR3+ 
immunoreactivity in the WMI cases compared to the control in the anterior frontal region 
(F1; p < 0.05; WMI 0.48 ± 0.11, n=7; control 0.29 ± 0.12, n=7) and in the lateral frontal 
region (F2; p < 0.001; WMI 0.54 ± 0.06, n=7; control 0.24 ± 0.06, n=7) (Figure 3.10 C). 
Both regions of the parietal lobe studied, also had a significant increase in cells expressing 
TLR3 in the WMI compared to controls (P1; p < 0.01; WMI 0.52 ± 0.14, n=7; control 
0.25± 0.09, n=7 and P2  p < 0.01; WMI 0.56 ± 0.15, n=7; control 0.27 ± 0.06, n=7) (Figure 
3.10 C). The One-way ANOVA revealed no significant changes in the total cell 
populations (i.e., hematoxylin nuclei) in the control cases compared to the WMI (Figure 
3.10 D) in any of the regions investigated. The ratio of TLR3 to cells demonstrate that 
TLR3 expression is increased in the PVWM after WMI, which may be in response to the 
surrounding DAMPs or other components of the inflammatory response however the cell 







Figure 3.10 Immunohistochemical stains of TLR3 in the anterior region of the 








An example of the TLR3 immunoreactivity from the control cases seen in the 
first image (A; blue arrows) which appears perinuclear and punctate. 
Whereas, in B an example of one of the WMI cases (blue arrows) it is diffuse 
(i.e., less concentrated around the nucleus and flowing into the axon hillock). 
A graph representing the ratio of TLR3 positive cells to the average cellular 
count/ mm2 (C). The graph in D represents the estimated hematoxlin positive 
cells per mm2 per region. Asterisks: significant differences in ratio of 
immunopositivity counted in the WMI cases compared to the control, in the 
anterior region of the PVWM from the frontal (F1) and parietal (P1) lobes; 
and in the lateral region of the PVWM from the frontal (F2) and parietal (P2) 





 TLR3 immuno-labeling is seen in neurons and glial cells. 
Of interest the number of neurons identified with anti-NeuN was significantly higher in 
the WMI group (p < 0.01; WMI 62.2 ± 11.2, n=6; control 32.5 ± 2.3, n=6) than the control 
group in the WM region sampled (center of F1, refer to Figure 3.1).  The amount of 
identifiable TLR3 expression seen in the neurons was not significantly different between 
the control and WMI groups, but to study differences in the pattern of neuronal expression 
we examined the intracellular location of TLR3 protein by IF double labelling techniques 
using rabbit anti TLR3 and rabbit-anti-NeuN conjugated CY3 (refer to section 2.5.4 for 
double labeling immunofluorescence techniques). Interestingly, in the control cases, the 
TLR3 expression was globular and restricted to the perinuclear region (Figure 3.11 A), 
whereas in the WMI cases the TLR3 immunoreactivity was diffuse and intra-axonal, 
being expressed along the axon hillock (Figure 3.10 B and Figure 3.11 B). The increase 
of neurons suggests that after WMI has occurred, migrating neurons may get “trapped” 
in the PVWM. The changes in TLR3 morphology seen in the migrating neurons 




















Confocal microscope photomicrographs demonstrating the distribution of 
TLR3 (green) around the nuclei (NeuN-Cy3) from the anterior region of the 
PVWM in the frontal lobe of a control case (A) and WMI case (B).  Note that 
in the control case TLR3 is located densely around the nucleus (blue arrows), 
whereas, in the WMI case the TLR3 expression is axonal (yellow arrowheads). 





To address whether the increase in TLR3 positivity seen in the periventricular white 
matter of the WMI brains was due to TLR3 activation in glial cells, IF colocalisation was 
used to identify the glial population(s) that also express TLR3 protein within the frontal 
lobe. This was achieved by combining anti-TLR3 with glial markers, such as anti-GFAP 
(astrocytes), anti-Iba-1 (microglia) and anti-Olig2 (oligodendrocytes) in brain tissue 
sections.  
There was a significant increase in the number of astrocytes identified in the WMI group 
(p < 0.01; WMI 46.4 ± 4.3 n=6; control 23.8 ± 2.2 n=7). Double labelling IF showed that 
astrocytes were the glial cell that predominately expressed TLR3, which significantly 
increased in the WMI group (p < 0.01; WMI 31.2 ± 1.8 n=6; control 16.6 ± 2.3 n=7). 
TLR3 expression was frequently seen along the processes of the reactive astrocytes 
outside of their irregularly shaped nuclei in the WMI cases (Figure 3.12 B and D), 
whereas TLR3 was sparsely identified within astroglial processes in the control cases 
(Figure 3.12 A and C). The increase in astroglia demonstrates that an inflammatory 
response was occurring in the WMI cases. The upregulation of the TLR3 seen in the 

















Examples of the immunofluorescence staining of  anti-TLR3 (red) and  the 
astrocytic marker (GFAP; green) in a control case (A and C) and a WMI 
cases (B and D). In image B and D, the astrocytes are reactive and 
prominent intracellular expression of TLR3 can be seen in the 
immunofluorescence image and with the confocal photomicrograph 
(yellow arrow heads). Whereas in images A and C, there is less TLR3 
expression in the astrocytes, which is confirmed by the confocal 
photomicrographs (C; red arrow). Scale bar =25 µm images A and B; and 




Very small amounts of TLR3 was identified adjacent to the nuclei of oligodendrocytes 
(i.e., those positive for Olig2), and this was more frequent in the cases of WMI. Identified 
in Figure 3.13 (image D) in the photomicrograph are Olig2 immuno-labeled cells with 
TLR3 immunoreactivity seen in proximity to the nuclear membrane. Surprisingly, in the 
WMI group only a low level of TLR3 expression were observed within the cellular 
boundaries in microglia as determined by iba-1 immunoreactivity (Figure 3.13 B). 
However, of interest Figure 3.13 A and B demonstrate microglia of different 
morphologies located next to neurons with high TLR3 expression which may indicate an 
interaction between microglia and neurons via this receptor (Figure 3.13 A and B). The 
relatively small amount of TLR3 receptors identified in the oligodendroglia and microglia 
respectively suggests that TLR3 is not upregulated in these two glia population after WMI 











Double-labeling of anti-TLR3 (red) with the microglial marker Iba-1 
(A and B; green) and TLR3 (red) with oligodendrogial marker Olig2 
(C and D; green). The expression of TLR3 was not seen in the differ-
ent morphologies of microglial, such as intermediate (control case; A) 
and amoeboidal (WMI case; B). Confocal microscopy confirmed that 
TLR3 expression was seen in minute amounts detected in Olig2 posi-
tive cells in the WMI case (red arrows; image D) but not in the control 
case (C). Scale bar =25 µm images A and B; and 17 µm C and D.
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 Discussion  
In this study we have demonstrated the expression of TLR3 in the preterm neonatal 
human brain and in the fetal sheep brain. In addition, we showed that TLR3 expression 
was altered in the presence of overt brain injury which was evident in the LPS treat sheep 
and WMI cases compared with the sham sheep and human controls. The results between 
the sham and LPS exposed fetal sheep, demonstrated that TLR3 expression differs when 
the brain is subjected to inflammation and injury. The differences seen in the cortical 
regions between the two human groups, control cases and the WMI cases seem to 
correspond to that seen in the sheep.  
Cortical expression of TLR3 identified in layers 2/3 was seen as a dense cellular band 
that had very specific polar morphology seen in all of the groups. The human WMI and 
the sheep LPS brains demonstrated that layers 5 and 6 are affected by injury and 
inflammation as these layers appear less organized and have distinct TLR3 expression 
not seen in either the human controls nor in the sham sheep sham. The most noticeable 
difference seen in large pyramidal cells of layer 5 was that the LPS treated sheep group 
and the WMI human group tended to have more diffuse TLR3 expression that extended 
into intracellular spaces of the neurons.  
TLR3 was detected in human brains that did not have WMI, which indicates that protein 
expression of TLR3 may be normal in fetal brain development even though we cannot 
exclude the possibility that TLR expression in the control brains is part of an early 
evolving pathological process related to extreme prematurity. In the preterm WMI cases, 
we saw more neuronal nuclei in PVWM compared with the control cases. Whilst the 
overall expression within neurons was not increased, the pattern of expression of TLR3 
was altered in WMI cases, being more diffuse and visible in the axonal hillock that 
extended into intracellular spaces of the neurons rather than being close to the endosome-
like structures.   
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We hypothesized that in cases of neonatal injury there would be an increase in microglia 
and astroglia populations and that these would express TLR3. The PVWM of the WMI 
group showed a wide spread of cellular populations that were positive for TLR3. Of 
interest is that most expression was within astroglia and not microglia as identified by 
double labelling techniques. In the WMI group we identified activated microglia (i.e., 
Iba-1 positive amoeboidal cells). Even though the activated phenotypic properties could 
be identified with Iba-1; double-labeling techniques with anti-TLR3 showed that these 
proteins did not colocalise, but may cluster around neurons with high TLR3 expression. 
It is useful to review the recent TLR3 animal model publications further to understand 
the significance of our findings and specifically to ascertain how over-expression may 
hinder the normal developmental process. Lathia et al (Lathia et al., 2008) found TLR3 
expressed on glial cells, neurons and neural progenitor cells and poly I:C (an activator of 
TLR3) administration inhibited neurite extension in wild-type mice but not in TLR3 
knock-out mice. Furthermore, Bsibsi et al. (Bsibsi et al., 2010) found that a non-infectious 
microtubule regulator, stathmin, acted as an agonist for TLR3. During the inflammatory 
process of multiple sclerosis, TLR3 and stathmin were colocalised on the surface of 
astrocytes, neurons and microglia. In the inflammatory injury of the preterm brain, such 
as WMI, there is a known increase in activated microglia (Supramaniam et al., 2013) and 
astrocytes (Ligam et al., 2009), which may underlie the documented alterations in 
neuronal connectivity between the thalamus and the cortex (Leviton and Gressens, 2007). 
In animal models of injury, stathmin or cytokines released from astroglia activates TLR3 
in neurons of the premature brain, which in turn induces premature apoptosis (Cameron 
et al., 2007, Bsibsi et al., 2010, Deleidi et al., 2010).  
Excessive TLR3 stimulation on astroglial cells may, therefore, interrupt the neuronal 
migration to the cortex in the developing human brain. The increase in neuronal numbers 
seen in PVWM and corresponding decrease in the cerebral cortex in the WMI group, have 
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also noted in other studies (Haynes et al., 2011) and might indicate interference with the 
migration of late migrating interneurons. This may underly the alterations in 
thalamocortical connectivity and result in thalamic atrophy and/or cortical 
disorganization seen in WM injury in the developing brain (Dean et al., 2011).  
 We have demonstrated the presence of TLR3 in all cell types of the immature brain. In 
the presence of white matter injury, TLR3 expression was increased and the pattern of 
expression altered. We speculate this may play a role in the altered thalamocortical 
connectivity seen in preterm infants. The anatomical information gathered from our study 
provides a solid foundation for future study of the axonal development, which is 
imperative in comprehending life-long disabilities after premature birth.  
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 Cellular Mechanisms of toll-like receptor 3 activation 
in the thalamus are associated with white matter injury in 
the developing brain 
 
 Introduction 
In Chapter 3, we analysed the PVWM and the frontal cortex and showed that astroglia 
and neuronal TLR3 expression was upregulated in response to WMI in the frontal lobes 
of human preterm infants and LPS treatment (Vontell et al., 2013a). We also found that 
the cellular density in the cortex was significantly lower with an increase in neuronal 
number in the PVWM in the WMI cases suggesting an interference in migration(Vontell 
et al., 2013b) . 
Within the thalamus the medial dorsal (MD) region and the ventral lateral posterior (VLp) 
region project axons to the white matter regions of the orbital medial and dorsal lateral 
frontal lobes, respectively. After WMI has occurred, injury to the thalamic neurons and 
processes may lead to cognitive and motor impairments, as these axons extend into the 
white matter region at the sites where the periventricular infarctions lie (i.e., in the motor 
pathways) (Lagercrantz, 2010). The ventral posterior lateral (VPL) thalamic regions send 
efferents to the somatosensory cortex in the parietal lobe. The effects that WMI has on 
the sensorimotor circuits in the preterm brain is not well established, but recent studies 
demonstrate that survivors of preterm WMI have deficits with touch and proprioception 
in addition to motor and cognitive impariments (Hoon et al., 2009). In order to understand 
the effects of WMI, this study investigates the glial expression and neuronal counts 
between control cases and WMI cases, in the the MD, VLp and VPL thalamic regions 
and in the adjacent PLIC regions (VLp PLIC and VPL PLIC). 
The specific nuclei of the thalamus (i.e., the lateral region; see Chapter 1) have life-long 
round large (RL) neurons with large cytoplasmic domains that support thalamocortical 
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axons. We extended our study to examine the localization and cellular mechanisms of 
TLR3 in the VL thalamus, to investigate how RL cope with surrounding WMI’s or 
pretreatment of LPS. One mechanism involved may be autophagy and recruitment of 
TLR3. Hence, we explored the TLR3 colocalisation with late endosomes (LAMP-1) and 
phagosomal compartments in the VLp thalamic region. We hypothesise that after WMI 
has occurred, the localization and activation of TLR3 alters in grey matter structures in 
response to DAMPs and activated glia. Our findings may have implications for the health 
of thalamocortical connections after WMI. 
 Results 
 Intense mRNA expression of beta-actin is seen both the sham and the LPS 
treated sheep  
The integrity of the mRNA was tested using the house-keeping gene beta-actin in the VL 
thalamic region. In the sham and LPS group the in situ hybridisation results for the 
antisense probe of beta-actin showed similar expression in the cytoplasmic domain of the 
RL neurons in the VL region of the thalamus (Figure 4.1 A and B) and in the PLIC (Figure 
4.1 C and D). These results suggest that the paraffin sections had adequate amounts of 
mRNA to resume with the TLR3 detection in the thalamic region. (Refer to sections 2.4 
and 2.9) 
 Messenger RNA staining of TLR3 is widespread in LPS treated sheep 
In the sham and LPS group the in situ hybridisation results for the antisense probe of 
TLR3 showed expression in perinuclear region of the neurons in the VL region of the 
thalamus and in the posterior portion of the internal capsule sham group (Figure 4.2). 
However, in the LPS treated group there was widespread expression of TLR3 not only in 
the large neurons but also in other cell populations (Figure 4.2 B)  compared to the sham 
(Figure 4.2 A).  In the PLIC region, the LPS treated sheep had a widespread distribution 
of cells that expressed the TLR3 gene (Figure 4.2 D), compared to the sham (Figure 4.2 
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C). To investigate if the increase in the TLR3 gene seen in the sham sheep translated to 






Figure 4.1 Detection of beta-actin mRNA in the sheep using in situ hybridisation 
B A 
C D 
Sham LPS Exposed 











The integrity of the mRNA, in the thalamic region is seen with the house-keeping 
in situ hybridisation probe beta-actin, in the sham (A and C) and in the LPS (B and 
D) treated sheep. Beta-actin gene expression is seen in the RL neurons of the VL 
are seen in (A and B) and the cells of the posterior limb of the internal capsule 
(PLIC) in (C and D). The intense staining reflects that the gene expression in well 




Figure 4.2 TLR3 mRNA in the sheep using in situ hybridisation
Detection of TLR3 mRNA in the sham sheep (A and C) and in the LPS exposed group 
(B and D) using in situ hybridisation. The ventral lateral thalamus (A and B) has large 
neuronal cells that are expressing TLR3 (blue arrows). Images of the posterior limb of 
the internal capsule (PLIC; C and D) show neurons expressing TLR3 mRNA seen 
within the white matter (yellow arrow heads). However, in B and D, the LPS group, 
there are smaller glial-like cells, which may be astrocytes, microglia or oligodendro-











 The TLR3 protein expression differs between the sham and the LPS treated 
sheep in the thalamus and PLIC 
In the VL region of the thalamus the fetal sheep brains, had TLR3 immunoreactivity that 
was similar to that seen in the cortical neurons. In the sham group, the VL thalamus had 
neurons with globular and perinuclear TLR3 expression (Figure 4.3 A). In the LPS 
exposed fetal sheep, neuronal TLR3 expression diffusly encompassed the cytoplasmic 
domain of the RL neurons (Figure 4.3 B). The PLIC region of the LPS group (Figure 4.3 
D) showed more neuronal and glial expression of TLR3 than that seen in the sham (Figure 
4.3 C) with very dense cells with TLR3 positivity that had glial-like morphology. The 
increase in TLR3 mRNA observed in the thalamus and PLIC regions of the LPS treated 







Immunoreactivity of anti-TLR3 in the sham (A and C) and the LPS exposed (B and 
D) sheep from the VL thalamus (A and B) and the PLIC (C and D). In the VL thala-
mus, the sham sheep TLR3 expression appears globular and perinuclear (red arrows 
and insert), whereas, in the LPS exposed sheep the TLR3 expression is more diffuse 
and extends into the axonal hillock (blue arrows and insert). In images C and D the 
staining in the PLIC regions, the TLR3 expression is seen in large neuronal-like cells 
in both groups. The LPS group has glial cells with dense TLR3 expression (D; inset) 
which is not seen in the sham (C; inset). Images taken at 400x













 The morphology of the glial cells and neuronal counts differed between WMI 
and control cases in the preterm human brain 
A hematoxylin and eosin stain enabled the identification of the thalamic region in each 
tissue section (Figure 4.4 A). The orientation and labelling of the thalamic regions were 
confirmed by using the fetal brain atlas (Figure 4.4 B) and a thalamic morphology 
textbook (Figure 4.4 C) (Bayer and Altman, 2002, Jones, 2007). 
We first evaluated the total cell count with each assessment of the glial populations and 
neurons in control cases and those cases with WMI (refer to section 2.8.2). There was no 
difference in average total cell counts between control and WMI cases in the thalamic 
regions or the PLIC regions (Figure 4.4 D). We then established that there was no effect 
of the gestational age or postmenstrual age on the total number of cell in our regions of 
















Global view of the thalamus (A). The strategy for the quantification of the different 
cell populations and the TLR-3-positive expression are demonstrated in a control 
brain (28.2 weeks PMA; A). Boxes represent the contours that were made in MD, 
VLp and VPL nuclei of the thalamus and the PLIC in regions adjacent to the VLp 
and VPL (PLIC-VLp, PLIC-VPL). Semi-quantitative analysis of the thalamus was 
completed in the VLp region (dotted lines in VLp). The anatomical location of the 
thalamic regions can be seen on image B (preterm brain atlas;(Bayer and Altman, 
2002) and C (adult thalamic atlas (Jones, 2007). The total population of cells 
(i.e.,nuclei identified with hematoxylin) did not significantly differ between the 
controls and the WMI cases in MD, VLp and VP thalamic nuclei nor in the regions 
of the PLIC (D). Medial dorsal (MD), ventral lateral posterior (VLp), ventral 
posterior lateral  (VPL) posterior internal capsule (PLIC) adjacent to the VLp 
(PLIC-VLp) and the VPL (PLIC-VPL), lateral dorsal (LD), zona incerta (ZI), 
globus pallidus internal (GPi) and globus pallidus external (GPe). Diagrams B and 




However, there was a significant increase in the ratio of astrocytes to total cell count in 
the thalamic regions in WMI cases compared with the control cases in the MD (p < 0.01)  
and VLp (p < 0.01) thalamic region but not in the VPL thalamic region. The astroglial 
ratio was increased in the corresponding white matter regions PLIC-VLp (p < 0.01) and 
PLIC-VPL (p < 0.05) in the WMI cases compared with the controls (Table 4.1). In the 
WMI cases, the astroglia was hypertrophic with fibrous and long extensive processes 
(Figure 4.5 B) compared with those seen in the control group (Figure 4.5 A).  















Next, we assessed the Iba-1 positive microglial cells and identified a significant increase 
in the WMI cases in the MD (p < 0.01), VLp (p < 0.01), VLP (p < 0.05) thalamic regions 
and in the adjacent white matter regions PLIC-VPL (p < 0.05), but not in the PLIC-VLp 
(Table 4.2). Microglia in the control cases were more consistent with an intermediate 
morphology (with extensive complex branching and ruffling; Figure 4.5 C) whereas in 
the WMI cases, microglia consisted of amoeboidal (round to amorphous structures with 
a variety of short pseudopodia) and intermediate morphologies (Figure 4.5 D). 
 











Finally, we counted the neuronal population positive for HuC/HuD antibody in the 
thalamic and PLIC regions. There was a significant decrease of neurons in the WMI cases 
in the MD (p < 0.05), VLp (p < 0.001) and in the VLP (p < 0.05) thalamic regions. 
However, we found that in the WMI group there was a significant increase in neurons 
detected in the PLIC-VPL (p < 0.05), but not in the PLIC-VLp (Table 4.3).The controls 
had mossy fibrous extensions protruding from the cell body (Figure 4.5 E). In the WMI 
cases, there was less fine fibrous protrusions extending from the neuronal cell bodies, but 
axonal extensions were well defined (Figure 4.5 F).  
 































The astrocytes are less fibrous and reactive in the controls (A) than in WMI cases 
(B). The astroglia ratio (A and B) to the total cell population was significantly 
different in the MD (p < 0.01); VLp (p < 0.01) and in the adjacent PLIC-regions 
(PLIC-VLp p < 0.01 and PLIC-VPL p < 0.05) in the WMI cases compared with the 
control cases. Different morphologies of microglia are seen in the VLp thalamic 
region between the control (intermediate; C) and the WMI cases (amoeboidal; D). 
The ratio of microglia to total cells increased significantly in the MD (p < 0.01); 
VLp (p < 0.01) and VPL (p < 0.05) and in the PLIC-VPL. A decreased number of 
neurons was seen in the WMI cases (F) compared with controls (E) the MD (p < 
0.05); VLp (p < 0.001) and VLP (p < 0.05). The neurons in the WMI group cell 
bodies had thick swollen protrusion compared to the control group. Medial dorsal 
(MD), ventral lateral posterior (VLp), ventral posterior lateral (VPL) posterior 
internal capsule (PLIC) adjacent to the VLp (PLIC-VLp) and the VPL (PLIC-VPL). 




 mRNA expression of TLR3 is detected in a widespread population of cells in 
the WMI cases. 
Using in situ hybridisation we compared TLR3 mRNA expression in the VLp thalamic 
region in the control cases and the WMI cases. In controls, the VLp region of the thalamus 
had faint cytoplasmic TLR3 mRNA expression (Figure 4.6 A), whereas in WMI cases, 
the cytoplasmic mRNA expression of TLR3 was very dense and granular, which may be 
indicative of an upregulation of TLR3 expression in response to the surrounding injury 
(Figure 4.6 B).  
 The area of TLR3 Positivity increased in WMI Cases. 
The density of the TLR3 mRNA differed in the WMI cases compared with the controls. 
In order to ascertain if this translated to a change in the protein expression of TLR3, we 
measured the area of immunoreactivity (refer to section 2.7.2). There was a significant 
increase in TLR3 positivity in the WMI cases compared with the controls in the MD (p < 
0.05), VLp (p < 0.05), VPL (p < 0.01) thalamic regions and in the adjacent white matter 
regions, PLIC-VLp (p < 0.05) and PLIC-VLP (p < 0.05; Table 4.4). In neurons in thalamic 
regions (MD, VLp and VPL) and neurons in the posterior limb of the internal capsule, 
the TLR3 immunoreactivity was globular and had a ribbon-like formation in the 
perinuclear region in the control cases (Figure 4.6 C). However, although WMI cases also 
showed TLR3 expression, there was more punctate and granular staining seen outside of 
the nucleus of the cells and along processes in contrast to the more globular and focal 
localization seen in non-injured brains (Figure 4.6 D). Of interest, TLR3 was identified 
in glutamatergic axonal region of RL glutamatergic neurons (Sherman and Guillery, 
2013) in the controls and WMI cases (not shown). In contrast, TLR3 was not identified 
within the GABAergic neurons in controls (Figure 4.6 E) or in WMI cases (Figure 4.6 F) 








































TLR3 mRNA was detected mainly in neurons (A and B). In the control (A), the 
TLR3 mRNA expression was very punctate however, in the WMI cases the TLR3 in 
situ hybridisation was dark and granular (B). Protein expression of TLR3 in the 
VLp nuclei of the thalamus in cases with and without WMI. In C, a case without 
any known pathology, the staining was globular and perinuclear, whereas, in D, a 
case with WMI has granular and diffuse morphology. The WMI cases had a 
significant increase in area (µm2) of TLR3 immunoreactivity in all the regions of 
interest (MD; p < 0.05, VLp p < 0.05, VPL p < 0.01 and in the WM in of the PLIC 
in regions adjacent to the VLp p < 0.05 and VPL p < 0.05). TLR3 was not identified 
in the small GABergic neurons or processes identified with GAD 67 and VGAT 
(control (E) and WMI (F)). Ventral lateral posterior (VLp). Scale bar =20 µm (A 














 IRF-3 expression is perinuclear in controls but nuclear in WMI cases 
As the most substantial differences between WMI injury cases and control cases were 
observed in the VLp (i.e. higher ratio astrocytes and microglia with a lower ratio of 
neurons), we focused on this region to investigate TLR3 signaling further. Translocation 
of IRF-3 from the cytosol to the nucleus is a reported consequence of TLR3 signalling 
(Johnsen et al., 2006). As we previously identified the upregulation in the expression of 
TLR3 post injury (Figure 4.7), we used IRF-3 translocation as a surrogate to investigate 
its expression as a correlate for TLR3 function. To evaluate nuclear IRF-3 expression in 
the VLp thalamus, we defined the nuclear boundary with DAPI staining and measured 
the amount of immunoreactivity of the anti-IRF-3 (refer to section 2.7.2). We found that 
nuclear IRF-3 expression was markedly increased in WMI cases (Figure 4.7 B) compared 
with controls (Figure 4.7 A; WMI 51.4 ± 9.97, n=7; control 7.2 ± 1.4, n = 7; p < 0.01; 
Figure 4.7 C). This suggests that TLR3 elicited more IRF-3 activation in the WMI cases 

























































































































































































































































































































































































































 TLR3 is more prevalent in the endoplasmic reticulum in WMI 
TLR3 is known to be synthesized in the endoplasmic reticulum (ER) (Johnsen et al., 
2006). In order to study whether WMI altered the production of TLR3, we performed 
immunofluorescence colocalisation studies using TLR3 and an ER marker, Calreticulin, 
in the VLp thalamic region. TLR3 expression was frequently attached with the ER 
surfaces in the WMI cases, whereas TLR3 in the control cases was sparsely identified in 
the ER, but could be seen weaving alongside the convolutions but not attached to the ER. 
There was a significant increase in the colocalisation of ER (Figure 4.8 E) and TLR3 (p 
< 0.01) identified in WMI group (Figure 4.8 B) compared to the control (Figure 4.8 A). 
The data suggests that in the WMI injury cases TLR3 protein is being upregulated.  
 TLR3 is found in late endosomes in both control and WMI cases 
As TLR3 is known to translocate to the endosome on stimulation and as we observed an 
increase in the expression of TLR3 in the ER in WMI (Fig 4.8 B), we performed 
colocalisation studies of TLR3 with early (EEA1) and late (LAMP-1) endosome markers 
(refer to section 2.5.8) . In contrast with previous studies using dendritic cells (Johnsen et 
al., 2006), we found that TLR3 expression colocalised with late endosomal makers (p < 
0.05; LAMP-1) but not with early endosomal proteins (EEA1; not shown). Colocalisation 
between LAMP-1 and TLR3 was significantly higher in the WMI cases (Figure 4.8 D) 
compared with controls (Figure 4.8 C). Hypothetically, WMI stimulates excessive DAMP 
production and as a consequence, upregulates the necessary clearance mechanisms 







































Confocal photomicrographs demonstrating the colocalisation of TLR3 (red) within 
the endoplasmic reticulum (ER; A, B) and the late endosomes (LAMP-1; C, D,). 
The confocal images with anti-TLR3 (red) and an endoplasmic reticulum marker 
(green; anti-calreticulin) differ between control (A) and WMI (B). The average 
correlation value for the TLR3 and calreticulin overlap in the WMI cases is 
significantly higher than observed in the controls (E; p < 0.01**). In contrast, the 
TLR3 and the late (lysosome-associated membrane protein 1 (LAMP-1) endosomal 
marker (green) from the VL region of the thalamus colocalise in both control cases 
(C) and in WMI (D). TLR3 is more prevalent in late endosomes than in early 
endosomes (F; p < 0.05*). Note: anti-NeuN (neuronal marker; purple) was added 
to identify the neurons and is shown in the side panels along with the individual 
antigens and the orthogonal view. Scale bar= 15 µm (A); 8 µm (B) and 20 µm (C 
and D).  
 
Confocal photomicrographs demonstrating the colocalisation of TLR3 (red) within 
the endoplasmic reticulum (ER; A, B) and the late endosomes (LAMP-1; D, E). The 
confocal images with anti-TLR3 (red) and an endoplasmic reticulum marker 
(green; anti-calreticulin) differ between control (A) and WMI (B). The average 
correlation value for the TLR3 and calreticulin overlap in the WMI cases is 
significantly higher than observed in the controls (C; p<0.01**). In contrast, the 
TLR3 and the late (lysosome-associated membrane protein 1 (LAMP1) endosomal 
marker (green) from the VL region of the thalamus colocalise in both control cases 
(C) and in WMI (D). TLR3 is more prevalent in late endosomes than in early 
endosomes (E; p<0.05*). Note: anti-NeuN (neuronal marker; purple) was added to 
identify the neurons and is shown in the side panels along with the individual 
antigens and the orthogonal view. Scale bar= 15 µm (A); 8 µm (B) and 20 µm (D 
and E).  
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 An increase in autophagy is seen after WMI 
In addition to showing the role of TLR3 in endosomal-mediated degradation, very recent 
studies have implicated TRIF and, by association, TLR3 in autophagy (Oh and Lee, 2014, 
Xu et al., 2008, Zhan et al., 2014). Indeed, another nucleic-acid sensing TLR, TLR9 is 
implicated in a noncanonical autophagy pathway known as microtubule-associated 
protein light chain (LC3) associated phagocytosis (LAP), where rapid recruitment of LC3 
to phagosomes facilitates the fusion with lysosomes (Henault et al., 2012, Oh and Lee, 
2014). We therefore examined the colocalisation of TLR3 with LC3-II, a marker of 
autophagosome formation. In all the cases TLR3 colocalised with the LC3-II marker of 
autophagy, but there was no difference in the colocalisation (Figure 4.9 G) values between 
WMI (Figure 4.9 D) and control (Figure 4.9 A). However, an increase in the cytoplasmic 
staining of LC3-II was observed in WMI cases compared with control, suggesting not 
only that TLR3 is localised on the autophagosome, but that WMI may increase autophagy 




 Levels of mitophagy increase after WMI 
Finally, as autophagy appeared to be activated in WMI, we determined whether a subset 
of this recycling mechanism, mitophagy, was also altered. Mitochondrial dysfunction has 
been implicated in the development of brain injury in both term and preterm infants 
(Rousset et al., 2012) and mitochondria have an increasing role as a platform for innate 
immunity (Hagberg et al., 2014, Weinberg et al., 2015). Mitophagy (or recycling of 
damaged mitochondria) would therefore represent a potential mechanism for cell 
survival. Therefore, we assessed the colocalisation of LC3-II, TLR3 and mitochondrial 
antigen. Interestingly we found that there was a significant increase in colocalisation of 
anti-LC3-II immunoreactivity with TLR3 and  mitochondria in WMI (p <0.001; Figure 
4.9 H and 4.9 I), suggesting that after WMI has occurred there is a catabolic response of 
induced autophagy that occurs to free the cell of damaged proteins and organelles 






Figure 4.9 TLR3 expression colocalised with autophagy and mitochondrial protein 
(MTC02) 
Confocal photomicrographs demonstrating the distribution of TLR3 (red), anti-LC3-II 
(green) and mitochondria (anti-mitochondrial antigen; white) from the VLp thalamic 
region in a control case (A-C) and WMI case (D-F). The immunoreactivity of LC3-II 
increased after WMI, but LC3-II and TLR3 equally colocalise (G) in both cases with 
WMI (D) and control (A). The colocalisation of LC3-II and mitochondria is 
significantly higher in WMI (E) than in the controls (B) suggesting that mitophagy 
may be occurring (H). In the control case, TLR3 is located densely around the nucleus 
but does not colocalise with the mitochondria (C) whereas in the WMI case, the TLR3 
expression does appear to be localised with the mitochondria but only in conjunction 
with LC3-II expression (F,I) ***  p < 0.001. Bottom images show orthogonal views 








Figure 4.10 A cartoon depicting the hypothetical pathway of TLR3 activation after 
WMI and in controls.  
TLR3 receptors are synthesized in the endoplasmic reticulum (ER). TLR3 
production is increased in response to damage-associated molecular patterns 
(DAMPs) and stays on the fragments of the ER that are recruited to form 
phagophores. The phagophore elongates, forming the LC3-II-positive 
autophagosome, which engulfs the DAMPs and fuses with the lysosome, where 
components such as mitochondria are recycled. TLR3 is upregulated in the ER and 
autophagosomal components in response to WMI, which suggests that another 
method of cellular adaptation to WMI may include autophagy. Another pathway to 
recycle damaged components is via the endosomes. As the endosome matures, TLR3 
is recruited to the late endosome (LAMP-1) and the components of the 
macromolecules are acidified as it fuses with the lysosome. TLR3 is present in 
endosomes in both control and WMI tissue where it responds to DAMPs. However 
after WMI this response is exaggerated. Activation of TLR3 also results in the 
recruitment, nuclear translocation and subsequent activation of interferon 
regulatory factor 3 (IRF-3) which regulates the production of type I interferons. 
 
 
TLR3 receptors are synthesized in the endoplasmic reticulum (ER). TLR3 
production is increased in response to damage-associated molecular patterns 
(DAMPs) and stays on the fragments of the ER that are recruited to form 




In this study, we have identified TLR3 expression in different cellular components of the 
neuron in the immature brain; to the best of our knowledge, this is the first time this family 
of receptors has been demonstrated in neurons of the thalamus in the fetal sheep brain and 
in the human neonatal brain. The results presented in this study are compatible with the 
hypothetical model outlined in Figure 4.10 that describes how TLR3 responds to an 
increase in endogenous DAMPs being released after WMI has occurred. It is still 
unknown whether there is a cause-effect relationship between WMI and the TLR3 
alterations in the thalamus (so called network injury (Dudink et al., 2012)) or if the 
exposure causing WMI is also inducing cellular stress in the thalamic nuclei with 
subsequent changes in TLR3. We showed that in the neurons of the VLp thalamus, there 
is an increase in mRNA expression of TLR3 which then is consistent with protein 
synthesis in the endoplasmic reticulum in cases with WMI. Furthermore, there was an 
increase in late endosome, autophagy and lysosomal proteins in the WMI cases, whereas 
in the control, TLR3 mainly colocalised with the late endosomes. Moreover, we 
demonstrated that neuronal TLR3 increases and activates the TRIF pathway as IRF-3 was 
translocated to the nucleus in association with WMI. 
 TLR3 in the fetal sheep  
The differences seen between the human groups in the thalamus and internal capsule 
regions seem to correspond to that seen between the sham and LPS exposed fetal sheep. 
However, the LPS sheep tended to have more positive TLR3 immunoreactivity and in 
situ detection than that detected in the human cases, especially in white matter regions. It 
is not known if this difference is due to autolysis, which could have occurred in the human 
cases or a difference in the extent of injury caused during human WMI pathology 
compared to sheep LPS exposure. Another consideration for the differences in the TLR3 
expression may be from species effects with the staining.  
199 
  
It was hypothesized that in cases of neonatal injury there would be an increase in 
microglia and astroglia populations, and that these would express both protein and mRNA 
for TLR3. The fetal sheep that were exposed to LPS had increased TLR3 expression on 
cells, where the size and morphology indicated glial activation, seen in both the thalamus 
and in the internal capsule. The findings in the fetal sheep brains demonstrate that the 
thalamic atrophy and cortical disorganization might be due to an over abundance of TLR3 
stimulation on glial cells, which may interrupt the neuronal migration.  
 Thalamic nuclei segregation and pathological findings in the human immature 
brain 
Previous studies focused on the MD region have shown that atrophy in the thalamus is 
associated with selective microstructural abnormalities (Zubiaurre-Elorza et al., 2012).  
Although segregating the different regions of the ventral thalamic nuclei is an arduous 
undertaking (Sherman et al., 2006, Jones, 2007), we were able to use lateral anatomical 
landmarks from the globus pallidus and the established cytoarchitecture (Jones, 2007) of 
the different thalamic regions to define three regions of interest. It is imperative that future 
histologic investigations on preterm neurological function include defined thalamic 
regions. For instance, the reduction of the MD and pulvinar thalamic regions have been 
strongly associated with abnormal cognitive outcome in preterm infants with WMI 
(Ligam et al., 2009, Zubiaurre-Elorza et al., 2011). But preterm birth also has a high risk 
of a range of motor impairments and the severity of motor impairments increase with 
WMI (Spittle and Orton, 2014). Motor impairments occur because the sites of 
periventricular infarctions lie in the motor pathways (Lagercrantz, 2010, Volpe, 2008). 
Hence, after WMI has occurred in preterm neonates, there may be pathologies that can 
be identified in the specific thalamic regions which can be correlated to both cognitive 
and motor impairments. 
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Our investigation substantiates the findings of other researchers that have identified 
abnormalities seen in the thalamus in preterm infants with WMI. Ligam et al (2009) found 
reactive astrocytes in the MD and the reticular nucleus (a structure that surrounds and 
modulates the lateral thalamic nuclei (Jones, 2007) with GABAergic neurons) in preterm 
post-mortem cases with WMI (Ligam et al., 2009).  In the present study, we demonstrate 
that the ratio of astrocytes increased in the WMI cases in the MD and in the VLp thalamic 
nuclei and in the adjacent PLIC in humans. 
Normally, in grey matter, one would expect to find protoplasmic astrocytes that exhibit 
short and highly branched processes and possess a large quantity of organelles (Benjamin 
Kacerovsky and Murai, 2015). In the WMI cases, astroglia were hypertrophic with 
extensive processes and an increased expression of GFAP which is indicative of a reactive 
form that may promote a prolonged pro-inflammatory response (Hagberg and Mallard, 
2005, Kinney and Back, 1997).  
In conjunction with an increase in astroglia we found an increase of microglia in the MD, 
VLp and VPL thalamic nuclei and in the PLIC-VPL in the WMI cases. These findings 
are consistent with previous studies that correlated pathology in the surrounding white 
matter structures with abnormalities seen in the thalamus (Haynes et al., 2011, Zubiaurre-
Elorza et al., 2011).  In inflammatory injury of the preterm brain, such as WMI, there is 
a known  activation of microglia (Supramaniam et al., 2013).  Microglia and astroglia 
respond to the injury and upon activation, release pro-inflammatory cytokines such as 
tumor necrosis factor (TNF)-α, interleukin-6 (IL-6), interferon-γ (INF-γ) and nitric oxides 
(Rezaie and Dean, 2002).  
In parallel with glial cell increase, we found a decrease in the neuronal population in the 
MD, VLp and VPL thalamic nuclei in the WMI case. The neuronal loss in the VLp 
substantiates studies of preterm cases that describe WMI impairing motor coordination 
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of the limbs (Spittle and Orton, 2014). Residual damage fragments released during the 
WMI (or some cell injury locally in the thalamus) continuously activate TLR3 as it 
responds to the endogenous stimuli (Kariko et al., 2004) in both the neuronal and 
astroglial population (Bsibsi et al., 2010). Further studies that correlate thalamic 
abnormalities warrant more detailed investigation to fully comprehend motor and 
cognitive deficits associated with preterm pathologies.  
 TLR3 molecular mechanism 
Previously, Johnsen and colleagues (2006) found that in dendritic cells, c-Src tyrosine 
kinase is activated by dsRNA viral stimuli in the endoplasmic reticulum (ER) where it 
recruits TLR3 and then mediates TLR3 translocation to endosomes and induces various 
signalling cascades (Johnsen et al., 2006).  The ER contains resident proteins such as 
calnexin and calreticulin (Desjardins, 2003)  that serve as chaperones; unstimulated TLR3 
was shown to colocalise with these resident proteins. Stimulated TLR3 was colocalised 
with lysosomal-associated membrane protein 1 (LAMP-1 which identifies both late-
endosomes and lysosomes) (Johnsen et al., 2006). Another possible platform for TLR-3 
activation is via the phagophore which works with conjugation with LC3-II to form the 
autophagosome; an important mediator to autophagy and mitophagy i.e. degradation of 
damaged proteins and dysfunctional mitochondria (Sun et al., 2011, Zhu et al., 2005, 
Hagberg et al., 2014).  
We have demonstrated that the TLR3 was present in late endosomes in both control and 
WMI and colocalised with LAMP-1 most likely being part of the molecular surveillance 
for extracellular DAMPs and PAMPs. Another source of surveillance and degradation 
may be via autophagy as TLR3 colocalised with LC3-II. In WMI injury LC3-II 
expression increased; autophagy is particularly important in long-lived cells like neurons 
and impairments in autophagy are associated with abnormal CNS development and 
neurological impairment (Hagberg et al., 2014). 
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Identifying changes in TLR-3 expression associated with WMI may improve our 
understanding of the molecular mechanisms associated with impaired development seen 








Neuronal circuits built during fetal development derive from growth cones that navigate 
the dendrites or axons (collectively referred to as neurites) through developing brain 
tissue to meet an appropriate synaptic target (Conde and Caceres, 2009). Growth cones 
are finger-like projections that survey the extracellular matrix in search of guidance cues 
in the neural environment (Geraldo and Gordon-Weeks, 2009). As growth cones advance 
through the variety of extracellular terrains they build the extending neurites behind and 
establish the presynaptic elements of the synapse ahead (Gordon-Weeks, 2000). See 
Figure 1.3. 
The effect of growth cones proteins on the morphology of axonal and dendritic spines in 
the developing and adult brain is under intense investigation (Ivanov et al., 2009b). 
Growth cone proteins found in dendritic spines can alter synaptic activity, which is 
important for plasticity and also to maintain long-term synaptic connections. 
Abnormalities in the expression of growth cone proteins may lead to synaptic dysfunction 
and cognitive impairments in the developing brain and the adult brain (Gordon-Weeks 
and Fournier, 2014, Tortoriello et al., 2014).  
 Activation of cell cycle arrest transcription factor p53 in microglia influences the 
neuronal synaptic integrity measured by reduced expression in both the growth cone 
protein, drebrin and synaptophysin (Jebelli et al., 2014).  A reduction of drebrin was also 
seen in neuronal cultures that were mixed with microglia with activated TLR4 (Jebelli et 
al., 2014). Also of interest is that growth cone collapse has been associated with the 
activation of TLR3 in cases of multiple sclerosis (Bsibsi et al., 2010). The following 
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experiments were designed to evaluate if growth cone structures are compromised in 
cases of WMI where there is an increase TLR3 expression.  
In concert with growth cone modulatory proteins, TLR3 has a functional role in regulating 
neuronal proliferation in the developing brain (Cameron et al., 2007, Lathia et al., 2008, 
Bsibsi et al., 2010). During the inflammatory process of multiple sclerosis, TLR3 and 
stathmin were colocalized on the surface of astrocytes, neurons and microglia (Bsibsi et 
al., 2010) preventing new dendritic connections from forming. This interruption may 
happen if glial cells or surrounding neurons are expressing inflammatory cytokines in 
response to DAMPs and PAMPs (Jebelli et al., 2014). Inflammatory responses may 
prematurely activate TLR3, which will function as an inhibitory process (Lathia et al., 
2008) on growth cone extension. Although the roles of neuronal TLR3 and growth cone 
proteins are not fully understood, both possess similar mechanism of action, such as 
inhibition of the growth of neuronal precursors, axons, and dendrites (Bsibsi et al., 2010).  
During brain development, there are waves of migrating neurons that travel from the 
germinal matrix and ganglionic eminence via the periventricular white matter to the 
cortex. After white matter injury has occurred, there are endogenous DAMPs released 
that may activate TLR3. TLR3 activation may not only occur in the migrating neurons 
but also in the neurons awaiting synaptic connections in the grey matter (i.e., cortex and 
thalamus). Our hypothesis is that TLR3 activation after WMI has occurred may result in 
the premature collapse of the growth cone. Furthermore, the collapse of the growth cone 






 CRMP2 and Semaphorin 3A growth cone markers are not easily identified in 
paraffin sections 
Growth cone markers, CRMP2 and Semaphorin 3A, have been found to be up-regulated 
in neurons in animals models of hypoxia (Xiong et al., 2012) and spinal cord injury 
(Tsuchida et al., 2014) . Since CRMP2 and Semaphorin 3A are found in the growth cone 
structure of migrating neurons, the subplate zone was investigated first. The full growth 
cone structures were not identified with anti-CRMP2 immunostaining, in the subplate 
zone, although we did find remnants of filopodia which were seen close to the cell nucleus 
that had fine punctate immunostaining (Figure 5.1 A). As described in Chapter 1, during 
fetal development the cortical and thalamic neurons have extensive dendritic branching 
as synaptic connections form. CRMP2 is thought to promote microtubule assembly 
(Conde and Caceres, 2009). Thus we checked to see if CRMP2 could be identified on 
apical dendrites of cortical neurons. We did not identify any CRMP2 protein expression 
in the cortical neurons (Figure 5.1 B). CRMP2 expression was seen  as perinuclear in the 
thalamic neurons (Figure 5.1 E and F), but we failed to see any differences between 
controls and WMI cases. 
Axonal microtubular bundles in the growth cone display highly sophisticated and 
dynamic behaviours including a splay formation, which allows for the advancement and 
mobility (Gordon-Weeks, 2000). Semaphorin 3A is thought to be one such protein 
involved in the depolymerization of the growth cone tip. We failed to identify the growth 
cone in using anti-Semaphorin 3A antibody in the subplate zone (Figure 5.1 C). Fine 
punctate fragments of Semaphorin 3A immunoreactivity were identified in neurons in the 
cortical region, but the immunoreactivity was not specific enough to attempt any 
quantitative studies (Figure 5.1 D). Finally, we examined if Semaphorin 3A could be 
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identified in thalamic neurons. Similar to the CRMP2 results, only faint staining of the 
protein could be seen in the cytoplasmic domain in the thalamic neurons of both the 
control (Figure 5.1 G) and WMI cases (Figure 5.1 H).  
The confocal micrographs revealed CRMP2 and Semaphorin 3A cytoplasmic expression 
but it was not seen in the processes. Since the specificity of the immunoreaction was 
uncertain, it was decided that quantitative TLR3 colocalisation should not be performed 
although the proteins seem to be present in the same region of the cytoplasmic domain 
(Figures 5.1 E-H). 
The growth cone is a highly mobile fluid-filled structure that elongates and shrinks by 
microtubule assembly or catastrophe. The use of paraffin processing might have 


















 Immunostaining of growth cone remnants after paraffin processing. In A, the 
subplate zone of a control brain some of the cells have perinuclear CRMP2 
immunoreactivity (A; blue arrows). Image B, the cortical region from the same case 
as A (i.e., control brain), the CRMP2 staining is absent. Semaphorin 3A in the 
control brain is absent in C, the subplate zone, but the cortical region shows small 
punctate structures (D; red arrows). Images from the VLp thalamic region seen in 
images (E-H) show that TLR3 (red) is seen in the cytoplasmic domain. Scant 
amounts of CRMP2 (E and F) and Semaphorin 3A (G and H) are visible. There is 
perinuclear expression of CRMP2 (green) seen in the controls (E), but this 
expression is faint in the WMI cases (F). The Semaphorin 3A immunoreactivity 
was faint in both the control (G) and WMI (H) thalamic region. Scale bar = 100 µm 
(A-D).  
 
Immunostaining of growth cone remnants after paraffin processing. In A, the 
subplate zone of a control brain some of the cells have perinuclear CRMP-2 
immunoreactivity (A; blue arrows). Image B, the cortical region from the same case 
as A (i.e., control brain), the CRMP-2 staining is absent. Semaphorin 3A in the 
control brain is absent in C, the subplate zone, but the cortical region shows small 
punctate structures (D; red arrows). Images from the VLp thalamic region seen in 
images (E-H) show that TLR3 (red) is seen in the cytoplasmic domain. Scant 
amounts of CRMP-2 (E and F) and Semaphorin 3A (G and H) are visible. There is 
perinuclear expression of CRMP-2 (green) seen in the controls (E), but this 
expression is faint in the WMI cases (F). The Semaphorin 3A (Sem 3A) 
immunoreactivity was faint in both the control (G) and WMI (H) thalamic region. 
Scale bar = 100 µm (A-D).  
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 Drebrin immunopositive cell counts are lower in the WMI cases than controls 
in the ganglionic eminence  
Parallel microtubule bundles with MAP proteins (i.e., MAP1B or MAP2) are captured in 
the growing axons and dendrites via linking proteins, such as drebrin (Conde and Caceres, 
2009). Phosphorylation of  the drebrin protein is essential for forming links with EB3 to 
solidify synaptic connections and is required for neuritogenesis (Ivanov et al., 2009b, 
Ivanov et al., 2009a). Thus we investigated drebrin in the proliferative portion of the 
subventricular zone, the lateral ganglionic eminence, which is highly active during mid-
late fetal gestation and important for the productions GABAergic neurons (refer to section 
1.6). The drebrin positive cells and cell density (drebrin and hematoxylin positive cells) 
were counted in both the controls and WMI cases (refer to section 2.8.2). There was a 
significant reduction in averaged drebrin positive cells (per mm2; p < 0.05; control 10554 
± 3319 n=5; WMI 3230 ± 332 n=5; Figure 5.2 C) in the WMI cases (Figure 5.2 B) 
compared to the controls (Figure 5.2 A) in the lateral ganglionic eminence. In addition, 
the cell density was significantly higher in control versus WMI cases in the lateral 
ganglionic eminence (p < 0.01; control 29200 ± 7086 n=5; WMI 4596 ± 479 n=5; Figure 
5.2 D). Triple labeling using antibodies made against drebrin, GFAP and HuC/HuD show 
drebrin is identified in neurons (Figures 5.2 E, 5.2 F and side panels). Drebrin expression 
was identified around nuclei that were HuC/HuD positive (Figures 5.2 E and F; side 
panels). Drebrin did not colocalise with GFAP perinuclear expression in either control 
(Figure 5.2 E) or WMI (Figure 5.2 F) cases. The decrease in cell counts suggests that after 
WMI there are less neurons in the lateral ganglionic eminence. The decrease in drebrin 











Neurons positive with the mouse anti-drebrin antibody are seen emerging from the 
lateral ganglionic eminence of the preterm brain (A and B; inserts). In A,  an image 
from the control group there are significantly more drebrin positive cells cell than 
identified in the WMI cases (B). A graph representing the drebrin positive cells and 
the average cellular count (mm2) (C and D). Confocal micrographs demonstrating 
that the drebrin signal (green) is highly expressed in neurons identified with HuC 
and HuD (yellow arrows in E and F; side panels, white) in controls and WMI cases. 
The orange arrows are pointing to astrocytes (E and F; GFAP;red) that do not have 
drebrin expression. Asterisks: significant differences in the cellular densities count-
ed in the control cases compared to the WMI.  *p < 0.05; **p < 0.01. Scale bar =50 
µm images A and B; 10 µm images E and F. 




 Drebrin positive elements decrease in the PVWM in WMI cases 
As discussed in Chapter 1, migrating neurons leave the subventricular zone and move to 
the subplate region. Migrating neurons have a enlongated growth cone structure, that 
gives the neuron a bipolar appearance (Gordon-Weeks, 2000). In WMI cases, the PVWM 
region shows dissolution of the white matter and axonal injury (Haynes et al., 2011, 
Leviton and Gressens, 2007) and foamy appearing histiocytes (Rodts-Palenik et al., 
2004). Therefore, the next series of investigations involved measuring the drebrin positive 
extensions, counting the drebrin positive elements and calculating the cellular density in 
the control and WMI cases in the PVWM region. In the control sections, the PVWM had 
multiple cells with bipolar drebrin staining (Figure 5.3 A and C). The PVWM in the WMI 
was more edematous with fewer visible drebrin bipolar structures (Figure 5.3 B and D). 
There was a significant difference found in the average length of the drebrin extensions 
between the control and WMI (p < 0.05; control 13 ± 1.8  n=5; WMI 8 ± 0.53 n=5; Figure 
5.3 E). The number of drebrin positive elements were significantly higher in controls 
cases compared to the WMI cases (p < 0.05; control 25088 ± 1257  n=5; WMI 15477 ± 
1347 n=5; Figure 5.3 F). However, the total cell population was not significantly different 
between control cases and the WMI (Figure 5.3 G). The difference in drebrin positive 
elements seen in the WMI cases could be a consequence of neurons emerging from the 
ganglionic eminence lacking drebrin protein or an effect of the surrounding injury. This 
is of interest as the findings in Chapter 3 suggests that the neuronal count is higher in the 
PVWM region in the WMI cases (see Chapter 3), meaning that these neurons might be 










Figure 5.3 Drebrin positive cells in the PVWM region
Drebrin immunoreactivity is seen as bipolar structures emerging from the cell body 
in the PVWM region. In A and C, control brain there are multiple bipolar cells. 
Whereas, in B and D, WMI brain these structures are more fragmented. The graph 
in E shows that the average length of drebrin positive processes of the bipolar neu-
rons is significantly different between controls and WMI. The graph F, represents 
that there is a significant difference in the number of structures identified. However, 
the total cell population did not change between controls and WMI (G). *p < 0.05; 




 Subplate zone drebrin expression differs in WMI compared to control 
At 28 PCW the subplate zone is seen as a vast region that lies below the subcortical plate 
(Kostovic and Judas, 2010) (Figures 1.2 and 1.7).  In the subplate zone, the neurons 
undergo a stage of synaptic development with afferent fibres penetrating the cortical plate. 
The subplate zone drebrin expression appeared as a bipolar structure with long radial 
extensions (Figure 5.4). This morphology was more apparent in the controls (Figure 5.4 
A and C) than in the WMI cases (Figure 5.4 B and D).  Similar to that found in the PVWM 
the average length of the drebrin positive structures were significantly different between 
the controls and the WMI cases (p < 0.05; control 25 ± 1.6  n=5; WMI 8.8 ± 1.0 n=5; 
Figure 5.4 E). There was a significant difference in the amount of drebrin positive 
elements between the control and the WMI cases in the subplate zone (p < 0.05; control 
31759  ± 2753  n=5; WMI 11360 ± 885 n=5; Figure 5.4 F).  However, there was no 
significant difference in the cellular density (hematoxylin positive nuclei; Figure 5.4 G) 
between the control and WMI groups. The data in the PVWM and subplate zone 





Figure 5.4 Subplate zone expression of drebin
 Anti-drebrin expression in control (A and C) and WMI (B and D) in the subplate 
zone. In A and C, there are radial extensions that have the morphology resem-
bling axonal or dendritic extensions (black arrows; C) in controls. The subplate 
zone of the WMI cases has fewer drebrin extensions which are more fragmented 
than those seen in the control cases (B and D; red arrow). Graph E represents the 
average drebrin length between controls and WMI, which was significantly 
different. The number of elements identified was significantly decreased in WMI 
cases (F). Graph G, represents the total cell count which did not significantly alter 
between control and WMI cases. *p < 0.05; scale bar = 50 µm images A and B, 10 





 Cortical drebrin expression differs in the WMI cases versus control cases 
In the frontal lobe cortical sections, drebrin staining revealed fine fibres that ran parallel 
to the cells in the layers II-VI of the cortex in the control cases (refer to sections 2.8.2.7 
and 2.8.2.8). In the WMI cases, the drebrin immunoreactivity was more sporadic (Figures 
5.5 thru 5.7). Granular or koniocortex (i.e., layers II-III) such as those found in the frontal 
lobe (specifically motor cortex) are dominated by small cells that are thought to have 
numerous dendritic extensions (Nolte and Sundsten, 2002, Gadisseux et al., 1989). 
Therefore, in layers II-III of the motor cortex one would expect to find drebrin positive 
fibers with extensive branching. The control cases had a mossy appearance  (Figure 5.5 
A)  with extensive dendritic branching that innervated layers II-III, but this morphology 
was almost absent in the WMI cases (Figure 5.5 B). However, the number of drebrin 
positive elements identified in this upper cortical region was not significantly different 
between WMI and control groups (Figure 5.5 C). However, there was a significant 
difference in the cell population between control and WMI (p < 0.05; control  9859 ± 
4971  n=5; WMI 3790 ±  1307 n=5; Figure 5.5 D) in layers II-III of the motor cortex. The 
reduction of drebrin positive elements and the decrease in cells seen in the WMI cases 
may have implications for proper modulation of cortical signals. 
Layers IV-VI of the motor cortex have large pyramidal neurons with dendrites that have 
short processes and axons with long processes that project to all cortical layers and 
provide corticothalamic collaterals to thalamic nuclei (West DC et al., 2006). The drebrin 
expression simulated these processes in the control cases (Figures 5.6 A and 5.7 A) with 
long and short fibrous extensions through layers IV-VI. The drebrin protein was not as 
prominent in the WMI cases, although some staining could be seen (Figures 5.6 B and 
5.7 B). The number of drebrin positive elements identified in layer IV of the motor cortex 
in controls was significantly different compared to the WMI group (p < 0.05; control 
120821  ± 17519  n=5; WMI 30039 ± 8299 n=5; Figure 5.6 C).  The decrease in drebrin 
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elements was seen in  Layers V-VI (p < 0.05; control 148581 ± 19048  n=5; WMI 33834 
± 10802 n=5; Figure 5.7 C) of the WMI cases. This data indicates that drebrin expression 
and cortical density is altered after WMI in layer IV-VI, this may impair the ability to 
modulate thalamic projections. 
Also of interest, the cell count assessed in layers IV  (p < 0.05; control 8204  ± 876 n=5; 
WMI 4382 ± 597 n=5; Figure 5.6 D) and in layer V-VI (p < 0.05; control 8025 ± 916  
n=5; WMI 3714 ± 708 n=5; Figure 5.7 D) was significantly different in the control versus 
WMI cases. This series of investigations demonstrate that in the motor cortex, cortical 
cell density is lower in the WMI group compared with the controls. This is consistent 
with the findings in Chapter 3, where the cortical cell count was lower in the WMI cases 







Figure 5.5 Layers II-III of the motor cortex reveal fine drebrin postive fibers in 
controls
The cortical expression of drebrin represents the potential synaptic branching. In the 
control cases (A) the drebrin fibres are mossy in the layer II of the cortex (A). This mor-
phology is not as extensive in the WMI cases (B). Graph C shows that the drebrin posi-
tive elements identified (graph C) are not significantly different between control and 
WMI. In D, the graph demonstrates that there are differences in the cortical cell counts 
between the control and WMI group in the upper (p < 0.05) cortical region. *p < 0.05; 






Figure 5.6 Layers III- IV of the motor cortex shows a decrease in drebrin expres-
sion in WMI cases 
The drebrin expression in layers III-IV of the motor cortex show elongated fibers (A) 
seen in the control cases but not in the WMI cases (B). The graphs in C and D, repre-
sent the changes in morphology between the control and WMI groups. There is a 
significant difference in the number of drebrin elements seen in the control cases com-
pared to the WMI (C). The cell population was significantly different between the 




































































































































































































































































 Thalamic expression of drebrin differs between control cases and WMI 
The thalamus has extensive dendritic processes that serve to modulate the long axonal 
extensions that send relay signals to the cortex. During development of the thalamus, 
there is an enlargement of the cell body and axon that precedes the expansion of the 
dendritic trees (Jones, 2007). In Chapter 4, we showed that neurons are significantly 
decreased in the MD, VLp and VPL thalamic regions of the WMI cases. Thus in the 
following section of the study, we investigate if drebrin expression is altered in dendritic 
processes in the MD, VLp  and VPL thalamic regions in cases of WMI and control.  
In the control brains, fine drebrin positive fibres were seen outlining sections of the cell 
body of the thalamic RL neurons (Figure 5.8 A) in the VLp region. In the WMI cases, 
lower levels of drebrin expression were seen around the RL neurons of the VLp thalamus 
(Figure 5.8 B). In order to ascertain differences seen in the drebrin expression, we 
measured the immunoreactivity by applying filters to thin the immunopositive processes 
and segment the branches. Similar to the other brain regions the average drebrin length 
did not significantly alter between control and WMI cases (Figure 5.8 C) in any of the 
thalamic regions. However, there was a significant change in the number of drebrin 
positive elements between the control and WMI cases found in the MD (p < 0.001; control 
125636  ± 12279 n=5; WMI 13652 ± 5197 n=5),  VLp (p < 0.001; control 118975  ± 1752 
n=5; WMI 28833 ± 14055 n=5),  and VPL (p < 0.001; control 148408  ± 13662 n=5; 
WMI 29453 ± 12013 n=5) thalamic regions (Figure 5.8 D). The drebrin data gathered in 
the thalamic regions suggests that in WMI there is a lack of  drebrin, which impairs the 
synaptic branching in both the non-specific (MD) and specific thalamic nuclei (VLp and 
VPL). This is consistent with the findings in Chapter 4, where the thalamic neuronal ratio 
was lower and the glia ratio was higher in the WMI cases (see Chapter 4) in the MD, VLp 








Figure 5.8 Drebrin positivity in the thalamic regions  
Drebrin positive elements were more numerous in the thalamus of control (A) than 
in WMI (B) cases. The graphs in C and D demonstrate that although the average 
length of the drebrin positive structures identified did not change between controls 
and WMI (p>0.05) the number of drebrin elements were significantly decreased in 
all regions of the thalamus. ***p < 0.001; Medial Dorsal (MD); Ventral Lateral 
posterior (VLp) and Ventral Posterior Lateral (VPL); scale bar = 50 µm images A 
and B.  
 
 
Drebrin positive elements were more numerous in the thalamus of control (A) than 
in WMI (B) cases. The graphs in C and D represent that although the average 
length of the drebrin positive structures identified did not change between controls 
and WMI (p>0.05) the number of drebrin elements were significantly different in 
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 Drebrin and TLR3 do not colocalise 
TLR3 was found to colocalise with the catabolic microtubule protein stathmin in inflamed 
areas of MS patients, in astrocytes, microglia and neurons in the grey matter, but not in 
normal appearing tissue sections (Bsibsi et al., 2010). We conducted double labeling with 
TLR3 and drebrin proteins in order to identify if the TLR3 colocalises with drebrin 
expression. In layers II-III of the cortex, the two proteins failed to overlap (Figure 5.9 D) 
in either the control cases (Figure 5.9 A and C) or WMI cases (Figure 5.9 B and E).  
The next area that was investigated was the thalamic region, as seen in figure 5.8, there 
was a substantial decrease in drebrin staining in the WMI group. Drebrin was double-
labeled with TLR3 to establish if the two proteins interacted in the VLp thalamic region 
in the control and WMI group. There was no significant change in colocalisation values 
seen in the VLp region between the control value and the WMI (i.e., less than 0.3). Instead 
the drebrin and TLR3 revealed a negative correlation in staining intensities (i.e., when 
drebrin increased, TLR3 decrease and vice versa), even in the WMI cases where the 










The interaction of anti-Drebrin (green) and TLR3 (red) in the cortex (A-E) and in 
the VLp thalamus region (F-J). In the cortical region the controls have numerous 
drebrin fibres (A and C; green), whereas in the WMI these appear as fragments (B 
and E; green). However, the TLR3 expression is stronger in the WMI cases (B and 
E; red) than what is seen in the controls (A and C; red). A decrease in drebrin 
expression is seen in the thalamus of the WMI brains (G and J; green) with an 
increase in TLR3 expression (G and J; red) in the cytoplasmic domain. The control 
cases show large amounts of drebrin (F and H; green) that did not colocalise with 
TLR3 (F and H; red) seen in the perinuclear region. The graph in I demonstrates 
that drebrin and TLR3 did not colocalise in either group. 
 
The interaction of anti-Drebrin (green) and TLR3 (red) in the cortex (A-E) and in 
the VLp thalamus region (F-J). In the cortical region the controls have numerous 
drebrin fibres (A and C; green), whereas in the WMI these appear as fragments (B 
and E; green). However, the TLR3 expression is stronger in the WMI cases (B and 
E; red) than what is seen in the controls (A and C; red). A decrease in drebrin 
expression is seen in the thalamus of the WMI brains (G and J; green) with an 
increase in TLR3 expression (G and J; red) in the cytoplasmic domain. The control 
cases show a vast amounts of drebrin (F and H; green) that did not colocalise with 
TLR3 (F and H; red) seen in the perinuclear region. The graph in I demonstrates 





This chapter describes the characterisation of growth proteins in the preterm human brain 
in cases with and without WMI. Here we used three growth cone proteins to identify the 
growth cone structure in migrating neurons and in post-migrated neurons that have to 
sustain cellular processes over a considerable distance (i.e., thalmo-cortical connections). 
The data obtained show that the expression of proteins involved with growing 
microtubule bundles differ after WMI injury has occurred.  
 Why CRMP2 and Semaphorin 3A did not identify growth cones 
Animal models show that CRMP2 and Semaphorin 3A are highly upregulated during the 
early postnatal period (Conde and Caceres, 2009). After hypoxic insults, an increase in 
CRMP2 represents an attempt at the repair of axons to maintain the structural integrity of 
neurons in the developing brain. In this study, we failed to see growth cone structures 
with the common growth cone markers, which was probably due to the paraffin 
processing. Growth cone structures are highly porous with a high fluid content (Gordon-
Weeks, 2000). The high fluid content makes this structure vulnerable to dissolution 
during the paraffin processing that functions to remove unbound water molecules 
(Dawson et al., 2003). Normally electron microscopy is employed to visualise the growth 
cone structure in cell cultures.  Fixatives such as gluteraldehyde and formalin can alter 
the morphology of the organelles seen in the growth cones (Gordon-Weeks, 2000).  
However, visualisation of growth cone structures with the novel growth cone maker, 
drebrin seems possible in post mortem studies. Drebrin studies on adult brain tissue 
(identified as A-Drebrin) show that synaptic plasticity is altered in cases of known bipolar 
disorder (Kim et al., 2010).  
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 Drebrin protein expression in the ganglionic eminence to the subplate 
In this study, we found a significant decrease in drebrin positive cells in the ganglionic 
eminence in cases with WMI. GABAergic neurons originate from the ganglionic 
eminence (Wonders and Anderson, 2006, Haynes et al., 2011). This area is of intense 
interest as Del Bigio, 2011 found a suppression of cell proliferation in premature human 
infants (18-34 GA weeks) that had GMH via the activation of p53 (a marker of cell cycle 
arrest) (Del Bigio, 2011). Haynes et al (2011) found that in the later gestational periods 
(i.e., 35-42 GA weeks) the subventricular zone compensates for neuronal loss after WMI 
has occurred with an increase in postmitotic migrating neurons (Haynes et al., 2011). The 
post-injured intrinsic repair was found to have an increase of doublecortin 
immunoreactivity in the subventricular zone (Haynes et al., 2011), but not specifically 
the ganglionic eminence. The cases used in this study represent an earlier gestation time 
point (GA < 32 weeks), thus the ganglionic eminence may not have had the chance to 
change to a compensatory mode. Future studies in the ganglionic eminence that include 
markers for inflammatory mediators, cell cycle arrest and proliferation are necessary to 
fully comprehend how WMI affects the GABAergic neurons. 
The total cellular counts in the PVWM region did not differ between control and WMI, 
but there were multiple areas of oedema present in the WMI cases. In Chapter 3, I describe 
that in WMI cases there is a significant increase in astroglia compared to the controls in 
the PVWM. Comorbid with an increase in astrocytes, the WMI cases showed a decrease 
in drebrin length and positive elements. The morphology of the drebrin was bipolar in the 
controls and more fragmented in the WMI cases. The loss of the drebrin protein could 
indicate a loss of migration cues that may hinder the neuron’s journey to the subplate. 
The lack of drebrin might have devastating results for synaptogenesis as neurons that fail 
to have proper growth cone proteins could be targeted by active microglia (Leviton and 
Gressens, 2007).  
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The decrease in drebrin positive processes were also seen in the subplate region of the 
WMI cases. The controls had elongated drebrin positive extension that extended into the 
subcortical region, whereas in WMI cases these structures were more fragmented. The 
cellular densities were not significantly different between the two groups, but we did not 
evaluate the glial population in these regions. The potential loss of synaptic mechanisms 
seen in the WMI cases indicates that thalamic-cortical connections that occur in the 
subplate might be jeopardised during the inflammatory state. Hence even if the intrinsic 
repair does take place (Haynes et al., 2011) these neurons may miss a critical time point.  
 Cortical drebrin expression 
In the cortical investigations, we show that drebrin elements in the WMI cases are not as 
prominent in all the cortical layers compared to the controls. Furthermore, the cellular 
densities were significantly decreased throughout the cortical layers. The middle cortical 
layer (i.e., layer IV) have spiny stellate neurons with multiple dendritic arborizations that 
is innervated by thalamic projections (Bannister, 2005) and are modulated by GABAergic 
basket cells (Huang et al., 2007). Formation of thalamocortical projection in layer IV is 
one of the fundamental neuronal circuits in the neocortex (Erzurumlu et al., 2006). Other 
investigations of surface molecules from the unc5 family, the unc5h4 gene, have been 
found in certain migrating neurons destined for layer IV. This gene produces adhesion 
molecules that allow thalamocortical fibers to form axonal fasciculation (Erzurumlu et 
al., 2006). Studies on proteins such as unc5h4 may demonstrate that drebrin loss is 
associated with a decrease of axonal fasciculation. Another interpretation might be that 
the loss of cell densities and drebrin expression may simply be an effect of the 
GABAergic neurons failing to proliferate or migrate from the ganglionic eminence. 
Further investigations are warranted to comprehend fully the decrease in cortical volume 
seen in this study. 
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 Thalamic drebrin expression 
The neurons of the thalamus require GABAergic and glutamatergic innervation for 
inhibitory or excitatory modulation (Sherman et al., 2006). In this study, there was a 
substantial loss of drebrin in the MD, VLp and VPL thalamic regions. Although drebrin 
loss alone does not conclude that synaptic connections will not form, it does suggest that 
these thalamic regions may lack plasticity. The loss of drebrin has been associated with a 
decrease in synaptophysin protein (Kim et al., 2010) in adult brain tissue from known 
bipolar patients. The lack of drebrin in multiple brain regions may indicate that 
synaptogenesis is inhibited and essential branching behaviour will not occur.  
Drebrin protein failed to colocalise with TLR3 in either the control or WMI cases. TLR3 
has been shown to reduce neurospheres as it is found in growth cones and interacts with 
catabolic proteins, such as stathmin-1 (Bsibsi et al., 2010). However, this finding might 
not be a simple interaction as knock-out of stathmin genes reveals a compensatory 
mechanism among stathmins (Chauvin and Sobel, 2015). In WMI cases there were fewer 
drebrin elements. Recently it has been suggested that p53 activities in microglia can 
promote cognitive deficits in neurodegenerative diseases via synaptic degeneration (e.g. 
loss of drebrin) in neurons during inflammation or TLR4 activation (Jebelli et al., 
2014).  The effects of drebrin loss seen in various brain regions in the WMI cases needs 








 Summary of findings and new approaches 
This series of studies have described the expression and characterisation of TLR3 in all 
cell types of the preterm neonatal human brain; to the best of our knowledge, this is the 
first time this family of receptors has been demonstrated in the human neonatal and fetal 
sheep brain. TLR3 was detected in human and sheep brains that did not have pathologies, 
which indicates that both the mRNA expression and protein expression of TLR3 is normal 
during brain development and may serve to guide cortical connections and solidify 
placement of the thalamic neurons and cortical layers. In addition, we showed that TLR3 
expression was altered in the presence of overt WMI or LPS exposure that was evident 
in the comparison made with the controls. This chapter summarises the important points 
resulting from this work and outlines proposals for further investigations based on the 
findings. 
In Chapter 2, the methods developed for this series of studies are described which 
employed the use of stereology and image analysis software in large contours taken from 
the tissue sections. Both methods provide a means to discuss unbiased cell counts for 
group comparisions. However, image analysis has the added advantage of providing 
measures of immunoreactivity that can calculate area and percentage of stained area for 
single or multiple dyes. The ability to measure staining has the potential role of 
strengthening results and identifying cellular interactions in pathological examinations.  
This study demonstrated how in situ hybridisation and immunohisotochemistry can be 
used as complementary tools to show the expression of proteins and mRNA. In situ 
hybridisation is the process of establishing a non-covalent, sequence-specific interaction 
between two or more complementary strands of nucleic acids using a labeled 
complementary DNA or RNA strand (i.e., probe) to localize a specific DNA or RNA 
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target in a section of tissue (in situ). In situ hybridisation represents a merger between 
molecular biology and histochemical techniques to study genetic expression. In situ 
hybridisation is distinctly different from immunohistochemistry, which localizes proteins 
in tissue sections based on the affinity of an antibody to a particular antigen. In situ 
hybridisation is used to determine the structure of chromosomes, and to measure and 
localize mRNAs within tissue sections (Lee et al., 2013) offering the ability to visualize 
very low levels of transcripts while preserving the cell’s integrity. For instance, studies 
that used mRNA probes to analyze the developmental expression of myelin specific 
genes, namely proteolipid protein (PLP), myelin basic protein (MBP), and 2',3'-cyclic 
nucleotide 3' phosphodiesterase (CNP), showed that ISH was more sensitive in detecting 
gene expression. The data indicated that myelin RNA transcripts have a more rapid 
turnover rate, hence discriminating changes were not affected by pre-existing older 
proteins (Jordan, 1990, Verity et al., 1990, Bessert and Skoff, 1999) Furthermore, Jordan 
1999, found that myelin transcripts were detected in earlier stages in development, then 
what has been shown by using myelin protein staining (Jordan, 1990). Hence, in situ 
hybridization could reveal some interesting findings for our work in TLR’s. Although the 
steps are time consuming and may need many attempts to perfect, the probes created for 
this project are clean, specific and reliable as they have passed our rigorous checking 
system. Proteins can last longer than the mRNA in tissue sections, but yet, the antibodies 
commercially produced may not be specific, which may not be detected using pre-
adsorption, thus in situ hybridisation used in this study confirmed what was seen using 
immunohisotochemistry. 
In Chapter 3, evidence is provided that supports the conclusion made in previous studies 
(Cameron et al., 2007, Lathia et al., 2008, Bsibsi et al., 2010) which stated that TLR3 is 
found in neurons and that it is a negative regulator of axonal growth. In the human cases 
of WMI, there were more cells in the cortex that had TLR3 expression compared to the 
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control cases and the cortex in the human WMI cases was grossly disorganized. 
Disorganized cortical neurons that also strongly expressed TLR3 were also seen in the 
fetal sheep exposed to LPS. This concept of cortical disruption after WMI or LPS 
exposure has been described in other studies (Dean et al., 2011, Haynes et al., 2011). One 
could speculate that the loss of beta-actin and TLR3 mRNA expression seen in the cortical 
samples from the WMI group and the LPS exposed group might be due to a reduction in 
the neuronal populations determined in the cell density counts. Recent advances in 
preterm WMI demonstrate that axonal injury is complex with several mechanisms 
involved in the pathogenesis (Hagberg et al., 2015) and that quantitative deficits in 
susceptible granular neurons occurs at a distance from the injury (Haynes et al., 2011). 
Diffuse axonal damage may be a consequence of secondary degeneration of neuronal cell 
bodies in the grey matter or retrograde axonal degeneration (Haynes et al., 2008).  
It was hypothesized that in cases of neonatal injury there would be an increase in 
microglia and astroglia populations and that these would express both protein and mRNA 
for TLR3. We identified the TLR3 protein in neurons and astroglia in the frontal PVWM 
and in the cortical regions. In cases of WMI, the microglia changed in morphology and 
were seen as amoeboidal shape rather than intermediate. However even despite the 
change in microglial morphology TLR3 protein was not detectable in the microglia.  
In Chapter 4, the human cases of WMI and the fetal sheep that were exposed to LPS had 
increased TLR3 expression on cells, where the size and morphology indicated glial 
activation, seen in the thalamus and the internal capsule. In the WMI cases, there was an 
increase in astroglia and microglia compared to the controls in the thalamus and posterior 
internal capsule. The increase in glia was comorbid with a decrease in neurons in the 
thalamus and PLIC regions. This demonstrates the dynamic of the signal events that lead 
to thalamic atrophy might be due to an over-abundance of TLR3 stimulation on glial cells, 
which may interrupt the axonal projections from the thalamus.  
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The results between the two human groups, control cases and the WMI cases, 
demonstrated that TLR3 expression differs when the brain is subjected to inflammation 
and injury. In both the human WMI cases and the LPS exposed sheep there were diffuse 
patterns of TLR3 expression in the thalamic and cortical neurons. The most noticeable 
difference was seen in the ventral lateral thalamus. The TLR3 mRNA expression was 
punctate in controls, however, in the WMI cases the TLR3 in situ hybridisation was dark 
and granular. The TLR3 protein expression in the WMI group tended to have more 
granular and diffuse distribution that extended into extracellular spaces. The control 
group had staining that was globular and perinuclear. 
Dual and triple labeling immunohistochemical techniques identified that the increase in 
TLR3 seen in the WMI cases also lead to the translocation of IRF-3 protein from the 
cytoplasm to the nucleus. This translocation of IRF-3 suggests that TLR3 elicited more 
proinflammatory mediators in the WMI cases compared with the controls. Another 
finding was that the molecular mechanisms of TLR3 altered when associated WMI. 
Normally c-Src tyrosine kinase is activated by viral dsRNA in the endoplasmic reticulum 
(ER) where it recruits TLR3 and then mediates TLR3 translocation to endosomes and 
induces various signalling cascades (Johnsen et al., 2006). After WMI, TLR3 colocalised 
with the ER chaperone protein and with lysosomal-associated membrane protein 1 
(LAMP-1 that identifies both late-endosomes and lysosomes). The increase of TLR3 seen 
in WMI cases also suggested that another platform for TLR3 activation is via the 
formation of the autophagosome, which mediates autophagy and mitophagy.  
In Chapter 5, the loss of drebrin expression seen in the ganglionic eminence and in the 
cortex demonstrates that guidance signals that normally occur on the neurons have 
prematurely ruptured after WMI. The drebrin protein expression also decreased in the 
thalamic region, suggesting that neurons may not be forming proper synaptic connections. 
This could, in turn, be detrimental to the non-specific and specific thalamic connections 
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that require reciprocal cortical input for proper motor function. Thus the overall role of 
drebrin expression and how it can affect the non-specific and specific cortical-thalamic 
signals is unknown. It remains to be seen whether the decrease in drebrin would affect 
other synaptic proteins. Other research has correlated a loss of drebrin protein and mRNA 
with neurodegenerative disorders (Julien et al., 2008, Nishijima et al., 2013) and in 
bipolar disorders (Kim et al., 2010). In WMI, the drebrin loss may signify that the 
thalamic neuron is occupied with saving the long axonal processes and dendritic 
extensions are delayed after stressful events. 
 Limitations of the study  
The differences seen between the human groups seem to correspond to that seen between 
the sham and LPS exposed fetal sheep. However, the sheep tended to have more positive 
TLR3 immunoreactivity and in situ detection than in the human cases, especially in the 
cortical region. It is not known if this difference is due to autolysis, in the human cases or 
a difference in the extent of injury in the human brains compared to sheep LPS exposure. 
Another possibility for the staining effect may be a difference between species. The 
detection TLR3 in the regions of the cortex, thalamus and posterior internal capsule in 
the immature human and sheep brain demonstrate that this protein is important for normal 
brain development and is activated after injury has occurred. 
In the human studies, the GA at birth was similar in the WMI and control group, but 
survival was longer in the WMI group. In the control group the causes of death were 
complications due to extreme preterm birth, pneumonia and congestive heart failure and 
the infant survival rate was less than 24 hours. The WMI group had similar complications 
as the control group but lived up to 5 weeks longer than the control. The PMA of the 
WMI group was significantly higher than the control (p < 0.05; WMI 28.86 ± 0.80, n=7; 
control 25.16 ± 0.62, n=7) but these groups were not significantly different at birth (GA; 
p > 0.05). (Case details are shown in Table 2.1). We cannot exclude the possibility that 
234 
  
WMI would have also developed in some control cases if they had lived longer. 
Nevertheless, our data suggest that changes in TLR3 expression in neurons and glia 
accompanied the development of WMI in the brains of the extremely preterm infant. 
Dual labeling TLR3 in situ hybridisation with markers for axons and glial populations 
might have provided more knowledge about the mechanisms of TLR3 expression in the 
developing brain after an infectious exposure. The formamide in the hybridization buffer 
made it difficult to achieve dual labeling with combined in situ hybridisation and 
immunohistochemical techniques. In order to prevent distortion of the proteins, I 
attempted to replace the formamide with tRNA from Baker’s yeast, a method described 
in Roth et al (1998) which should have allowed for successful dual labeling (Roth, 1998), 
but the sensitivity of the probe was reduced and we decided to concentrate on 
immunohistochemical double-labeling and use confocal micrographs to address protein 
colocalisation. 
 Future work 
The cortical and thalamic densities in the caudal brain regions were not calculated in this 
study. Examinations of the other brain regions therefore, remains a goal of future work in 
this field to identify if WMI leads to a global degeneration.  
Several TLR genes are expressed in the choroid plexus (Stridh et al., 2013a) and in the 
forebrain (Stridh et al., 2011). TLR2 and TLR4 protein identification was attempted in 
the human and sheep sections, however the results were inconsistent and it was thought 
that the antibodies may not be specific. Other cytoplasmic TLR’s (e.g., TLR7 or TLR9) 
that could respond to different forms of DAMPs and increase cytokine expression or the 
autophagy process. Further work on other TLR’s in other brain regions remains a goal for 
future work in this field.   
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Idenitification of reactive astroglia via intracellular phosphorylation of signal transducer 
kand activation of transcription (STAT3) (Choi et al., 2003) would allow for more insight 
as to confirmed that the astrocytes are inducing proinflammatory IL-6 signaling. Future 
work demonstrating that JAK-STAT pathway is being activated after WMI may lead to 
a clearer understanding of the development of astrogliosis, which reduces the axonal 
regeneration (Hashioka et al., 2015, Wang et al., 2015).  
Although this study suggests that autophagy and mitophagy occurs after WMI, further 
analysis using cell culture experiments and animal models would provide more thorough 
details on TLR3 activation and autophagosomal formation. Future studies using neuronal 
cell culture populations and transgenetic animals would add complementary information. 
The anatomical information gathered from these series of studies provided a more 
extensive comprehension of the brain, its anatomy, and its developmental process. These 
studies also demonstrated that the neurons of the developing brain are exposed to 
proinflammatory signals after WMI has occurred which may be critical for the 
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markers (GFAP for astrocytes, Iba-1 for microglia and Olig2 
for oligodendrocytes). We observed an increase in the neu-
ronal (28 vs. 17%) and astroglial (38 vs. 21%) populations in 
the WMI group compared to controls in the anterior regions 
of the periventricular white matter in the frontal lobe. The 
increase in neurons and astrocytes in the WMI cases was as-
sociated with an increase in TLR3 immunoreactivity. This ex-
pression was significantly increased in the astroglia. The 
morphology of the TLR3 signal in the control cases was glob-
ular and restricted to the perinuclear region of the neurons 
and astrocytes, whilst in the cases of WMI, both neuronal, 
axonal and astroglial TLR3 expression was more diffuse (i.e., 
a different intracellular distribution) and could be detected 
along the extensions of the processes. This study demon-
strates for the first time that neurons and glial cells in human 
neonatal periventricular white matter express TLR3 during 
development. The patterns of TLR3 expression were altered 
in the presence of WMI, which might influence normal devel-
opmental processes within the immature brain. Identifying 
changes in TLR3 expression during fetal development may 
be key to understanding the reduced volumes of grey matter 
and impaired cortical development seen in preterm infants. 
 Copyright © 2013 S. Karger AG, Basel 
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 Abstract 
 Toll-like receptors (TLRs) are members of the pattern recog-
nition receptor family that detect components of foreign 
pathogens or endogenous molecules released in response 
to injury. Recent studies demonstrate that TLRs also have a 
functional role in regulating neuronal proliferation in the de-
veloping brain. This study investigated cellular expression of 
TLR3 using immunohistochemistry on human brain tissue. 
The tissue sections analysed contained anterior and lateral 
periventricular white matter from the frontal and parietal 
lobes in post-mortem neonatal cases with a postmenstrual 
age range of 23.6–31.4 weeks. In addition to preterm brains 
without overt pathology (control), preterm pathology cases 
with evidence of white matter injuries (WMI) were also ex-
amined. In order to identify TLR-positive cells, we utilized 
standard double-labelling immunofluorescence co-label-
ling techniques and confocal microscopy to compare co-ex-
pression of TLR3 with a neuronal marker (NeuN) or with glial 
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 Fetal neuronal and glial development is highly active 
between 8 and 32 weeks of gestation. During this time, 
there are proliferative regions of the brain, such as the 
germinal matrix, that are vulnerable to injury as seen in 
germinal matrix haemorrhage/intraventicular haemor-
rhage or viral infections such as cytomegalovirus. Neuro-
nal migration from the germinal matrix to the cerebral 
cortex is almost complete by 24 weeks of gestation  [1, 2] . 
This process may be impaired in the very preterm infant 
who sustains a germinal matrix haemorrhage. Premature 
infants are also susceptible to periventricular white mat-
ter injury (WMI) between 22 and 32 weeks of gestation 
 [1, 3, 4] . Injury in these regions is thought to be the result 
of inflammation/infection and ischaemia with immature 
oligodendrocytes showing increased susceptibility. WMI 
affects both local cell survival and maturation  [5] and may 
inhibit axonal growth, cortical development and subse-
quent thalamic cortical connectivity occurring during 
this time period  [6, 7] .
 In human preterm infants, WMI is identified by grey 
sunken soft tissue patches seen macroscopically. Micro-
scopically the histopathology of WMI shows dissolution 
of the white matter, granular neurophil, axonal injury  [8, 
9] and foamy appearing histiocytes  [10] . WMI is associ-
ated with a disturbance to differentiating premyelinating 
oligodendrocytes, impaired myelination, astrogliosis and 
microglial activation  [11–13] . WMI has characteristic 
signs of focal cysts and diffuse low signal intensity in re-
maining white matter on both ultrasound and magnetic 
resonance imaging (MRI) during the neonatal period  [14, 
15] . Despite advances in neonatal care, there is still sig-
nificant mortality and morbidity arising from injuries to 
the developing brain following preterm delivery. Preterm 
infants have high rates of injury to white matter struc-
tures and subsequent reduced volume of grey matter 
structures  [16–18] . 
 In the innate immune system, toll-like receptors 
(TLRs) and other pattern recognition receptors recog-
nize pathogen-derived compounds (pathogen-associat-
ed molecular patterns) or endogenous molecules re-
leased by the host in response to an infection or inflam-
matory injury (damage-associated molecular patterns) 
 [19] . Pathogen-serum complexes activate macrophages 
and microglia that respond to the injury  [20, 21] via dif-
ferent pattern recognition receptors, such as TLRs  [22] . 
For instance, TLR3 has been identified intracellularly in 
the endosomal membrane in a variety of cells and has 
been shown to detect viral molecular patterns  [23] , such 
as double-stranded RNA, associated with viral infection 
 [24] .
 In recent years, TLRs were identified in the mamma-
lian nervous system. Members of the TLR family were 
originally thought to be limited to the glial cells; however, 
recent in vitro studies suggest that neurons and neural 
progenitor cells express TLRs and regulate cell fate deci-
sion  [25–29] . Several TLRs have been reported to be ex-
pressed in developing neurons and influence both prolif-
eration and differentiation  [26, 27] . Recent studies dem-
onstrate that TLR3 has a functional role in regulating 
neuronal proliferation in the developing brain  [26–29] . 
TLR3 activation via synthetic polyinosinic-polycytidylic 
acid or mRNA has been shown to reduce the numbers of 
neurospheres as it is concentrated in the growth cone and 
can cause growth cone collapse inhibiting neurite exten-
sion  [28] . Thus studies on the consequences of TLR3 ac-
tivation are necessary for comprehending developmental 
and degenerative pathologies seen in the central nervous 
system after infection and/or damage. 
 The role of TLR3 and the cellular populations which 
express this protein in the developing human brain needs 
to be clarified. Our hypothesis is that in cases of WMI, 
there is a redistribution of TLR3 receptors in neurons and 
enhanced TLR3 expression in certain microglia and as-
troglial populations. An improved understanding of the 
expression of TLR3 will provide important insights into 
its role in the normal and abnormal developing brain and 
potentially inform on therapeutic strategies. 
 Materials and Methods  
 Informed parental consent was acquired according to National 
Health Service UK guidelines. Study ethics were obtained from the 
National Research Ethics Service, Hammersmith and Queen Char-
lotte’s and Chelsea Research Ethics Services, London, UK. Four-
teen extremely preterm post-mortem brains [<32 weeks gestation-
al age (GA)] of vaginally delivered neonates were obtained from 
the Perinatal Pathology Department, Imperial Health Care Trust, 
London, UK. The primary cause of death of each case was assessed 
by a pathologist (J.W.A.). Brain tissue blocks of these 14 cases 
stored in our neonatal brain bank were used in this study and had 
a postmenstrual age (PMA) range from 23.6 to 31.4 weeks deter-
mined by GA plus age at death (weeks). Amniotic fluid infections 
were identified in the majority of the cases; however, none of the 
cases had leptomeningitis or vascular thrombosis. Seven of the 
brains which showed no significant brain pathology on gross and 
microscopic examination from post-mortem examination and no 
visible brain abnormalities on post-mortem MRI were used as 
non-neuropathological controls (control cases). The remaining 7 
brains showed focal lesions with evidence of WMI upon patho-
logical examination (WMI cases). Three of the controls and 2 of 
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the WMI cases showed evidence of focal necrotizing enterocolitis. 
Congestive heart failure was noted in 5 of the controls and in 3 of 
the WMI cases. Case details are shown in  table 1 .
 Tissue Preparation and MRI 
 The bodies were refrigerated (2–4   °   C) prior to post-mortem 
examination which was performed within 1–3 days of death. 
Whole post-mortem brains were fixed in 4% formalin for 5–7 
weeks depending on size. Towards the end of the fixation period, 
MRI was performed on fixed whole brains at 3 Tesla. T1- and T2-
weighted images were obtained in 3 orthogonal planes. Visual 
analysis was performed by an experienced neuroradiologist to 
confirm normal anatomy and absence of pathology in all control 
cases and the confirmation of WMI in the WMI cases. The whole 
brains were sliced by a pathologist (J.W.A.) and the tissue blocks 
were processed on a Bright Tissue Processor (Bright lnstrument 
Co. Ltd., Cambridgeshire, UK). Then the paraffin-embedded tis-
sue blocks were sectioned at 6 μm using a Leica RM2245 micro-
tome (Leica Microsystems Ltd., Bucks, UK). Paraffin-embedded 
tissue sections from the frontal and parietal lobes (at the level of 
Ammon’s horn) were used for immunohistochemistry. 
 Immunohistochemistry 
 After routine paraffin removal and rehydration, endogenous 
peroxidase activity was quenched by placing the slides into 3% hy-
drogen peroxide (H 2 O 2 ) for 10 min. Sections were immersed in 
preheated 10 m M citric acid (VWR International Ltd., Leicester-
shire, UK), pH 6.0, for 30 min and cooled in cold water. Sections 
were blocked in 5% goat serum (Vector Laboratories, Burlingame, 
Calif., USA) for 20 min before being incubated overnight at 4  °  C in 
Table 1.  Case data









1 M 25.4 21 h 25.6 Respiratory distress syndrome and congestive heart failure as a result of 
extreme prematurity
2 M 23.86 9 h 23.9 Congestive heart failure and neonatal death due to extreme prematurity
3 M 26.3 1 d 26.4 Asymmetric intra-uterine growth restriction; neonatal death due to 
congestive heart failure
4 F 24.1 4 h 24.1 Confirmed amniotic fluid infection; neonatal death due to extreme 
prematurity
5 M 24.2 <1 h 24.2 Confirmed amniotic fluid infection; neonatal death due to extreme 
prematurity
6 M 23.6 <1 h 23.6 Prematurity, confirmed amniotic fluid infection, congestive heart failure
7 M 28.2 <1 h 28.2 Oligohydramnios; neonatal death due to extreme prematurity and 
congestive heart failure 
Mean 26.8 26.9
WMI cases
1 M 27.7 12 d 29.6 Amniotic fluid infection, focal WMI, neonatal death due to congestive 
heart failure 
2 F 28.9 18 d 31.4 Focal small GMH, focal WMI
3 F 27.7 22 d 30.6 Extensive WMI, congestive heart failure
4 F 27 7 d 28 Focal necrotizing enterocolitis, WMI, neonatal death due to extreme 
prematurity
5 M 24 5 wk 1 d 29.1 Focal necrotizing enterocolitis; confirmed amniotic fluid infection, WMI, 
death due to extreme prematurity
6 M 24.9 16 d 26.9 Mild oligohydramnios, confirmed amniotic fluid infection, early neonatal 
death due to congestive heart failure, WMI
7 M 25.7 1 d 25.9 Asymmetric intra-uterine growth restriction, WMI; neonatal death due 
to extreme prematurity
Mean 26.7 27.75
 GMH = Germinal matrix haemorrhage; M = male; F = female; d = days; wk = weeks; h = hours.
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a solution of rabbit anti-TLR3 (0.1 μg/ml; Abcam, Cambridge, UK) 
in PBS. Specificity of the antibody was determined by using syn-
thesized antigenic peptides from the protein of interest in a 10-fold 
excess with respect to the primary antibodies. The next day, sec-
tions were exposed to the biotinylated goat-anti-rabbit IgG sec-
ondary antibody (15 μg/ml; Vector Laboratories) in PBS for 1 h 
followed by avidin-biotin complex for 1 h (1: 200, ABC; Vector 
Laboratories). The reactions were visualized with 3,3 ′ -diamino-
benzidine (Sigma-Aldrich Company Ltd., Gillingham Dorset, UK) 
for 10 min. Finally, the sections were dehydrated, cleared in xylene 
and coverslipped. As negative controls, we performed staining in 
the absence of the primary antibodies and preabsorption with the 
TLR3 peptide (1.0 μg/ml; Abcam); no specific staining was identi-
fied in these preparations.
 Immunofluorescence Double-Labelling 
 To identify the cellular location of the TLR3 protein in our tis-
sue immunofluorescence (IF) double-labelling was performed on 
the WMI and on the control cases. The mouse monoclonal pri-
mary antibodies that were compatible with the rabbit anti-TLR3 
(0.1 μg/ml) were mixed in separate cocktail solutions in conjunc-
tion with the anti-TLR3, as follows: mouse monoclonal glial fibril-
lary acidic protein, clone G-A-5 (GFAP; 1: 1,000; Sigma-Aldrich 
Company Ltd.), a marker for astrocytes, and oligodendrocyte lin-
eage marker, clone 211F1.1 (Olig2; 1 μg/ml; Millipore, Temecula, 
Calif., USA). Sections were pretreated as described above and 
blocked in 5% goat serum for 20 min before the primary antibod-
ies were applied and incubated overnight at 4   °   C. Following pri-
mary antibody incubation, sections were rinsed three times in PBS, 
for 3 min each time before these secondary antibodies were added. 
The samples were finally soaked for 1.5 h in PBS containing the 
following secondary antibody cocktail: goat anti-mouse IgG con-
jugated to Alexa Fluor 488 (4 μg/ml; Invitrogen, Eugene, Oreg., 
USA) and goat anti-rabbit IgG conjugated to Alexa Fluor 546 
(4 μg/ml; Invitrogen).
 In order to co-label with incompatible markers, such as a spe-
cific marker of microglia, rabbit anti-ionized calcium-binding 
adaptor molecule 1 (Iba-1; Wako Chemicals GmbH, Neuss, Ger-
many), the antibodies were applied separately. Thus, after the sec-
tions were blocked in 5% goat serum for 20 min, the anti-TLR3 (0.1 
μg/ml; Abcam) was applied and incubated overnight at 4   °   C. The 
sections were rinsed three times in PBS, for 3 min each time and 
were soaked for 1.5 h in PBS containing goat anti-rabbit IgG con-
jugated to Alexa Fluor 488 (4 μg/ml; Invitrogen) followed by 3 
rinses in PBS. Additional block in 5% goat serum for 20 min was 
applied to the sections. During the blocking step, the Fab-antibody 
complex was made, 0.5 μg/ml of rabbit-anti-Iba-1 was conjugated 
to 2.0 μg/ml of Zenon Alexa Fluor 488 rabbit IgG (Invitrogen) for 
5 min followed by 2.0 μg/ml of Zenon blocking reagent for an ad-
ditional 5 min. The sections were then incubated in the Fab-anti-
body complex for 1.5 h, which was followed by PBS rinses and 
postfixation in 4% paraformaldehyde for 20 min. Another incom-
patible marker was rabbit anti-neuronal nuclear antigen (NeuN, 
Cy3 conjugate; Millipore), which stains the cytoplasm and nucleus 
of neurons. Identification of anti-TLR3 was the same as previous-
ly described in the TLR3/Iba-1 section, except the secondary anti-
body to detect TLR3 consisted of goat anti-rabbit IgG conjugated 
to Alexa Fluor 546 (4 μg/ml; Invitrogen). Following the identifica-
tion of TLR3, the sections were rinsed in PBS and postfixed in 4% 
paraformaldehyde for 10 min followed by incubation with NeuN, 
Cy3 conjugate (1: 500) for 1 h. Finally, the sections were placed un-
der a coverslip using ProLong Gold antifade reagent with DAPI 
(Invitrogen) and then kept in the dark at 4  °  C until analysis. 
 Microscopy 
 An unbiased count of the number of TLR3-immunopositive 
cells and the total number of cells were screened by 2 individuals 
(R.V. and C.T.; blinded to the case data) using the optical fraction-
ator program (MicroBrightfield, Inc., Colchester, Vt., USA). The 
sections were examined under bright-field microscopy using a 
light microscope (DM6000 B; Leica Microsystems Ltd., Bucks, 
UK) equipped with a motorized specimen stage for automated 
sampling (MicroBrightfield, Inc.), CCD colour video camera (Mi-
croBrightfield, Inc.) and stereology software (Stereo Investigator, 
v8.27; MicroBrightfield, Inc.). The average area of each contour 
was 14 × 10 3 mm 2 , which was made using a ×1.25 objective. Cells 
were counted in a 0.9 mm 2 counting frame on an average of 54 
counting sites and conducted using a ×40 objective. In the pilot 
study, the dissector profile described above estimated a sufficient 
number of cells and the coefficient of error (Schmitz-Hof) was 
within an acceptable range  [30] . The cellular density and the TLR3-
immunopositive cell counts were performed in the anterior (F1, 
P1) and lateral (F2, P2) regions of the periventricular white matter 
in the frontal and parietal lobes and in the frontal cortex (F3) as 
outlined using a standard haematoxylin and eosin stain ( fig. 1 ). 
 Data were analysed with a Student t test or one-way ANOVA 
followed by Tukey’s range test to compare the ratio of TLR3-pos-
itive cells between groups (WMI and control) in the periventricu-
lar white matter region of the frontal lobe and frontal-parietal lobe. 
Data were presented as mean ± SD and significance was set at p < 
0.05. All statistical analyses were performed using GraphPad Prism 
5.0 (GraphPad Software, San Diego, Calif., USA). 
 Multichannel images were captured with a Leica microscope 
DM6000 B (Leica Microsystems Ltd.) and processed in Image J 
(version 1.42; National Institute of Health, Bethesda, Md., USA) 
before final processing in Adobe Photoshope (version 11.0.2; Ado-
be Systems Inc., San Jose, Calif., USA). A semi-quantitative analy-
sis through the centre of the contour of region F1 was used to assess 
the density of TLR3-positive neurons (NeuN) and astrocytes 
(GFAP). The average number of immunopositive cells was calcu-
lated from images taken with a ×40 objective (0.0426 mm 2 ) and 
was counted using Image J (version 1.42) by 2 student volunteers 
(M.H.A. and C.S.A.) who were blinded to the case data. Confocal 
double-labelled microphotographs were captured using a Leica 
SP5 spectral confocal microscope with settings appropriate to the 
fluorophores present. 
 Results 
 These experiments were designed to determine the 
distribution of TLR3 in periventricular white matter of 
preterm human brains (23–32 weeks of PMA) from the 
anterior frontal, lateral frontal, anterior parietal and lat-
eral parietal regions ( fig. 1 ). We also sought to determine 
whether the presence of WMI in the human brain altered 
the expression of TLR3. Furthermore, we investigated 
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whether glial TLR3 expression differed between control 
cases and those with WMI, with the use of immunohisto-
chemistry and IF techniques. In the control group, the 
causes of death were complications due to extreme pre-
term birth, pneumonia and congestive heart failure and 
the infant survival rate was less than 24 h. The WMI 
group had similar complications as the control group but 
lived up to 5 weeks longer than the control. Although the 
PMA of the WMI group was significantly higher than that 
of the controls (p < 0.05; WMI 28.86 ± 0.7978 weeks, n = 
7; control 25.16 ± 0.6213 weeks, n = 7), these groups were 
not significantly different at birth (GA; p > 0.05). Case 
details are shown in  table 1 . 
 The Ratio of TLR3-Positive Cells Increased in the 
Periventricular White Matter in WMI Cases 
 In the periventricular white matter of the cases without 
overt brain pathology, the TLR3 immunoreactivity was 
globular and restricted to the perinuclear region of cells, 
which is consistent with endosomal staining ( fig. 2 a). The 
WMI cases also showed TLR3 expression in the periven-
tricular white matter, but there was more diffuse staining 
outside of the nucleus of cells and within the processes in 
contrast to the more focal nuclear localization seen in 
non-injured brains ( fig. 2 b). One-way ANOVA showed a 
significant increase in cells with TLR3+ immunoreactiv-
ity in the WMI cases compared to the controls in the an-
terior frontal region (F1; p < 0.01; WMI 0.48 ± 0.11, n = 
7; control 0.27 ± 0.12, n = 7) and in the lateral frontal re-
gion (F2; p < 0.001; WMI 0.54 ± 0.06, n = 7; control 0.24 
± 0.06, n = 7) ( fig. 2 c). A significant increase in cells ex-
pressing TLR3 in the WMI cases compared to controls 
was also found in both regions of the parietal lobe studied 
(P1 p < 0.01; WMI 0.52 ± 0.14, n = 7; control 0.25 ± 0.09, 
n = 7; P2 p < 0.001; WMI 0.56 ± 0.15, n = 7; control 0.27 
± 0.06, n = 7) ( fig. 2 c). 
 TLR3 Immunolabelling in Neurons and Glial Cells 
 Of interest, the number of neurons identified with an-
ti-NeuN was significantly higher in the WMI group 
(WMI 62.17 ± 11.20, n = 6; control 32.45 ± 2.259, n = 6; 
p < 0.01) than the control group in the region sampled 
(centre of F1). The amount of identifiable TLR3 expres-
sion seen in the neurons was not significantly different 
between the control and WMI groups, but to study dif-
ferences in the pattern of neuronal expression, we exam-
ba
 Fig. 1. Global view of the frontal cortex ( a ) and the parietal cortex 
( b ). The strategy for the quantification of the cell population and 
the TLR3-positive expression are demonstrated in WMI 1 (at 29.6 
weeks PMA;  a ) and in WMI 2 (at 31.4 weeks PMA;  b ). Boxes rep-
resent the contours that were made in periventricular white matter 
regions of the frontal (F1, F2) and the parietal (P1, P2) lobes above 
the anterior germinal matrix (F1, P1) and adjacent to the lateral 
germinal matrix (F2, P2). The semi-quantitative analyses were 
completed in the periventricular white matter of the frontal lobe 
(dotted lines in F1). Cortical density was analysed in the anterior 
frontal lobe (F3). GM = Germinal matrix; PVWM = periventricu-
lar white matter. 
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ined the intracellular location of TLR3 protein by dou-
ble-labelling IF techniques using rabbit-anti TLR3 and 
rabbit-anti-NeuN conjugated Cy3. Interestingly, in the 
control cases, the TLR3 expression was globular and re-
stricted to the perinuclear region ( fig. 3 a), whereas in the 
WMI cases, the TLR3 immunoreactivity was diffuse and 
intra-axonal, being expressed along the axon hillock 
( fig. 2 b,  3 b). 
 To address whether the increase in TLR3 positivity 
seen in the periventricular white matter of the WMI 
brains was due to TLR3 activation in glial cells, IF colo-
calization was used to identify the glial population(s) that 
also express TLR3 protein within the frontal lobe. This 
was achieved by combining anti-TLR3 with glial markers, 
such as anti-GFAP (astrocytes), anti-Iba-1 (microglia) 
and anti-Olig2 (oligodendrocytes) in brain tissue sec-
tions. 
 There was a significant increase in the number of as-
trocytes identified in the WMI group (p < 0.01; WMI 
46.37 ± 4.309, n = 6; control 23.84 ± 2.151, n = 7). Double-
labelling IF showed that astrocytes were the glial cells that 
predominately expressed TLR3, which significantly in-
creased in the WMI group (WMI 31.24 ± 1.794, n = 6; 
control 16.56 ± 2.273, n = 7; p < 0.001). TLR3 expression 
was frequently seen along the processes of the reactive 
astrocytes outside of their irregularly shaped nuclei in the 
WMI cases ( fig. 4 b, d), whereas TLR3 was sparsely iden-
tified within astroglial processes in the control cases 
( fig. 4 a, c).
 Some TLR3 was identified adjacent to the nuclei of oli-
godendrocytes (i.e., those positive for Olig2), and this was 
more frequent in the cases of WMI. Identified in  figure 
5 d in the photomicrograph is one Olig2 immunolabelled 
cell with TLR3 immunoreactivity seen in proximity to the 


























































 Fig. 2. Immunohistochemical stains of 
TLR3 immunoreactivity in control 3 ( a ) 
and in the WMI case 2 ( b ) from the ante-
rior region of the periventricular white 
matter (F1). In the first image ( a ; arrows), 
the immunoreactivity appears perinuclear 
and punctate, whereas in the second image 
( b ; arrows), it is diffuse (i.e., less concen-
trated around the nucleus and flowing into 
the axon hillock). Scale bar = 100 μm.  c A 
graph representing the ratio of TLR3-posi-
tive cells to the total cellular count. The as-
terisks indicate significant differences in 
the ratio of immunopositivity counted in 
the WMI cases compared to the control, in 
the anterior region of the periventricular 
white matter from the frontal (F1) and pa-
rietal (P1) lobes, and in the lateral region of 
the periventricular white matter from the 
frontal (F2) and parietal (P2) lobes. ** p < 
0.01; *** p < 0.001. 




 Fig. 3. Confocal microscope photomicro-
graphs demonstrating the distribution of 
TLR3 (green) around the nuclei (NeuN-
Cy3) from the anterior region of the peri-
ventricular white matter in the frontal lobe 
of control case 5 ( a ) and WMI case 5 ( b ). 
Note that in the control case, TLR3 is lo-
cated densely around the nucleus (blue ar-
rows), whereas in the WMI case, the TLR3 
expression is both nuclear and axonal (yel-
low arrowheads). Scale bar = 25 μm. 
a b
dc
 Fig. 4. Examples of the IF staining of anti-TLR3 (red) and the as-
trocytic marker (GFAP; green) in one of the control cases (7;  a,  c ) 
and in one of the WMI cases (1;  b,  d ). In  b and  d , the astrocytes 
are reactive and prominent intracellular expression of TLR3 can 
be seen in the IF image and with the confocal photomicrograph 
(yellow arrowheads), whereas in  a and  c , there is less TLR3 expres-
sion in the astrocytes, which is confirmed by the confocal photo-
micrograph ( c ; red arrow). Scale bar = 50 μm ( a,  b ) and 10 μm ( c, 
 d ). 
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levels of TLR3 expression were seen within the cellular 
boundaries in microglia as determined by Iba-1 immuno-
reactivity. However, of interest,  figure 5 a and b demon-
strates microglia of different morphologies located next 
to neurons with strong TLR3 expression, which may in-
dicate an interaction between microglia and neurons via 
this receptor ( fig. 5 a, b). 
 Fewer Cells in the Frontal Cortex in the WMI Group 
than in the Control Group 
 The number of neurons in the region F1 was higher in 
the WMI cases than in controls. In order to ascertain if 
this difference reflects a decrease in cortical density, we 
counted the cells in an average of 52 sites in a region of 
the superior frontal cortex (F3). In the control group, the 
cell density of the cortex was significantly higher in the 
region sampled of the frontal cortex compared to the 
WMI group (p < 0.05; control 1,455 ± 75.62, n = 7; WMI 
1,012 ± 97.84, n = 6). 
 Discussion  
 In this study, we have demonstrated the expression of 
TLR3 in several cell types of the preterm neonatal human 
brain; to the best of our knowledge, this is the first time 
this family of receptors has been demonstrated in the hu-
man neonatal brain. In addition, we showed that TLR3 
expression was altered in the presence of overt brain in-
jury, which was evident in the WMI cases compared with 
the controls. 
 The GA at birth was similar in the WMI and control 
groups, but survival was longer in the WMI group. We 
cannot exclude the possibility that WMI would have de-
veloped also in some control cases if they lived longer. 
Nevertheless, our data suggest that changes in TLR3 ex-
pression in neurons and glia accompanied development 
of WMI in the central nervous system of the extremely 
preterm infant. 
20.7 μm 20.7 μm
a b
c d
 Fig. 5. Double-labelling of anti-TLR3 (red) 
with the microglial marker Iba-1 ( a,  b ; 
green) and the oligodendrogial marker 
Olig2 ( c,  d ; green). The expression of TLR3 
was not seen in the different morphologies 
of microglia, such as intermediate (control 
case 7;  a ) and amoeboidal (WMI case 1;  b ). 
Confocal microscopy confirmed that TLR3 
expression was detected with Olig2 in the 
WMI case 7 (red arrow;  d ) but not in the 
control case 6 ( c ). Scale bar = 50 μm ( a,  b ) 
and 20.7 μm ( c,  d ). 
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 TLR3 was detected in human brains that did not have 
WMI, which indicates that protein expression of TLR3 
may be normal in fetal brain development even though 
we cannot exclude the possibility that TLR3 expression in 
the control brains is part of an early evolving pathological 
process related to extreme prematurity. In the preterm 
WMI cases, we saw more neuronal nuclei in periventric-
ular white matter compared with the control cases. Whilst 
the overall expression within neurons was not increased, 
the pattern of expression of TLR3 was altered in WMI 
cases, being more diffuse and visible in the axonal hillock 
that extended into intracellular spaces of the neurons 
rather than being close to the endosome-like structures. 
 We hypothesized that in cases of neonatal injury, there 
would be an increase in microglia and astroglia popula-
tions, and that these would express TLR3. The periven-
tricular white matter of the WMI group showed a wide 
spread of cellular populations that were positive for TLR3. 
Of interest is that this expression was predominantly on 
astroglia and not microglia as identified by double-label-
ling techniques.
 It is useful to review the recent TLR3 animal model 
publications to further understand the significance of our 
findings and specifically to ascertain how overexpression 
may hinder the normal developmental process. Lathia et 
al.  [27] found TLR3 expressed on glial cells, neurons and 
neural progenitor cells and polyinosinic-polycytidylic 
acid (an activator of TLR3) administration inhibited neu-
rite extension in wild-type mice but not in TLR3 knock-
out mice. Furthermore, Bsibsi et al.  [28] found that a non-
infectious microtubule regulator, stathmin, acted as an 
agonist for TLR3. During the inflammatory process of 
multiple sclerosis, TLR3 and stathmin were colocalized 
on the surface of astrocytes, neurons and microglia. In 
inflammatory injury of the preterm brain, such as WMI, 
there is a known increase in activated microglia  [31] and 
astrocytes  [16] , which may underlie the documented al-
terations in neuronal connectivity between the thalamus 
and the cortex. In animal models of injury, stathmin or 
cytokines released from astroglia activate TLR3 in neu-
rons of the premature brain, which in turn induces pre-
mature apoptosis  [26, 28, 32] . 
 Excessive TLR3 stimulation on astroglial cells may 
therefore interrupt the neuronal migration to the cortex. 
The increase in neuronal numbers seen in periventricular 
white matter and the decrease in the cerebral cortex in the 
WMI group and noted in other studies might indicate in-
terference with the migration of late-migrating interneu-
rons  [8] . This may underly the alterations in thalamocor-
tical connectivity and results in thalamic atrophy and/or 
cortical disorganization seen in WMI  [33] . 
 We have demonstrated the presence of TLR3 in all cell 
types of the immature brain. In the presence of WMI, 
TLR3 expression was increased and the pattern of expres-
sion altered. We speculate that this may play a role in the 
altered thalamocortical connectivity seen in preterm in-
fants. The anatomical information gathered from our 
study provides a solid foundation for future studies of the 
axonal development, which is imperative in compre-
hending lifelong disabilities after premature birth. 
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Abstract
Toll-like receptor-3 (TLR3) has been identiﬁed in a variety of in-
tracellular structures (e.g. endosomes and endoplasmic reticulum); it
detects viral molecular patterns and damage-associated molecular
patterns. We hypothesized that, after white matter injury (WMI) has
occurred, localization and activation of TLR3 are altered in gray
matter structures in response to damage-associated molecular pat-
terns and activated glia. Therefore, we investigated the subcellular
localization of TLR3 and its downstream signaling pathway in post-
mortem brain sections from preterm infants with and without WMI
(7 patients each). We assessed astroglia (glial ﬁbrillary acidic proteinY
positive), microglia (ionized calcium-binding adaptor molecule-
1Ypositive), and neuronal populations in 3 regions of the thalamus
and in the posterior limb of the internal capsule and analyzed TLR3
messenger RNA and protein expression in the ventral lateral posterior
thalamic region, an area associated with impaired motor function. We
also assessed TLR3 colocalization with late endosomes (lysosome-
associated membrane protein-1) and phagosomal compartments in this
region. Glial ﬁbrillary acidic protein, ionized calcium-binding adaptor
molecule-1, and TLR3 immunoreactivity and messenger RNA ex-
pression were increased in cases with WMI compared with controls.
In ventral lateral posterior neurons, TLR3 was colocalized with the
endoplasmic reticulum and the autophagosome, suggesting that auto-
phagy may be a stress response associated with WMI. Thus, altera-
tions in TLR3 expression in WMI may be an underlying molecular
mechanism associated with impaired development in preterm infants.
Key Words: Interferon regulatory factor-3, Microtubule-associated
protein light chain, Toll-like receptor-3, White matter injury.
INTRODUCTION
Preterm infants have high rates of white matter injury
(WMI) with altered white matter development and associated
reduced volume of gray matter structures (1Y5). Numerous
imaging and pathologic studies have demonstrated thalamic
injury and subsequent atrophy within the developing white
matter (5Y9). Imaging studies on preterm infants with overt
WMI have identiﬁed reduced thalamic volumes in medial dor-
sal (MD) and pulvinar regions, which have been correlated with
long-term impairment in cognitive function in working mem-
ory and a decline in verbal intelligence (5, 8, 10).
Alongside hypoxia-ischemia, infection and inﬂammation
are important contributors to the etiology of acquired injuries in
the developing brain (11Y13). The ﬁrst line of defense for the
detection and elimination of pathogens is provided by the in-
nate immune system. Pathogen-associated molecular patterns
or endogenous molecules (damage-associated molecular pat-
terns [DAMPs]) released in response to injury are recognized
by Toll-like receptors (TLRs), which are members of the pat-
tern recognition receptor family (14). Thus, TLRs are capable
of recognizing both exogenous pathogens and certain endoge-
nously produced stimuli that are produced after injury (15, 16).
TLR3 is a type I transmembrane receptor that recognizes exogenous
double-stranded RNA (dsRNA). All TLRs are synthesized in
the endoplasmic reticulum (ER) and are secreted on stimulation;
most TLRs reside on the cell surface, but TLR3, TLR7, and
TLR9 migrate to endosomes through the action of UNC93B1
(17Y19). Once there, TLR3 recognizes its dsRNA ligand and
activates a cascade of events mediated by the adaptor protein
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Toll/IL-1Yinducing interferon-A nuclear (20). Toll/IL-1Yinducing
interferon-A nuclear interacts with Tank binding kinase-1,
resulting in the phosphorylation and nuclear translocation of
interferon regulatory factor-3 (IRF-3) and the subsequent pro-
duction of type I interferons. Toll/IL-1Yinducing interferon-A
nuclear also binds to tumor necrosis factor receptorYassociated
factor-6, ultimately activating transcription mediated by nu-
clear factor J light chain enhancer of activated B cells (21).
Toll-like receptor-3 responses to endogenous DAMPs
and the versatile roles they play in development are areas of
intense investigation. Recent studies have suggested that RNA
released from either damaged tissue or dying cells serves as
ligands for TLR3, triggering necrotic or apoptotic pathways
and the canonical TLR3 pathway (22Y24). Furthermore, in the
developing brain, TLR3 may negatively regulate neural pro-
genitor cell proliferation and neurite development (25). Thus,
TLR3 activation may inﬂuence neuron fate during fetal devel-
opment (26). Indeed, it was recently shown that TLR3 sen-
sitizes the brain to hypoxic-ischemic injury (27), and TLR3
activation with polyinosine:polycytidylic acid (synthetic dsRNA)
during early fetal life produces behavioral problems resembl-
ing autism and schizophrenia in animal models (28, 29).
Identiﬁcation of TLR3 in neurons and glial intracellular
structures is important in fully comprehending neuronal dys-
function after WMI because TLR3 could respond to endoge-
nous damage signals and may inﬂuence premature collapse of
neurons with resultant atrophy of gray matter structures (22).
Previously, we showed that glia and neuronal TLR3 ex-
pression was upregulated in response to periventricular WMI
in the frontal lobes of human preterm infants (30). We also
found that cellular density in the cortex was signiﬁcantly lower,
with an increase in neuronal number, in the periventricular white
matter in WMI cases indicating migration interference. Medial
dorsal and ventral lateral thalamic axons extend into the white
matter regions of the orbital medial and dorsal lateral frontal
lobes, respectively. Thus, these nuclei are more susceptible to
injury because these are the sites where periventricular infarcts
occur, and they may impair motor and cognitive pathways.
Here we extend our study to examine the localization and cel-
lular mechanisms of TLR3 in areas of the thalamus. Our ﬁnd-
ings may have implications for the health of thalamocortical
connections after WMI.
MATERIALS AND METHODS
A written informed parental consent form was acquired
according to National Health Service UK guidelines. Study
ethics approval was obtained from the National Research Ethics
Service (West London) UK (ethics number 07/H0707/139;
PostmortemMagnetic Imaging Study of the Developing Brain).
Fourteen extremely preterm postmortem brains (G32 weeks’
gestational age) of vaginally delivered neonates were used in
this study. The primary cause of death of each case was assessed
by a pathologist (Josephine Wyatt-Ashmead). Amniotic ﬂuid
infections were identiﬁed in most of the cases; however, none of
the cases had leptomeningitis or vascular thrombosis. Seven
of the brains showed no signiﬁcant brain pathology on gross
and microscopic examination from postmortem examination
and had no visible brain abnormalities on postmortem magnetic
resonance imaging. These were used as nonneuropathologic
controls (control cases). The remaining 7 brains showed cere-
bral white matter gliosis, lipid-laden macrophages, and focal
lesions with evidence of WMI on pathologic examination
(WMI cases). Cases with known cortical maldevelopment
and germinal matrix hemorrhages were excluded from this
study. Case details, tissue preparation, and magnetic res-
onance imaging analyses have already been described (30)
and are summarized in Data, Supplemental Digital Content 1,
http://links.lww.com/NEN/A703.
Tissue Preparation
The bodies were refrigerated (2-CY4-C) before postmor-
tem examination, and whole postmortem brains were ﬁxed in
4% formalin for 5 to 7 weeks depending on size. The whole
brains were sliced prospectively for this study by a pathologist
(Josephine Wyatt-Ashmead) on the neural axis, which included
key anatomic regions based on speciﬁc landmarks. The tissue
blocks were processed on a Bright Tissue Processor (Bright
Instrument Co Ltd, Cambridgeshire, United Kingdom). Parafﬁn-
embedded tissue blocks were sectioned at 6 Km using a Leica
RM2245 microtome (Leica Microsystems UK Ltd, Bucking-
hamshire, United Kingdom). Parafﬁn-embedded tissue sections
from the cerebral hemispheres at the level of the globus pallidus
were used for immunohistochemistry.
Immunohistochemistry and
Immunoﬂuorescence
Standard immunohistochemistry procedures for these
brain sections have been described previously (30). Primary
antibodies, dilutions and sources, and species-appropriate sec-
ondary antibodies are listed in Table 1.
Microscopy and Quantitative Analyses
Unbiased counts of TLR3-immunopositive, glial ﬁbril-
lary acidic protein (GFAP)Yimmunopositive, and ionized calcium-
binding adaptor molecule-1 (Iba-1)Yimmunopositive cells and
the averaged cell density (hematoxylin positive nuclei/mm2)
were obtained using the CM1 and CM2 modules for vir-
tual tissue scan (MicroBrightﬁeld Inc, Colchester, VT)
using stereology software (Stereo Investigator version
8.27; MicroBrightﬁeld Inc). The average area of each
contour was encompassed by a 2.1-mm2 region, which was
made using a 5 objective microscope, to provide an av-
erage of 40 high-power ﬁeld images per scan collected
using a 40 objective microscope (0.0426 mm2); counts
were automated using the program Image Pro Premier
(Media Cybernetics, Warrendale, PA). In the pilot study, the
counting proﬁle described previously counted the correct num-
ber of labeled cells and nuclei (using an Image J cell counter).
Three thalamic regions were determined by the cellular
architecture described (31, 32): the MD nuclei lateral to the
internal medullary lamina, the ventral lateral posterior (VLp)
nuclei medial to the external globus pallidus, and the ventral
posterior lateral (VPL) nuclei medial to the internal globus pal-
lidus. In addition, 2 regionsVposterior limb of the internal cap-
sule (PLIC) adjacent to the VLp (PLIC-VLp) and PLIC adjacent
to the VPL (PLIC-VPL)Vwere investigated. Sampling areas
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and strategies for identifying regions of interest are shown
using a standard hematoxylin-and-eosin stain (Fig. 1A).
All cells (identiﬁed by hematoxylin counterstain) were
counted in MD, VLp, and VPL thalamic nuclei and in adjacent
PLIC regions for every stain. After the nuclei had been counted,
the cellular densities of GFAP-immunopositive and Iba-1Y
immunopositive cells were quantiﬁed by the ﬁrst author (Re-
gina Vontell) and a student volunteer (Megan Holly Atkins)
who were blinded to case data. Tissue scans were reviewed
(by Regina Vontell) to ensure that the glia had met the criteria
(e.g. hematoxylin-positive nucleus [G10 Km2] and GFAP-
positive cytoplasm) to avoid duplicate counts. Neuronal counts
were performed using track-and-trace morphometry data anal-
ysis. In brief, after the cells had been counted, we identiﬁed
those cells that were HuC/HuD-immunopositive using track-
ing data analysis (Image Pro Premier; Media Cybernetics).
For glial and neuronal investigations, data were normal-
ized by using the ratio of immunopositive cells to the entire
population (hematoxylin-positive) . The area of TLR3 immu-
noreactivity was determined by dividing each TLR3 scan into 4
equal quadrants (500 Km2) using the Image Pro Premier parent-
child application (Image Pro Premier; Media Cybernetics). We
deﬁned the nucleus and the cytoplasm (‘‘parent’’) and averaged
the measured area (Km2) of TLR3 immunoreactivity (‘‘child’’)
detected per cell for each of the thalamic and PLIC regions (33).
Data were analyzed using 1-way analysis of variance
followed by the Tukey multiple comparison test to compare
ratios in different thalamic nuclei and different regions of PLIC
between groups (WMI compared with controls). Data are pre-
sented as mean T SE; signiﬁcance was set at p G 0.05. All sta-
tistical analyses were performed using GraphPad Prism 6.0
(GraphPad Software, San Diego, CA).
Cellular localization of TLR3 was performed via semi-
quantitative analysis through the center of the contour of the
VLp region (Fig. 1A) because this thalamic region has neu-
rons with the largest cell bodies and thick ﬁbrous axons. An
average of 8 confocal double-labeled and triple-labeled micro-
photographs per case were captured for each analysis using a
Leica SP5 spectral confocal microscope. Microscope settings
were appropriate for the ﬂuorophores present, using a 63 ob-
jective (0.00598 mm2) to provide an average resolution of
75 nm, which allowed for optimal oversampling of the struc-
tures of interest. Colocalization was tested with Image J version
1.42 (National Institutes of Health, Bethesda, MD) at 3 points
TABLE 1. Primary and Secondary Antibodies Used for Immunolabeling
Antigen Catalog
Number
Source Species Concentration Target
TLR3 ab62566 Abcam (Cambridge, United Kingdom) Rabbit 0.1 Kg/mL TLR3
GFAP clone G-A-5 G3893 Sigma-Aldrich Co Ltd Mouse 1 Kg/mL Astrocytes and radial glial cells
Iba-1 019-19741 Wako Chemicals GmbH (Osaka, Japan) Rabbit 5 ng/mL Microglia and macrophages
Vesicular glutamate transporter-1 ab79774 Abcam Sheep 1 Kg/mL Vesicular glutamate transporter-1
Glutamate decarboxylase-67 ab26116 Abcam Mouse 1 Kg/mL GABAergic nuclear marker
Vesicular GABA transporter 131 011 Synaptic Systems GmbH
(Gottingen, Germany)
Mouse 1 Kg/mL GABAergic processes
Early endosome antigen-1 E7659 Sigma-Aldrich Co Ltd Mouse 1 Kg/mL Early endosomal marker
LAMP-1 ab3298 Abcam Mouse 2.5 Kg/mL Late endosomal/lysosome marker
Calreticulin LSB3131 LifeSpan Biosciences
(Nottingham, United Kingdom)
Chicken 1 Kg/mL ER lumen
LC-3-II ab65054 Abcam Sheep 5 Kg/mL Autophagosomal vacuoles
(autophagosome)
Mitochondrial antigen ab3298 Abcam Mouse 0.5 Kg/mL Mitochondrial antigen
IRF-3 sc-15991 Santa Cruz Biotechnology
(Santa Cruz, CA)
Goat 10 Kg/mL IRF-3
NeuN ABN90P Millipore (Temecula, CA) Guinea pig 0.3 Kg/mL Postmitotic neurons
HuC/HuD A21271 Life Technologies Mouse 2.5 Kg/mL All neurons (newly differentiated,
mature)
Biotinylated antibody BA2000 Vector Laboratories (Burlingame, CA) Mouse 7.5 Kg/mL
Biotinylated antibody BA1000 Vector Laboratories Rabbit 7.5 Kg/mL
ABC kit PK6200 Vector Laboratories Universal 1:200 Secondary antibodies for
immunofluorescenceAlexa Fluor 488 A10684 Life Technologies Mouse 4 Kg/mL
Alexa Fluor 488 A21202 Life Technologies Mouse 4 Kg/mL
Alexa Fluor 488 A11039 Life Technologies Chicken 4 Kg/mL
Alexa Fluor 488 A11055 Life Technologies Goat 4 Kg/mL
Alexa Fluor 488 A11015 Life Technologies Sheep 4 Kg/mL
Alexa Fluor 546 A11010 Life Technologies Rabbit 4 Kg/mL
Alexa Fluor 546 A10040 Life Technologies Rabbit 4 Kg/mL
Alexa Fluor 647 A21450 Life Technologies Guinea pig 4 Kg/mL
IRDye 800 Mouse 1 Kg/mL
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in the z-stack of each image by a student volunteer (Chloe
Suzanne Atkins) who was blinded to case data. All colocali-
zation duals performed were ﬁrst evaluated using the Costes
approximation test, which determined whether all randomized
images had worse correlation than real images to assure that
the similarity of shapes between 2 images was not attributa-
ble to chance. We continued with the Mander’s correlation
analysis. Data were analyzed with Student t-test using a Mann-
Whitney post hoc test between groups (WMI compared with
controls) in the VLp thalamus. Data are presented as mean T
SD; signiﬁcance was set at p G 0.05. All statistical analyses
were performed using GraphPad Prism 6.0.
Translocation of IRF-3 signal from the cytoplasm to the
nucleus was determined using the Image Pro Premier parent-
child application (Image Pro Premier; Media Cybernetics). In
brief, each case had an average of 50 nuclei (obtained using
a 63 objective on the confocal microscope) in the VLp re-
gion of the thalamus (Fig. 1A). The nuclear boundary was
determined by DAPI staining, and the threshold was maxi-
mized to achieve a solid object (‘‘parent’’). Next, IRF-3 inten-
sity was averaged using Leica-LAS Lite report for each stack in
all of the cases (i.e. WMI and controls). The average IRF-3
signal intensity was used to set the threshold minimum and
maximum to register how much signal (‘‘child’’) was found in
each nucleus (33).
In Situ Hybridization
Human TLR3 complementary DNA was cloned from
human brain total RNA by reverse transcriptionYpolymerase
chain reaction (Multiscribe; Applied Biosystems), as recom-
mended by the manufacturer. Second-round ampliﬁcation
was performed with REDTaq (Sigma-Aldrich, Dorset, United
Kingdom) and 0.5 Kmol/L forward (5¶-GCA AGA ACT CAC
AGG CCA GG-3¶) and reverse (5¶-GGG-CCA-CCC-TTC-GGA-
GC-3¶) primers using the following cycling parameters: 95-C
for 5 minutes, 1 cycle; 95-C for 30 seconds; 65-C for 30 sec-
onds; 72-C for 1 minute, 30 cycles; 72-C for 5 minutes. Each
complementary DNA product was directionally cloned into
TOPO II plasmid (Life Technologies, Carlsbad, CA), which
incorporates T7 and SP6 RNA polymerase promoters ﬂanking
the cloning region deﬁned by the XhoI or HindIII restriction
enzyme site. Plasmids were sequenced, linearized, and tran-
scribed with T7 (sense) or SP6 (antisense) RNA polymerases
(Sigma) to yield digoxigenin-dUTPYlabeled riboprobes in
accordance with the manufacturer’s protocol (Ambion, Life
Technologies). Transcription was performed for 24 hours at
37-C. The template complementary DNA was digested
away by RNase-free DNase (2 KL, 15 minutes), and the
riboprobes were puriﬁed (Megaclear Puriﬁcation and Filtra-
tion System; Ambion) and quantiﬁed by spectrophotometry and
electrophoresis.
FIGURE 1. Global view of the thalamus. (A) The strategies for the quantification of different cell populations and TLR3 expression
are demonstrated in Control 7 (28.2 weeks’ gestational age). Boxes represent the contours made in MD, VLp, and VPL thalamic
nuclei and in PLIC-VLp and PLIC-VPL. Throughout the study semiquantitative analyses were performed in the VLp region (dotted
lines in VLp). (B)The (averaged) cell density (hematoxylin positive nuclei/mm2) in MD, VLp, and VPL thalamic nuclei or in PLIC
regions did not significantly differ between controls and WMI cases. Scale bar = 1,000 Km. GPe, globus pallidus externa; GPi,
globus pallidus interna; LD, lateral dorsal; ZI, zona incerta.
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In Situ Hybridization Procedure
Riboprobes (0.1 mg/mL) were denatured (5 minutes,
90-C) and added to hybridization buffer (50% formamide,
Denhardt solution 50 g, 5 saline-sodium citrate, and salmon
sperm DNA 40 Kg/mL; Sigma-Aldrich Co Ltd, St Louis,
MO). Tissue sections were processed as described previ-
ously (30). Sections were permeabilized with proteinase K
(1Y10 Kg/mL, 37-C, 5 minutes; Sigma-Aldrich Co Ltd),
postﬁxed in 4% paraformaldehyde, and blocked in hybridi-
zation buffer (10 minutes, 80-C) to prevent nonspeciﬁc
binding. Sections were incubated with denatured riboprobes
(200 KL per section), and hybridization was allowed to con-
tinue overnight (58-C). After hybridization, the sections were
equilibrated in 5 saline-sodium citrate (15 minutes, room
temperature; NaCl 0.75 mol/L and Na-citrate 0.075 mol/L)
and washed in 2 saline-sodium citrate (30 minutes, 65-C).
Afterward, the sections were placed in alkaline phosphatase
buffer-1 (Tris-HCl 0.1 mol/L [pH 9.2], NaCl 0.1 mol/L, and
MgCl2 0.5 mmol/L) for 10 minutes and incubated for 2 hours
at room temperature with an alkaline phosphatase buffer-
1Ycoupled anti-digoxigenin antibody cocktail (1:500; Roche
Diagnostics Corp, Indianapolis, IN) containing a 0.5%
bovine serum albumin blocking reagent. Sections were
rinsed for 10 minutes in alkaline phosphatase buffer-1
followed by 2  5-minute rinses in alkaline phosphatase
buffer-2 (Tris-HCl 0.1 mol/L [pH 9.2], NaCl 0.1 mol/L, and
MgCl2 50 mmol/L) and visualized in nitro blue tetrazolium
in dimethylformamide and 5-bromo-4-chloro-3-indolyl
phosphate solution (Roche Diagnostics Corp) in 10 mL of
alkaline phosphatase buffer-2 with levamisole 1 mmol/L
(Sigma-Aldrich Co Ltd). The sense probe was used as neg-
ative control for speciﬁcity.
RESULTS
Glial Cell Morphology and Neuronal Counts
Differ Between WMI Cases and Controls
We ﬁrst evaluated total cell count with each assessment
of glia populations and neurons in control cases and in cases
with WMI. There was no difference in the average cell density
in thalamic regions or white matter regions between control cases
and WMI cases (Fig. 1B). We established that gestational age
or postmenstrual age had no effect on the total number of cells
in our regions of interest within the thalamus or white matter
regions, regardless of the presence of WMI (Supplemental
Digital Content 1, http://links.lww.com/NEN/A703; Data,
Supplemental Digital Content 2, http://links.lww.com/NEN/A704).
However, there was a signiﬁcant increase in the ratio of
astrocytes to total cell count in thalamic regions in WMI cases,
compared with MD (p G 0.01) and VLp (p G 0.01)Vbut not
VPLVthalamic regions in control cases. The astroglia ratio
increased in the corresponding white matter regions, PLIC-VLp
(p G 0.01) and PLIC-VPL (p G 0.05), in WMI cases compared
with controls (Table 2). Astroglia were hypertrophic with ﬁ-
brous and long extensive processes (Fig. 2B) in WMI cases
compared with those seen in the control group (Fig. 2A).
Next, we assessed Iba-1Ypositive microglial cells and
identiﬁed a signiﬁcant increase in WMI cases in the MD (p G
0.01), VLp (p G 0.01), and VPL (p G 0.05) thalamic regions
TABLE 2. Astroglia Ratios in All Regions
Region Control WMI p Value
MD 0.16 T 0.031 0.44 T 0.039 *
VLp 0.15 T 0.045 0.43 T 0.050 *
VPL 0.23 T 0.045 0.37 T 0.050 ns
PLIC-VLp 0.31 T 0.032 0.64 T 0.070 *
PLIC-VPL 0.28 T 0.061 0.53 T 0.043 †
Data are expressed as mean T SE.
Ratios are expressed as GFAP-positive cells/total cells.
* p G 0.01, difference in means between WMI and control.
† p G 0.05, difference in means between WMI and control.
ns, not signiﬁcant.
FIGURE 2. Glial and neuronal staining in VLp thalamic nuclei.
Astrocytes are less fibrous and less reactive in controls (A) than in
WMI cases (B). The astroglia ratio in the total cell population in
the MD region (p G 0.01), VLp region (p G 0.01), and adjacent
PLIC regions (PLIC-VLp nuclei, p G 0.01; PLIC-VPL nuclei, p G
0.05) was significantly different between WMI cases and control
cases. Different morphologies of microglia are seen in the VLp
thalamic region between controls (intermediate; C) and WMI
cases (amoeboidal;D). The microglia ratio increases significantly
in the MD (p G 0.01), VLp (p G 0.01), and VPL (p G 0.05) regions
and in PLIC-VPL. A decreased number of neurons in the MD (p G
0.05), VLp (p G 0.005), and VPL (p G 0.05) regions were seen in
WMI cases (F) compared with controls (E). Scale bars = (AYF)
300 Km; (insets) 10 Km.
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and in the adjacent white matter region PLIC-VPL (p G 0.05),
but not in PLIC-VLp (Table 3). Microglia in control cases
were more consistent with an intermediate morphology (with
extensive complex branching and rufﬂing; Fig. 2C), whereas
in WMI cases, microglia consisted of amoeboidal (round to
amorphous structures with a variety of short pseudopodia) and
intermediate morphologies (Fig. 2D).
Finally, we counted the HuC/HuD-positive neuronal
population in the thalamic and PLIC regions. There was a
signiﬁcant decrease in neurons in WMI cases in the MD (p G
0.05), VLp (p G 0.005), and VPL (p G 0.05) thalamic regions.
However, we found that, in the WMI group, there was a sig-
niﬁcant increase in neurons detected in PLIC-VPL (p G 0.05),
but not in PLIC-VLp (Table 4). Controls had mossy ﬁbrous
extensions protruding from cell bodies (Fig. 2E). In WMI
cases, there were less ﬁne ﬁbrous protrusions extending from
neuronal cell bodies, but axonal extensions were well de-
ﬁned (Fig. 2F).
Messenger RNA Expression of TLR3 IsWidespread
in WMI
Using in situ hybridization, we compared TLR3 mes-
senger RNA (mRNA) expression in the VLp thalamic region
between control cases and WMI cases. In controls, the VLp
region of the thalamus had faint cytoplasmic TLR3 mRNA
expression (Fig. 3A), whereas in WMI cases, the cytoplasmic
mRNA expression of TLR3 was very dense and granular,
which may be indicative of upregulation of TLR3 expression
in response to the surrounding injury (Fig. 3B).
Areas of TLR3 Immunoreactivity Are Increased
in WMI
The density of TLR3 mRNA differed between WMI
cases and controls. To ascertain whether this translated to a
change in TLR3 protein expression, we measured the area of
immunoreactivity. There was a signiﬁcant increase in TLR3
positivity inWMI cases compared with controls in the MD (p G
0.05), VLp (p G 0.05), and VPL (p G 0.01) thalamic regions and
in the adjacent white matter regions PLIC-VLp (p G 0.05) and
PLIC-VLp (p G 0.05) (Table 5). Among neurons in thalamic
regions (MD, VLp, and VPL) and neurons in PLIC, TLR3
immunoreactivity was globular and had a ribbon-like formation
in the perinuclear region in control cases (Fig. 3C). Although
WMI cases also showed TLR3 expression, there was more
punctate and granular staining seen outside the nucleus of cells
and extending along processes, in contrast to the more sporadic
localization seen in noninjured brains (Fig. 3D). TLR3 was
identiﬁed in the glutamatergic axonal region of Round Large
glutamatergic neurons (34) in controls (Fig. 3E) and WMI
cases (Fig. 3F). In contrast, TLR3 was not identiﬁed within
GABAergic neurons in the VLp thalamic region in controls
(Fig. 3G) and WMI cases (Fig. 3H).
IRF-3 Expression Is Perinuclear in Controls But
Nuclear in WMI Cases
Because the most substantial differences between WMI
cases and control cases were observed in the VLp region (i.e.
higher ratio of astrocytes and microglia with lower ratio of
neurons), we focused on this region to further investigate TLR3
signaling. Translocation of IRF-3 from the cytosol to the nu-
cleus is a reported consequence of TLR3 signaling (20). Be-
cause there was upregulation in the expression of TLR3
postinjury (Fig. 3), we used IRF-3 translocation as a surrogate
to investigate whether the increased expression correlated with
increased TLR3 function. To evaluate nuclear IRF-3 expres-
sion in the VLp thalamus, we deﬁned the nuclear boundary
with DAPI staining and measured the amount of immunore-
activity of antiYIRF-3 antibodies. We found that nuclear IRF-3
expression was markedly increased in WMI cases compared
with controls (WMI, 51.4 T 9.97, n = 7; controls, 7.2 T 1.4, n =
7; p G 0.01; Figs. 4AYC). This suggests that TLR3 elicited
more IRF-3 activation in WMI cases compared with controls.
TLR3 Is More Prevalent in the ER in WMI
Toll-like receptor-3 is known to be synthesized in the ER
(20). To study whether WMI altered the production of TLR3,
we performed immunoﬂuorescence colocalization studies
using TLR3 and an ER marker, calreticulin, in the VLp tha-
lamic region. Toll-like receptor-3 expression was frequently
identiﬁed with ER surfaces in WMI cases. Toll-like receptor-3
in control cases was sparsely identiﬁed in the ER but could be
seen weaving alongside the convolutions but not attached to
the ER. There was a signiﬁcant increase in the colocalization of
the ER (Fig. 5C) and TLR3 (p G 0.01) identiﬁed in the WMI
group (Fig. 5B) compared with the control group (Fig. 5A).
TLR3 Is Found in Late Endosomes in Controls
and WMI Cases
Because TLR3 is known to translocate to endosomes
on stimulation and because we observed an increase in the
TABLE 3. Microglia Ratio in All Regions
Region Control WMI p Value
MD 0.076 T 0.01 0.25 T 0.050 *
VLp 0.038 T 0.009 0.22 T 0.040 *
VPL 0.044 T 0.006 0.19 T 0.059 †
PLIC-VLp 0.120 T 0.022 0.17 T 0.009 ns
PLIC-VPL 0.076 T 0.021 0.25 T 0.050 †
Data are expressed as mean T SE.
Ratios are expressed as Iba-1Ypositive cells/total cells.
* p G 0.01, difference in means between WMI and control.
† p G 0.05, difference in means between WMI and control.
ns, not signiﬁcant.
TABLE 4. Neuron Ratios in All Regions
Region Control WMI p Value
MD 0.55 T 0.053 0.36 T 0.026 *
VLp 0.61 T 0.053 0.33 T 0.021 †
VPL 0.55 T 0.048 0.37 T 0.020 *
PLIC-VLp 0.12 T 0.013 0.16 T 0.013 ns
PLIC-VPL 0.10 T 0.015 0.19 T 0.028 ‡
Data are expressed as mean T SE.
Ratios are expressed as HuC/HuD-positive cells/total cells.
* p G 0.05, difference in means between WMI versus control.
† p G 0.005, difference in means between WMI versus control.
‡ p G 0.01, difference in means between WMI versus control.
ns, not signiﬁcant.
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FIGURE 3. (A, B) In situ hybridization of TLR3 in the VLp thalamus. TLR3 mRNA was detected mainly in neurons. (A) TLR3 mRNA
expression was very punctate in controls, whereas TLR3 in situ hybridization was dark and granular in WMI cases (B). (C, D) Protein
expression of TLR3 in VLp thalamic nuclei in cases with and without WMI. In a case without any known pathology, staining was
globular and perinuclear (C), whereas in a case with WMI, staining had a granular and diffuse morphology (D). White matter injury
cases had a significant increase in the area (Km2) of TLR3 immunoreactivity in all regions of interest (MD nuclei, p G 0.05; VLp
nuclei, p G 0.05; VPL nuclei, p G 0.01; white matter in PLIC-VLp, p G 0.05; white matter in VPL, p G 0.05). Double labeling for TLR3
and glutamate synaptic vesicle protein (vesicular glutamate transporter-1 [VGLUT-1]) shows that TLR3 is more widely expressed in
glutamatergic neuronal processes (VGLUT-1; E, control; F, WMI case) than in GABergic neurons processes identified with
antiYglutamate decarboxylase-67 (GAD67) and antiYvesicular GABA transporter (VGAT; G, control; H, WMI). Scale bars = (A, B,
EYH) 20 Km; (D, C) 100 Km.
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expression of TLR3 in the ER in WMI (Fig. 5B), we per-
formed colocalization studies of TLR3 with early endosomal
antigen-1 and late endosome markers (lysosome-associated
membrane protein-1 [LAMP-1]). In contrast with previous
studies using dendritic cells (20), we found that TLR3 ex-
pression colocalized with late endosomal makers (p G 0.05;
LAMP-1), but not with early endosomal antigen-1 (data not
shown). Colocalization between LAMP-1 and TLR3 was
signiﬁcantly higher in WMI cases (Fig. 5E) compared with
controls (Fig. 5D), suggesting that WMI stimulates excessive
DAMP production and, as a consequence, upregulates the nec-
essary clearance mechanisms (Fig. 5F).
Increase in Autophagy in WMI
Besides showing the role of TLR3 in endosome-mediated
degradation, very recent studies have implicated Toll/IL-
1Yinducing interferon-A nuclear and, by association, TLR3 in
autophagy (35Y37). Indeed, another nucleic acidYsensing TLR,
TLR9, has been implicated in a noncanonical autophagy pathway
known as microtubule-associated protein light chainYassociated
phagocytosis, where rapid recruitment of microtubule-associated
protein light chain to phagosomes facilitates fusion with lyso-
somes (35, 38). Therefore, we examined the colocalization
of TLR3 with microtubule-associated protein light chain 3B
(LC-3-II), a marker of autophagosome formation. In all of the
cases, TLR3 colocalized with the LC-3-II marker of autophagy,
but there was no difference in the degree of colocalization
(Fig. 6G) between WMI cases (Fig. 6D) and controls (Fig. 6A).
TABLE 5. TLR3-Immunopositive Areas
Region Control WMI p Value
MD 22 T 2.3 62 T 12 *
VLp 26 T 5.4 63 T 6.8 *
VPL 23 T 4.4 65 T 12 †
PLIC-VLp 8.9 T 2.5 45 T 4.5 *
PLIC-VPL 18 T 3.1 54 T 8.3 *
Data are expressed as mean T SE.
Ratios are expressed as TLR3 immunoreactivity areas (Km2) in WMI cases and
controls.
* p G 0.05.
† p G 0.01.
FIGURE 4. Localization of IRF-3. Immunoreactivity of IRF-3 (green) and TLR3 (red) in a control (A) and a WMI case (B). (A)
Expression of IRF-3 is outside the nuclei (DAPI; blue), whereas IRF-3 expression is more nuclear (yellow arrowhead) in the WMI case
(B). The blue arrow points to IRF-3Ypositive structures that colocalize with astrocyte processes in the WMI case. Side panels show
separate channels for TLR3, IRF-3 with DAPI, and GFAP. The panels below the images are orthogonal views imaged within the z-
plane. (C) Graph illustrates an increase in the percent area of nuclei that has IRF-3 expression in WMI cases compared with control
cases. ** p G 0.01. Scale bars = (A) 13 Km; (B) 20 Km.
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An increase in the staining of LC-3-II was observed in WMI
cases compared with controls, suggesting not only that TLR3
is localized on the autophagosome but also that WMI may in-
crease autophagy as a possible alternative protective mechanism.
Mitophagy Increases After WMI
Finally, because autophagy seemed to be upregulated in
WMI, we determined whether a subset of this recycling mech-
anism (mitophagy) was also altered. Mitochondrial dysfunction
has been implicated in the development of brain injury in term
and preterm infants (39), and mitochondria have had an in-
creasing role as a platform for innate immunity (12, 40).
Mitophagy (or recycling of damaged mitochondria) would
therefore represent a potential mechanism for cell survival.
Therefore, we assessed the colocalization of LC-3-II, TLR3, and
mitochondrial antigen. Interestingly, we found that there was a
signiﬁcant increase in the colocalization of antiYLC-3-II immu-
noreactivity with TLR3 and mitochondria in WMI (p G 0.001;
Figs. 6H, I), suggesting that, after WMI has occurred, induced
autophagy (a catabolic response) occurs to free the cell of dam-
aged proteins and organelles, including mitochondria.
DISCUSSION
In this study, we have identiﬁed TLR3 expression in
different cellular components of neurons in the preterm neonatal
human brain; to the best of our knowledge, this is the ﬁrst time
that this family of receptors has been demonstrated in neurons
of the thalamus in the neonatal human brain. Our results are
compatible with the model outlined in Figure 7, which de-
scribes how TLR3 responds to an increase in endogenous
DAMPs being released after WMI has occurred. It is still un-
known whether there is a cause-effect relationship between
WMI and TLR3 alterations in the thalamus, or whether the
exposure causing WMI also induces cellular stress in thalamic
nuclei with subsequent changes in TLR3. We showed that, in
the neurons of the VLp thalamus, there was an increase in
FIGURE 5. Confocal photomicrographs demonstrating the colocalization of TLR3 within the ER and late endosomes. Confocal
images with anti-TLR3 (red) and an ER marker (green; anti-calreticulin) differ between controls (A) and WMI (B) cases. The average
correlation value for the TLR3-calreticulin overlap in WMI cases is significantly higher than that observed in controls (C) (** p G
0.01). In contrast, TLR3 and the late endosomal marker (LAMP-1; green) from the ventrolateral region of the thalamus colocalize in
control cases (D) and WMI cases (E). Toll-like receptor-3 is more prevalent in late endosomes than in early endosomes (F; * p G
0.05). Anti-NeuN (neuronal marker; purple) was added to identify neurons and is shown in the side panels along with individual
antigens and the orthogonal view. Scale bars = (A) 15 Km; (B) 8 Km; (D, E) 20 Km. EEA-1, early endosome antigen-1.
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FIGURE 6. Confocal photomicrographs demonstrating the distribution of TLR3 (red), antiYmicrotubule-associated protein light
chain (LC-3-II) (green), and mitochondria (antiYmitochondrial antigen; white) from the VLp thalamic region in a control case (AYC)
and a WMI case (DYF). The immunoreactivity of LC-3-II increased after WMI, but LC-3-II and TLR3 equally colocalized (G) in WMI
cases (D) and controls (A). The colocalization of LC-3-II and mitochondria is significantly higher in WMI cases (E) than in controls
(B), suggesting that mitophagy may be occurring (H). In the control case, TLR3 is located densely around the nucleus but does not
colocalize with the mitochondria (C), whereas in the WMI case, TLR3 expression seems to be localized with the mitochondria but
only in conjunction with LC-3-II expression (F, I). *** p G 0.001. Bottom images show orthogonal views within the z-stack. Scale
bars = (AYC) 16 Km; (DYF) 14 Km.
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the mRNA expression of TLR3, which translated to protein
synthesis in the ER in cases with WMI. Furthermore, there
was an increase in autophagy and lysosomal proteins in WMI
cases, whereas in controls, TLR3 mainly colocalized with late
endosomes. Moreover, these ﬁndings imply that neuronal
TLR3 increased and was activated via the Toll/IL-1Yinducing
interferon-A nuclear pathway because IRF-3 was translocated
to the nucleus in association with adjacent WMI.
Gestational ages at birth were similar in the WMI and
control groups, but survival was longer in the WMI group. We
cannot exclude the possibility that WMI would have developed
in some control cases had they lived longer, but we looked at a
very early time point before any established disease could be
detected. Nevertheless, our data suggest that TLR3 expression
was altered in the presence of overt WMI in the preterm brain.
Thalamic Nuclei Segregation and
Pathologic Findings
Previous studies focused on the MD region have shown
that atrophy in the thalamus is associated with selective
microstructural abnormalities (41). Although segregating the
different regions of the ventral thalamic nuclei is an arduous
undertaking (32, 42), we were able to use lateral anatomic
landmarks from the globus pallidum and the established
cytoarchitecture (31) of the different thalamic regions to deﬁne
3 regions of interest. It is imperative that future histologic in-
vestigations on preterm neurologic function include deﬁned
thalamic regions. For example, reductions of the MD and
pulvinar thalamic regions have been strongly associated with
abnormal cognitive outcomes and have been identiﬁed in pre-
term infants with WMI (8, 10). Preterm birth also is associated
with a high risk of a range of motor impairments, and the se-
verity of motor impairments increases with WMI (43) in part
because the sites of periventricular infarcts lie in the motor
pathways (44). Hence, after WMI has occurred in preterm ne-
onates, there may be pathologic processes in speciﬁc thalamic
regions that may be correlated with cognitive and motor
impairments.
Our investigation substantiates the ﬁndings of other
studies that have identiﬁed abnormalities in the thalamus of
FIGURE 7. Cartoon depicting the proposed pathway of TLR3 activation after WMI and in controls. TLR3 are synthesized in the ER.
TLR3 production is increased in response to DAMPs and stays on ER fragments that are recruited to form phagophores. The
phagophore elongates, forming the microtubule-associated protein light chain (LC-3-II)Ypositive autophagosome, which engulfs
DAMPs and fuses with the lysosome, where components such as mitochondria are recycled. TLR3 is upregulated in the ER and
autophagosomal components in response to WMI, suggesting that another method of cellular adaptation to WMI may include
autophagy. Another pathway for recycling damaged components is via endosomes. As endosomes mature, TLR3 is recruited to late
endosomes (LAMP-1), and components of macromolecules are acidified as they fuse with the lysosome. TLR3 is present in
endosomes in control and WMI tissues, where it responds to DAMPs. This response is exaggerated after WMI. Activation of TLR3
also results in the recruitment, nuclear translocation, and subsequent activation of IRF-3, which regulates the production of
type I interferons.
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preterm infants with WMI. Ligam et al (10) found reactive
astrocytes in the MD region and in the reticular nucleus (a
structure that surrounds and modulates the lateral thalamic
nuclei [32] with GABAergic neurons) of preterm postmortem
cases with WMI. In the present study, we demonstrate an in-
crease in the ratio of astrocytes in the MD and VLp thalamic
nuclei to astrocytes in adjacent PLIC among WMI cases.
Normally in gray matter, protoplasmic astrocytes ex-
hibit short and highly branched processes and possess a large
quantity of organelles. In WMI cases, astroglia were hyper-
trophic, with extensive processes and greater expression of
GFAP, which is indicative of a reactive form that may pro-
mote a prolonged proinﬂammatory response (45, 46).
In conjunction with an increase in astroglia, we found
an increase in microglia in MD, VLp, and VPL thalamic nu-
clei and in PLIC-VPL in WMI cases. These ﬁndings are in
line with previous studies that correlated pathology in the
surrounding white matter structures with abnormalities seen in
the thalamus (8, 47). In inﬂammatory injury of the preterm
brain, such as in WMI, there is an inﬂux of activated mi-
croglia (48). Microglia and astroglia respond to the injury and,
on activation, release proinﬂammatory cytokines such as tu-
mor necrosis factor, interleukin-6, interferon-F, and nitric
oxides (49).
As glial cells increased, we observed decreases in the
neuronal populations in MD, VLp, and VPL thalamic nuclei
in WMI cases. The neuronal loss in VLp nuclei substantiates
studies of preterm cases that described WMI as impairing
motor coordination of the limbs (43). Residual damage frag-
ments released during WMI (or some cell injury locally in the
thalamus) may continuously activate TLR3 as it responds to
endogenous stimuli (50) in neuronal and astroglial populations
(51). Further studies correlating thalamic abnormalities warrant
more detailed investigation to comprehend motor and cognitive
deﬁcits associated with preterm pathologies.
TLR3 Molecular Mechanism
Previously, Johnsen et al (20) found that c-Src tyrosine
kinase in dendritic cells is activated by dsRNA viral stimuli in
the ER, where it recruits TLR3, mediates TLR3 translocation
to endosomes, and induces various signaling cascades. The
ER contains resident proteins such as calnexin and calreticulin
(52), which serve as chaperones; unstimulated TLR3 was
shown to colocalize with these resident proteins. Stimulated
TLR3 colocalized with LAMP-1, which identiﬁes late endosomes
and lysosomes (20). Another possible platform for TLR3 acti-
vation is the phagaphore, which works in conjugation with LC-
3-II to form the autophagosome (an important mediator to
autophagy and mitophagy, i.e. degradation of damaged pro-
teins and dysfunctional mitochondria) (12, 22, 53).
We have demonstrated that TLR3 was present in
endosomes in controls and WMI cases and colocalized with
LAMP-1, most likely as part of molecular surveillance for
extracellular DAMPs and pathogen-associated molecular
patterns. Another source of surveillance and degradation may
be autophagy, as TLR3 colocalized with LC-3-II. Expression
of LC-3-II increased in WMI; autophagy is particularly im-
portant in long-lived cells like neurons, and impairments in
autophagy are associated with abnormal central nervous sys-
tem development and neurologic impairment (12).
In conclusion, identifying changes in TLR3 expression
associated with WMI may improve our understanding of the
molecular mechanisms associated with impaired development
in preterm infants.
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